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ABSTRACT 
 
Background: Exercise exerts its beneficial effects on the cardiovascular system not just 
through reducing the burden of cardiovascular risk factors, but also by directly affecting 
the cellular structure and function of the heart. An elevation in workload imposed on the 
heart can occur either by exercise training, which is transient and non-pathological or by 
cardiovascular disease, which is chronic and pathological. Cardiomyocytes are the cells 
that make up the cardiac muscle and have a high mitochondrial density. As the heart 
grows and approaches maturity, the cardiomyocytes progressively lose their mitotic 
activity, and hypertrophy of myocytes becomes the principal process of cardiac 
enlargement. However, recent evidence suggests that cardiomyocyte proliferation may 
play an unrecognized role during the period of developmental heart growth between birth 
and adolescence. Exercise interventions during a critical window of development, such 
as that seen in juvenile or adolescent growth, may elicit a ‘reprogramming’ effect in the 
heart when it is undergoing rapid growth and plasticity during these times. The aims of 
this thesis were therefore to firstly investigate whether the effects of endurance training 
during juvenile life will improve cardiac output and left ventricle wall thickness, 
dimensions and heart mass, as well as cardiomyocyte number and size, without altering 
fibrosis. A further key aim was to establish the juvenile period (5-9 weeks of age) as a 
unique stage for short term endurance exercise-induced physiological cardiac growth in 
adulthood by comparing the juvenile exercise group with adolescent and adult groups. 
The third aim was to quantify the mRNA and miRNA expression to investigate the likely 
mediators of juvenile exercise-induced pathways in the adult heat. 
Methods: Male Wistar Kyoto rats were trained on a motorized treadmill at 20m/min 
(1h/day), 5 days/week for 4 weeks. Training was conducted in either juvenile (5-9 weeks 
old), Adolescent (11-15 weeks old) or adult (20-24 weeks old) rats, and compared to 
sedentary rats. Food intake over 24-hours was measured at 7, 13, 16 and 24 weeks of age. 
Indirect calorimetry and physical activity was measured by CLAMS (Comprehensive 
laboratory animal monitoring system) at 18 weeks of age. Cardiac structure and function 
were assessed at 9 and 24 weeks of age using transthoracic echocardiography. At 9 or 24 
weeks of age rats were anaesthetized with intraperitoneal Ilium Xylazil-20 (30 mg/kg) 
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and Ketamine (100mg/kg), and either perfusion-fixed with the hearts excised for 
morphological analysis, or frozen in liquid nitrogen for mRNA and miRNA analyses. The 
total number of cardiomyocytes was stereologically measured, and the proportion of 
mononucleated and binucleated cardiomyocytes, longitudinal and cross-sectional 
cardiomyocyte area and levels of myocardial fibrosis determined using confocal 
microscopy and image analysis. Cytochrome oxidase activity was measured 
spectrophotometrically. RNA was extracted, reverse transcribed, optimised and mRNA 
and miRNA expression levels were measured using real-time PCR.  
Results: At 9 weeks of age, juvenile exercise increased heart mass (P=0.0004; 25%), 
posterior wall thickness (P<0.05; 17%), relative wall thickness (P<0.05; 11%), 
cardiomyocyte number (P<0.0001; 40%), cross sectional and longitudinal areas 
(P<0.0001) and doubled the proportion of mononucleated cardiomyocytes (P=0.0007). 
At 24 weeks of age, juvenile exercise rats sustained the exercise effects after a detraining 
period of 15 weeks with increased heart mass (P<0.05; 18%), posterior wall thickness 
(P<0.05; 15%), relative wall thickness (P<0.05; 6%), cardiomyocyte number (P=0.0037; 
36%), and longitudinal area of binucleated cardiomyocytes (P<0.0001). No changes in 
heart contractility and function at rest were detected. Adolescent exercise also increased 
heart mass (P<0.05; 18%), posterior wall thickness (P<0.0001; 15%) and relative wall 
thickness (P<0.0001; 11%), but it did not alter cardiomyocyte number in adulthood. 
However, the size of binucleated cardiomyocytes and the proportion of mononucleated 
cardiomyocytes increased (P<0.05). Adult exercise training also increased heart mass 
(P<0.0001), wall thickness (P<0.0001), and cardiomyocyte size (P<0.05) despite no 
change in cardiomyocyte number. When compared to sedentary rats, adult exercise 
training increased posterior wall thickness (P<0.0001; 6%), relative wall thicknesses 
(P<0.0001; 5%) and interventricular septum thickness (P<0.001). Juvenile and adult 
exercise training did not alter heart function, left ventricle chamber dimensions and 
fibrosis. The juvenile as well as the adult exercise did not reveal any specific gene (except 
coxIV for the juvenile exercise group) or miRNA species to be differentially regulated in 
the adult heart. However, juvenile exercise at 9 weeks of age differentially regulated the 
expression of miRNA-1 and miRNA-133b, with the expression of miR-1 being reduced 
(P<0.05) and miRNA-133b increased (P<0.05). Furthermore, adult exercise increased the 
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expression of miRNA-1 (P<0.05) and reduced the expression of miRNA-208b (P<0.05) 
and miRNA-222 (P<0.05) at 24 weeks of age.  
Conclusion: In summary, this study is the first to unveil the regenerative potential of 
juvenile exercise training in the adult heart, with novel findings of increased 
cardiomyocyte number, which may be due to proliferation without inducing fibrosis or 
cardiac dysfunction in the hypertrophied left ventricle. The findings suggest that the 
juvenile period in rats is a unique stage of heart growth that is amenable to long-term 
cardiac programming by short-term endurance training, with only juvenile exercise 
training leading to sustained increases in heart mass, wall thickness and cardiomyocyte 
number into adulthood despite 15 weeks of detraining. The changes in heart structure in 
all exercise groups suggest concentric hypertrophy. These findings demonstrate that the 
physiological cardiac adaptation produced by four weeks of juvenile exercise training 
persist into adulthood, and may protect against cardiovascular disease in later life. Further 
studies are now required to examine markers of cardiomyocyte proliferation and gene 
array to characterise the mechanisms of this profound effect in the heart. 
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CHAPTER 1 Review of the literature 
1.1 Introduction 
1.1.1 Cardiovascular disease and physical activity 
Cardiovascular disease (CVD) includes conditions such as coronary heart disease, heart failure, 
cardiomyopathy, congenital heart disease, peripheral vascular disease and stroke (Talbot et al. 
2002). According to the WHO 2012, CVD kills an estimated 17 million people each year 
worldwide. It is also one of the largest health problems in Australia and is the leading cause of 
death (Barker 1995). One Australian every 12 minutes is killed by CVD and about 3.5 million 
people in Australia are reported having the condition in 2007-08 (Barker 1995). CVD causes more 
deaths than any other disease (about 50,000 in 2008) despite significant advances in its treatment 
and management (Gerche et al. 2014). Treatment of CVD was the most expensive treatment in 
2004-2006 costing about $5.9 billion (Gerche et al. 2014). According to the demographic aging 
trends of 2011, the prevalence of CVD in Australia will grow to 24.2% of the population by 2051, 
which is about 6.4 million people (Gerche et al. 2014). CVD is mostly caused by risk factors that 
are controllable, treatable or modifiable. From the past two decades, international epidemiological 
evidence identifies physical activity as a major modifiable risk factor that can protect against CVD 
(Sahara et al. 2015). Furthermore, the Ehsani et al. (1978) estimates that more than 60% of the 
global population is physically inactive. According to the Australian Heart Foundation, 54% of 
18-75 year olds (approximately 7.3 million people) have insufficient physical activity levels and 
do not achieve the health benefits of exercise (Wadhwa et al. 2009). 
The heart has the ability to increase its size in response to internal or external stimuli and this 
increase in heart mass is termed cardiac hypertrophy (CH). Enlargement of the heart depends on 
the stimulus and results in either physiological or pathological hypertrophy. Pathological 
hypertrophy is associated with increased interstitial fibrosis, cell death, and cardiac dysfunction 
(Bernardo et al. 2010; Weeks et al. 2011). In contrast, physiological CH is the heart growth that 
occurs in response to exercise training, (also termed ‘athlete's heart’), is reversible and is 
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characterised by normal or enhanced cardiac function and cardiac morphology, with no fibrosis or 
apoptosis (Bernardo et al. 2010; Weeks et al. 2011).  
1.1.2 Endurance exercise and cardiovascular changes 
Endurance exercise has well-known effects on cardiac remodeling and cardiac function (Kemi et 
al. 2010; McMullen et al. 2007b; Xu et al. 2008). Endurance-trained hearts are subjected to 
increased volume and pressure loading which leads towards physiological hypertrophy with 
specific myocardial changes such as left ventricular (LV) dilatation and increased LV mass 
(Iemitsu et al. 2005; Pluim et al. 2000; Waring et al. 2012), LV wall thickness and LV cavity size 
(Iemitsu et al. 2005; Pluim et al. 2000; Rodriguez et al. 2010).  Cardiovascular adaptation to regular 
exercise is highly dynamic. For example, in rats, following cessation of training the heart reverts 
back to pre-training size in as little as 2 weeks . With detraining, most of the exercise-gained 
aerobic fitness acquired over 2 to 3 months is lost within 2 to 4 weeks. Early exercise training 
during a critical period of growth and development can exert a ‘reprogramming’ effect on the 
heart. Recently, (Wadley et al. 2016) reported the surprising findings of an approximate 10% 
increase in heart mass of adult rats who were endurance trained in their juvenile life (at 5-9 weeks 
of age) (Figure 1.1) despite remaining sedentary  between 9 to 24 weeks of age (early adulthood) 
when compared to untrained rats. The study concluded this effect to be physiological hypertrophy 
of the heart as there was no evidence of the development of hypertension in adult life (Wadley et 
al. 2016). However, changes in heart structure and function were not examined in the study by 
Wadley et al. (2016) and these analyses are required in order to provide a deeper insight into the 
short-term effects of endurance exercise on the heart in early life. This thesis will be conducted on 
the basis of this novel link between juvenile exercise and its sustainable effects on heart mass in 
adult life. 
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Figure 1.1: Exercise in Juvenile life increases relative heart mass in adulthood  
(Juvenile Ex, 5-9 weeks old and Adult Ex, 6 months old), Adapted from (Wadley et al. 2016). 
The overall aim of this thesis is to examine the impact of exercise performed in juvenile life on 
adult heart structure, function, morphology, gene and micro RNA (miRNA) expression. The 
following review will discuss findings of animal and human studies investigating the impact of 
endurance training on adult heart structure, function, cardiomyocyte growth, gene and miRNA 
expression. Firstly, this review will discuss cardiac development in neonatal and postnatal life, 
including the structural, functional and morphological differences of pathological and 
physiological hypertrophy. The review will then examine the effects of exercise and detraining on 
adult heart structure and function. Furthermore, the review will examine the current knowledge of 
growth and proliferation of cardiomyocytes both in normal development and in response to 
endurance training. Finally, expression of genes and miRNAs involved in both physiological and 
pathological cardiac hypertrophy will be discussed. At the end of the review, the project rationale, 
aims and hypothesis of this thesis will be discussed. 
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1.2 Developmental origins of health and disease  
A number of late life disorders are linked to early life factors including lifestyle, dietary habits and 
physical activity levels (Gluckman et al. 2009). These include diseases such as CVD, obesity, 
diabetes, metabolic disturbances, osteoporosis, chronic obstructive lung disease, mental illnesses 
and cancer (Gluckman et al. 2009). Exposure to a poor predisposes children to the development of 
disease later in life (Hanson et al. 2011). For instance, the developmental changes including 
physiology, structure, immunology, metabolism and behavior could be determined by the early 
life stages such as pregnancy, lactation, and childhood (Geddes et al. 2013). It is, therefore, 
important to create disease-prevention strategies in early life that could substantially impact health 
in later life (Geddes et al. 2013).  
The developmental origins of health and disease (DOHaD) concept describes a relationship 
between conception, infancy or early childhood and the environment (Hanson et al. 2011). It 
describes environmental factors that induce changes in the early developmental stages of life which 
have consequences on health and disease susceptibility in later life. Factors including smoking, 
obesity, lifestyle, diet and exposure to toxins, have been shown to affect endocrine functions 
(Hanson et al. 2011). The effect of such environmental could be subtle, yet result in the disruption 
of normal development and the acceleration of disease. There are a number of studies which 
suggest that both fetal and postnatal environments affect the developing heart. At birth, reduced 
heart weight is linked to an increased risk for the development of CVD (Black et al. 2012; Wlodek 
et al. 2007; Wlodek et al. 2008), and low birth weight in combination with postnatal growth is 
related to cardiac diseases in adult life (Adair et al. 2003; Cournil et al. 2009; Leeson et al. 2001). 
Mayhew et al. (1999) studied the effect of intrauterine growth restriction on the heart in humans. 
The study was conducted on growth restricted fetuses and babies that had either died during 
gestation or up to 42 days after birth. The intrauterine growth restricted offspring exhibited slower 
ventricular growth along with reduced volume of cardiomyocytes (Mayhew et al. 1999). In 
animals, Wlodek et al. (2008) showed that adverse environmental factors including both prenatal 
and early postnatal growth restriction program an increased risk for cardiovascular and renal 
diseases in later life. Corstius et al. (2005) also showed that a low protein diet restricts heart growth 
and reduces cardiomyocyte number in the next generation. Furthermore, the intrauterine growth 
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restricted offspring exhibited slower ventricular growth along with reduced volume of 
cardiomyocytes (Bubb et al. 2007). Similarly, restriction of growth by uteroplacental insufficiency 
reduced cardiomyocyte number by 29% in 1-week old male offspring (Black et al. 2012). This 
suggests that adverse intrauterine and, or postnatal environments are detrimental to cardiovascular 
health of the offspring (Gluckman et al. 2009). On the other hand, physical activity promotes 
growth and development while reducing the risk for heart disease, high blood pressure while also, 
improving other aspects of health including aerobic capacity and muscle strength (Barker 1993). 
Disease risk factors and health-related behaviours track from childhood to adulthood, indicating 
that early and ongoing opportunities for physical activity are needed for maximum health benefit 
(Barker 1993). Recent evidence also suggests that positive environmental factors such as exercise 
might confer beneficial programming effects for contractile tissues such as the heart (Wadley et 
al. 2016). 
There are critical periods during development in which a system or organ gain maturity which 
could be a short period, and occur at certain periods for different systems (Hanson et al. 2011). 
According to (Hanson et al. 2011), humans may have heightened regenerative capacity during 
early development, and could be influenced permanently by the structural and functional changes 
in the body; such phenomenon is called ‘programming’ (Hanson et al. 2011; Sahara et al. 2015). 
Reprogramming is the ‘‘ability of a single genotype to produce more than one alternative form of 
structure, physiological state or behaviour in response to the condition of the environment’’ 
(Hanson et al. 2011; Laube et al. 2006). For example, exercise training of juvenile rats leads to 
increases in heart weight that can be maintained into adulthood (Wadley et al. 2016). Also, Waring 
et al. (2015) highlighted the endogenous regenerative capacity of the adult heart by demonstrating 
that exercise during adolescent life increased cardiomyocyte number. This suggests that there may 
be a critical growth period in life that allows reprogramming in the heart by endurance exercise. 
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1.3 Cardiac development 
The heart is made up of different cellular components including fibroblasts, cardiomyocytes, 
endothelial and vascular smooth muscle cells (Banerjee et al. 2007). Heart development begins 
with the formation of two endocardial tubes which merge to form the tubular heart (the primitive 
heart tube) (Moorman et al. 2003). The heart tube loops and separates into the four chambers and 
paired arterial trunks that form the adult human heart (Franco et al. 1998; Moorman et al. 2003). 
The heart is the first embryonic organ to function, with contraction of the heart requiring the 
expression of a specific set of proteins that form the contractile apparatus called sarcomeres 
(Franco et al. 1998). The heart muscle is referred to as myocardium and is made up of specialized 
cells called cardiomyocytes. Heart muscle makes up the muscle layer of the right and left 
ventricles. The cardiomyocytes are responsible for the continuous rhythmic actions that generate 
the contractile forces and control perfusion levels to ensure adequate delivery of blood to all tissues 
in the body (Buja et al. 2008; Liao et al. 2012). Cardiomyocytes are round-shaped during neonatal 
life after which they change morphology to a characteristic rectangular shape upon adulthood 
(Geisse et al. 2009; Grosberg et al. 2011; Kuo et al. 2012). 
1.3.1 Cardiomyocytes 
Cardiomyocytes represent about 85% of the LV mass (Frey et al. 2004; Maillet et al. 2013). Each 
cardiomyocyte consists of myofibrils which are the contractile units of muscle cells and are made 
up of long chains of sarcomeres (Torrent-Guasp et al. 2005). Cardiomyocytes have a high density 
of mitochondria which produce ATP and are highly resistant to fatigue (Torrent-Guasp et al. 
2005). The fibers of cardiomyocytes must be flexible and capable of shortening and lengthening 
in order to allow beating of the heart (Torrent-Guasp et al. 2005). Cardiomyocytes are capable of 
increasing in number (proliferation) before birth after which they terminally segregate or 
differentiate in early postnatal life (Maillet et al. 2013). Consequently, in postnatal life the heart 
increases primarily through the hypertrophy of individual cardiomyocytes. However, under some 
conditions there is evidence to suggest that that heart mass in the postnatal life may also increase 
through other mechanisms including proliferation of fibroblasts, the renewal of cardiomyocytes, 
and perhaps also via the activity of progenitor cells (Maillet et al. 2013). In fact, Maillet et al. 
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(2013) showed that there is a turnover of cardiomyocytes due to proliferation, which occurs in 
postnatal life but at very low levels. 
1.3.2 Cardiomyocyte development in prenatal, neonatal and postnatal life 
Prenatal cardiac growth and development in humans and animals is categorised by the rapid 
proliferation of cardiomyocytes which is known as hyperplasia (Xie et al. 2013). In the prenatal 
period, essential processes occur in the cardiomyocyte including mitosis, cytoplasm differentiation 
and myofibril synthesis (Senyo et al. 2014). Cardiomyocytes are mononucleated during this period 
where one nucleus resides centrally positioned in the cell. Hyperplasia increases mononucleated 
cardiomyocyte number in the myocardium, resulting in the gradual development of the heart (Xie 
et al. 2013).  
After birth, the neonatal heart begins to undergo remodellings due to an increase in systolic 
pressure. This remodelling results in increased wall thickness and stiffness and is thought to be 
caused by fibroblast proliferation and concomitant formation of collagen fibrils (Lajiness et al. 
2012; Norris et al. 2008). This increase provides a potential “contact-signaling” of the 
cardiomyocytes and the fibroblasts. This is required as this prepares the postnatal heart wall for a 
structural adaptation required after birth (Lajiness et al. 2012; Norris et al. 2008). 
In mammals is is unclear if postnatal heart has regenerative capability or if it is switched off soon 
after birth. Other species including fish and amphibians retain a capacity in postnatal life for 
cardiac regeneration (Porrello et al. 2011). The human heart was only recently recognized as 
capable of cardiomyocyte regeneration in postnatal life (Bergmann et al. 2009). During the Cold 
War, carbon-14 was generated with nuclear bomb testing and was integrated into human 
Deoxyribose nucleic acid (DNA) which was used to establish the age of cardiomyocytes 
(Bergmann et al. 2009). Cardiomyocyte renewal can occur postnatally in humans, with gradual 
progressive decrease from 1% turnover per year until 20 years of age to 0.3% turnover per year 
between the age of 20 to 75 years (Bergmann et al. 2009). Following partial cardiac surgical 
resection, neonatal mice have been shown to have regenerative potential in the first day of life, 
however this regenerative capacity was shown to be lost after 7 days of age (Porrello et al. 2011). 
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The renewing potential in 1day old mice was not a repair process as the regeneration was 
categorized by cardiomyocyte proliferation without significant hypertrophy or fibrosis (Porrello et 
al. 2011). Cardiomyocyte renewal was further confirmed by genetic fate mapping with the majority 
of cardiomyocytes within the regenerated tissue found to be derived from already existing 
cardiomyocytes (Ali et al. 2014; Porrello et al. 2011; Senyo et al. 2014). Moreover, Mollova et al. 
(2013) showed that cardiomyocyte proliferation contributes to developmental heart growth in 
young humans and suggested that children and adolescents may be able to regenerate myocardial 
tissue. Mollova et al. (2013) suggested that abnormal cardiomyocyte proliferation could be 
involved in myocardial diseases and that these diseases might be treatable through stimulation of 
cardiomyocyte proliferation. Collectively, these above studies indicate that cardiomyocyte 
turnover in postnatal life occurs in both humans and rats; and are suggestive of a regeneration 
capability of heart in later life. 
1.3.3 Cardiomyocyte proliferation and hypertrophy 
In mammals, the heart grows markedly between the immediate post-neonatal period and puberty 
(Alkass et al. 2015; Naqvi et al. 2014). If cardiomyocytes are terminally differentiated, this growth 
should be almost entirely due to an increase in the volume of cardiomyocytes, which throughout 
post-neonatal life accounts for 80% of the volume of the cardiac muscle (Li et al. 1996). Stem cell 
differentiation and cardiomyocyte proliferation are known to contribute to the expansion of the 
population of cardiomyocytes in the prenatal heart (Bersell et al. 2009). Cardiomyocyte re-entry 
in cell cycle activity, the alterations in gene expression and also the reversal of epigenetic gene 
silencing mechanisms can occur in rats (Sdek et al. 2011). However, mitotic figures for 
cardiomyocytes are only reported in a few studies in model organisms such as mice and zebrafish 
(Bersell et al. 2009; Kikuchi et al. 2010; Porrello et al. 2011). Current studies in mice, humans and 
rats suggest that cardiomyocyte proliferation could play a role postnatally in cardiomyocyte 
renewal as well (Ali et al. 2014; Bostrom et al. 2010; Mollova et al. 2013; Waring et al. 2015; 
Waring et al. 2012).  
After birth in humans, the cardiomyocyte transition from cell division to incomplete cell cycles 
resulted in about 80-90% of binucleated cardiomyocytes (Mollova et al. 2013). Studies indicated 
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that an adult mouse shows 0.74-4.5% of an unstimulated rate of cardiomyocyte renewal in the 
heart by applying different approaches such as thymidine analogue which includes 
bromodeoxyuridine (BrdU) incorporation and, multiisotope imaging mass spectrometry (MIMS) 
(Malliaras et al. 2013; Senyo et al. 2014; Soonpaa et al. 1996). In rats from birth to age day 3, the 
manual counting of isolated cardiomyocytes showed an increase from 13.6 to 22.9 billion (Li et 
al. 1996). In humans, mitotic cardiomyocytes were detected with the highest rate of 0.016% in 0–
1 year olds, 0.01% in 2–10 year olds, and decreasing to 0.005% in 10–20 year olds (Bersell et al. 
2009). Cytokinesis in cardiomyocytes was not evident after 20 years of age, however, mitosis was 
detectable throughout life, which may help in the proliferation of cardiomyocytes in the postnatal 
life (Mollova et al. 2013). The measurement of cell cycle activity indicated an increase during 
different life periods. For example, a number of LV cardiomyocytes grew to 3.4-fold between age 
1 to 20 years of life (Mollova et al. 2013). The number of cardiomyocyte population increased by 
1.4-fold during the preadolescent period due to the proliferative burst on postnatal day 15 in mice, 
originated by thyroid hormone surge (Naqvi et al. 2014). However, no such changes in 
cardiomyocyte number were detected in preadolescent mice after 11 days of age in the postnatal 
life (Alkass et al. 2015). Alkass et al. (2015) suggested that most of the cardiomyocyte number is 
set within the first postnatal week followed by two waves of non-replicative synthesis of DNA 
(Figure 1.2). For postnatal DNA synthesis, the multinucleation of cardiomyocytes comprises 57% 
tracked by nuclear polyploidisation, contributing 13% of DNA production within the second and 
third weeks in postnatal life (Alkass et al. 2015). Cardiomyocyte cytokinesis may occur in human 
infants which decreases during childhood and adolescence to non-detectable levels in adults 
(Mollova et al. 2013). The cell cycle activity in cardiomyocytes may lead not only to division but 
also to formation of binucleated and polyploid daughter cells. Mollova et al. (2013) indicated that 
human cardiomyocytes undergo significant changes in their nuclear ploidy after birth. The cycling 
cardiomyocytes are predominantly mononucleated, and are the direct or indirect precursors of 
cardiomyocytes with a total DNA content of >2N (hyperdiploid mononucleated cardiomyocytes) 
(Mollova et al. 2013). During postnatal heart growth, the mean cardiomyocyte volume in newborns 
grew 13-fold until adulthood. Proliferation can contribute to 37% and the enlargement to 63% of 
the cardiomyocyte-dependent mechanisms of postnatal myocardial growth (Bersell et al. 2009). 
The mean cellular volume of cardiomyocytes was an 8.6-fold significant increase between 0-1 to 
20 years of life (Mollova et al. 2013). The volume density of cardiomyocyte nuclei in the LV was 
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1.5±0.9×109 in newborns and 5.6±1.5×109 in young adults. By correcting the number of 
cardiomyocyte nuclei by accounting for the corresponding The percentages of mono and 
binucleated cardiomyocytes showed a 3.4-fold increase in the age range of 0-1 to 20 years of life. 
Both cardiomyocyte proliferation and enlargement contribute to postnatal heart growth in humans 
(Mollova et al. 2013). These studies may suggest that the myocardium is capable of at least 
partially regenerating the heart in the postnatal life. 
 
Figure 1.2: DNA synthesis in postnatal cardiomyocytes  
The decline in nucleation and polyploidisation in the rat heart during the first 3 weeks of postnatal 
(P: postnatal days) life (Alkass et al. 2015). 
  
Page | 11  
 
1.4 Cardiac hypertrophy 
Cardiac hypertrophy is an increase in the size and mass of the heart. Cardiac hypertrophy depends 
on the stimulus and results in either physiological or pathological hypertrophy (Figure 1.2). An 
increased cell death, interstitial fibrosis and cardiac dysfunction are the characteristics of 
pathological hypertrophy (Bernardo et al. 2010; Weeks et al. 2011). However, physiological 
hypertrophy is reversible and characterized by normal or enhanced function and normal 
morphology of the heart (such as little apoptosis or fibrosis) (Bernardo et al. 2010; Weeks et al. 
2011). Hypertrophy follows the law of Laplace (Figure 1.4), which states “wall stress (or tension) 
is an opposite function of wall thickness [tension=(pressure×radius)/(2×wall thickness)]’’ 
(Basford 2002; Letić 2012). Therefore, hypertrophy decreases the stress on the wall of the left 
ventricle by increasing its thickness. Based on heart geometry and individual cardiomyocytes, 
cardiac growth can be classed as either concentric or eccentric hypertrophy which is explained 
below. 
a) Concentric hypertrophy 
A decrease in chamber dimensions of the LV with an increased thickness in free and septal walls 
and a decreased length to width ratio (an increase in cardiomyocytes thickness and not in length) 
is termed as concentric hypertrophy (Mihl et al. 2008; Norton 2001). Concentric hypertrophy 
generally occurs due to pathological conditions such as valvular stenosis or chronic hypertension 
(Norton 2001). However, exercise training such as weight-lifting or wrestling also induces a milder 
form of concentric hypertrophy in humans that is not considered as pathological hypertrophy 
(Norton 2001) (Figure 1.3).  
b) Eccentric hypertrophy  
Eccentric hypertrophy occurs due to chamber enlargement during physiological hypertrophy and 
is considered to be a proportional change in the left ventricular wall thicknesses (McMullen et al. 
2007a). The prominent difference between eccentric and concentric hypertrophy is that the heart 
does not decompensate into dilated cardiomyopathy or result in heart failure during eccentric 
hypertrophy (Carabello 2002; Fernandes et al. 2011b; McMullen et al. 2007a). Eccentric 
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hypertrophy involves an increased ventricle volume with a synchronized increase in wall and 
septum thicknesses and with growth in both the length and width of individual cardiomyocytes 
(Mihl et al. 2008; Norton 2001) (Figure 1.3). In humans trained over a period of one year, left 
ventricle responded to concentric remodeling for the first several months of endurance training 
and thereafter the left ventricle dilated and restored the baseline mass to volume ratios and 
remodelled to eccentric hypertrophy (Arbab-Zadeh et al. 2014). 
 
Figure 1.3: Major patterns of LV remodelling 
Concentric hypertrophy: increased growth in cardiomyocyte and wall thickness due to pressure 
overload; Eccentric hypertrophy: myocyte lengthening and increased chamber dimensions due 
to volume overload; Physiological hypertrophy: a proportional increase in the structure. Adopted 
from (Chung et al. 2014). 
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As mentioned earlier, a growth in mass of the heart is due to the hypertrophy of already existing 
cardiomyocytes rather than an increase in the number of cardiomyocytes, since soon after birth, 
cardiomyocytes become terminally differentiated (Paradis et al. 2014; Stacy et al. 2009). There is 
a parallel addition of sarcomeres, during pressure overload conditions including hypertension or 
aortic stenosis which leads to an increase in the thickness of cardiomyocytes, a sequential increase 
in wall thickness (Lorell et al. 2000) and concentric hypertrophy (an increased ratio of chamber 
dimension and wall thickness). In agreement with the Law of Laplace, an increased pressure can 
be offset by an increase in the wall thickness due to the burden or overload on any area of the heart 
muscle (Pressure×Radius)/(2×Wall thickness) (Figure 1.4). Systolic pressure (the amount of 
pressure during muscle contraction or during afterload) is the main factor of the performance of 
ejection. The regulation of systolic stress is believed to maintain a normal ejection fraction (EF; 
measurement of how much blood is being pumped out of the ventricle of the heart with each 
contraction) even when there is a need to generate systolic pressure at high levels (Lorell et al. 
2000).  
 
 
Figure 1.4: Laplace’s Law 
It represents a relationship between wall tension and radius of the sphere (myocardium) with the 
wall thickness. The tension in the sphere can be decreased with the increase in the thickness of the 
sphere’s wall. Adopted from (CEACCP 2013). 
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The overload of volume in circumstances such as anemia, chronic mitral regurgitation, and aortic 
regurgitation can risk the enlargement of cardiomyocytes by the copying of sarcomere in series 
and an increased volume in ventricles (Lorell et al. 2000). A decrease in the ratio of wall thickness 
or dimension within the heart cavity during eccentric hypertrophy is a  adapted intrinsic pattern so 
that the heart can meet the ultimatum to sustain a high stroke volume (SV) (Lorell et al. 2000).  
In the last few decades, many studies have investigated the characteristics of pathological and 
physiological hypertrophy which are accountable either for the weakened capability of the heart 
to endure the increase in pressure and volume load situations or for a better performance of the 
heart (Chelliah et al. 2009; Fernandes et al. 2011b; Hou et al. 2012; Iemitsu et al. 2001; Julie et al. 
2005; Maron et al. 2006; McMullen et al. 2007a). Physiological and pathological hypertrophy are 
caused by different stimuli and are functionally different and have distinct phenotypes at the 
structural and molecular levels (Chelliah et al. 2009; Fernandes et al. 2011b; McMullen et al. 
2007a). A list of the general characteristics of physiological and pathological hypertrophies are 
provided in Table 1.1 and will be further discussed in sections 1.4.1 and 1.4.2. 
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Table 1.1: Cardiac hypertrophy characteristics 
 
This table represents the characteristics associated with physiological and pathological cardiac 
hypertrophy. Adopted from (McMullen et al. 2007a). 
  
 Pathological  Physiological  
 
Stimuli 
Pressure overload during 
diseases such as aortic 
coarctation or hypertension. 
Or, during volume overload 
such as valve diseases 
Exercise training 
During volume overload  
Morphology 
 
 
 
 
Cardiomyopathy (due to 
metabolic, familial, toxicity 
or viral) 
During pressure overload  
Bigger cardiomyocyte 
volume 
Bigger cardiomyocyte 
volume 
Sarcomeres formation  Sarcomeres formation 
Fibrosis (Interstitial)   
Necrosis or apoptosis of 
cardiomyocytes 
  
Gene expression (Fetal) Upregulation Regular 
Heart function Low Regular or enhanced 
Complete reversibility Does not happen Usually happens 
Association with HF and 
high mortality 
Yes, there is an association No, there is not any 
association 
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1.4.1 Pathological hypertrophy 
Pathological hypertrophy is characterized by cell damage or death of cardiomyocytes that are 
substituted with excess collagen which thickens the ventricles, thus harming contraction and 
relaxation (Bernardo et al. 2010). Cardiac hypertrophy is not considered as a compensatory change 
in cardiac pathology. As the heart adopts pathological hypertrophy due to pressure overload, the 
systolic wall pressure then causes a concentric hypertrophy which is distinguishable by thick walls 
but small chambers (McMullen et al. 2007a). In pathological hypertrophy, during periods of 
volume overload, regurgitation in the aorta causes a surge in diastolic wall pressure and results in 
eccentric hypertrophy (McMullen et al. 2007a). On a cellular level, the cardiac myocytes enlarge 
and form new sarcomeric structures, intended to normalize the stress of wall and prevent normal 
CV function during resting periods (McMullen et al. 2007a). As a result of the CV function 
decompensating, the chamber size remains normal and the LV dilates, thus resulting in heart 
failure (McMullen et al. 2007a).   
1.4.2 Physiological hypertrophy 
Physiological hypertrophy is characterized by a normal increase in the heart size associated with 
a normal or improved function, generally considered to be a favorable adaptation. Cardiac 
hypertrophy is beneficial in the maturation during pregnancy, infancy, childhood and exercise 
(Lorell et al. 2000). Exercise training leads to an increase in the workload of the heart and hence 
towards cardiac hypertrophy that is not considered to be harmful as it comes with no adverse 
clinical symptoms and preserved cardiac function (Abel et al. 1999; Levy et al. 1990; Maillet et 
al. 2013; Vakili et al. 2001). With echocardiographic measurements, the systolic functions such as 
ejection fraction and fractional shortening are similar in sedentary and professional athletes 
(Baggish et al. 2011; Maillet et al. 2013; Pluim et al. 2000). The diastolic functions such as E/A 
ratio (ratio of the early (E) to late (A) ventricular filling velocities) and blood flow volume are 
either normal or slightly enhanced in the heart of athletes (Pluim et al. 2000). In a healthy pregnant 
woman, there is a 10-20% increase in total mass of the heart (Schannwell et al. 2002). However, 
pregnancy induced hypertrophy is not the focus of this review, and it will now focus on 
physiological hypertrophy induced by endurance exercise training. 
Page | 17  
 
1.5 Endurance exercise and physiological hypertrophy 
Endurance exercise has well-known effects on cardiac structure and function (Kemi et al. 2010; 
McMullen et al. 2007b; Xu et al. 2008). Endurance exercise training results in a number of changes 
in the heart such as increased LV mass, wall thickness and volume and is also called ‘‘athlete’s 
heart’’ (Seals et al. 1994). Endurance trained hearts are characterized by augmented volume or 
pressure loading leading to a physiological hypertrophy with specific cardiac changes such as LV 
dilatation and increased LV mass (Waring et al. 2012), LV wall thickness and LV cavity size 
(Rodriguez et al. 2010). Exercise training increases cardiac output through increased stroke 
volume, and enhanced ejection fraction with increased systemic and pulmonary arterial pressures 
and decreased vascular resistances (Seals et al. 1994). Cardiac hypertrophy improves cardiac 
functions and adapts a compensatory phenotype such as during exercise training to normalize 
stress on the heart wall and to maintain a normal or enhanced cardiac output (Tardiff 2006). 
Cardiac structural and functional changes occurring with endurance exercise training are provided 
in Table 1.2.  
1.5.1 Structural changes  
Endurance training causes structural adaptations such as increased cardiac muscle mass, left 
ventricular wall thickness and chamber size (Baggish et al. 2008; de Simone et al. 1991; Gaasch 
et al. 2011; Mihl et al. 2008; Scharhag et al. 2002). Cardiac hypertrophy was evaluated by cardiac 
weight and myocyte morphometry in 8-weeks swim trained Wistar Kyoto rats (WKY) adolescent 
rats (Medeiros et al. 2004). Exercise increased LV weight (13%) and myocyte dimension (21%), 
septal and posterior wall thicknesses were increased with a 15% increase in LV mass index, 
however, LV diameters were not changed (Medeiros et al. 2004) and, similar results of LV mass 
index and LV diameters were found in humans as well (Shi et al. 2014). Heart mass typically 
increases 15-30% following several weeks of endurance exercise training (Medeiros et al. 2004; 
Wisloff et al. 2002; Wisloff et al. 2001). Exercise training during adolescent life increased LV 
mass (approximately 32%), posterior and septal wall thickness (approximately 15%) compared to 
sedentary. Rossoni et al. (2011) reported 11% increase in the LV mass of WKY adult male rats 
trained for 13 weeks (Waring et al. 2015). Sprague Dawley rat swam for 8 weeks at moderate and 
high intensity mode, using echocardiography Wang et al. (2008) showed that septal and posterior 
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wall thickness increased with the increased LV mass by 40%. Male WKY rats were conditioned 
to run vigorously for 4, 8, and 16 weeks daily on a treadmill and direct measurement of wall 
thickness confirmed significant increments in postmortem interventricular septum (IVS) and LV 
free wall (FW) thickness after 8 weeks of intensive exercise, which were maintained at 16 weeks 
(Benito et al. 2011). Generally, endurance training is associated with increase in LVM, heart cavity 
size and also with a relative high values of wall thickness (Mihl et al. 2008; Spirito et al. 1994).  
In summary, endurance exercise has beneficial effects on the structural framework of the heart for 
better performance in both animal and human models. Increased wall thicknesses, improved LV 
chamber size, and mass are related to enhanced cardiac functions, however studies are conflicting 
in relation to structural changes including wall thicknesses and chamber size occurring with 
exercise training at different intensities and ages (Pluim et al. 2000). The structural changes in 
relation to functional changes are discussed in the next section 1.5.2. 
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Table 1.2: Cardiac structural and functional improvement 
 
VO2 max Chamber 
Size 
LVWT 
(IVSd/LVPWd) 
Heart 
Mass 
CO max Contractility SV max 
Low 
Intensity (55-
60%) 
 
      ↑ 
 
      ↑ 
 
      ↑ 
 
      ↑ 
 
      ↑ 
 
      ↑ 
Moderate 
Intensity (60-
75%) 
 
      ↑ 
 
      ↑ 
 
      ↑ 
 
      ↑ 
 
      ↑ 
 
      ↑ 
High 
Intensity (85-
90%) 
 
      ↑ 
 
      ↑ 
 
      ↑ 
 
      ↑ 
 
      ↑ 
 
      ↑ 
Duration 
(Minutes/day) 60  30-120  30-60  30-60  30-60  30-60  
Time Period 
4-16 
weeks 4 Weeks 
4-13 
Weeks 
Few 
Weeks-
Months 4-11 Weeks 
4-10 
weeks 
Endurance exercise performed at low, moderate and high intensity for 30-120 minutes per day for 
few weeks-months which increased chamber size, left ventricle wall thickness (LVWT) including 
left ventricle wall thickness (LVWT), left ventricle septum at diastole (IVSD) heart mass, cardiac 
output and stroke volume (Bombardini et al. 2005; Gielen et al. 2010; Gottdiener et al. 1990; 
Pelliccia et al. 1999; Pluim et al. 2000; Waring et al. 2012; Woodiwiss et al. 1995). 
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1.5.2 Functional changes  
Endurance exercise training results in several changes in cardiovascular systolic and diastolic 
function. The systolic function refers to the contraction of the heart muscle required to drive the 
blood out of the heart chamber (Boluyt et al. 2003; Fagard 1997; Jin et al. 2000; MacFarlane et al. 
1991; Maron et al. 2006; Rowland 2009; Seals et al. 1994; Spina et al. 1992; Warburton et al. 
1999). It is dependent on the preload and afterload of the heart and the intrinsic muscle 
contractility. LV diastolic function represents the adequate filling of the LV in order to produce an 
optimal cardiac output (CO). Endurance exercise training improves heart function, including 
increased maximal cardiac output, increased SV, and reduced heart rate (HR) at rest and during 
submaximal exercise (Boluyt et al. 2003; Fagard 1997; Jin et al. 2001; MacFarlane et al. 1991; 
Maron et al. 2006; Rowland 2009; Seals et al. 1994; Spina et al. 1992; Warburton et al. 1999). 
In humans and rats, evidence regarding the effects of endurance training on systolic function and 
LV contractility remains unclear. Whereas many investigators have detected no changes in systolic 
function in both short and long term exercise training (MacFarlane et al. 1991; Sadaniantz et al. 
1996), others have reported enhanced systolic function (Boluyt et al. 2003; Fagard 1997; Jin et al. 
2000; MacFarlane et al. 1991; Maron et al. 2006; Rowland 2009; Seals et al. 1994; Spina et al. 
1992; Warburton et al. 1999). In humans, LV systolic function was higher in endurance-trained 
athletes compared to sedentary controls, as evidenced by a greater LV contractile functional 
reserve and significantly higher fractional shortening (FS). Also, SV was higher in the trained 
group than in the sedentary controls and changes in SV correlated with changes in EF in the trained 
group but not in sedentary controls (Sadaniantz et al. 1996; Seals et al. 1994). While some studies 
including both in rats and humans found significant changes in LV diastolic and systolic functions, 
others have reported no change. For instance, LV EF (ejection fraction), FS, FAC (fractional area 
change), and HR were normal or increased slightly in both trained and untrained groups (Douglas 
1989; Pela et al. 2004). While another study showed no or less differences between the trained and 
sedentary groups for the resting and maximal HR (Migliaro et al. 2001), SV and SV index, CO, 
and CO index (Arbab-Zadeh et al. 2014; Veiga et al. 2011).  
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In rats, EF and resting HR were reported to be similar for the trained group and the sedentary rats 
(Vieira et al. 2016). After 8 weeks of swim training, resting heart rate was significantly reduced in 
swim trained rats (355 vs 330 bpm). In contrast, HR was similar between trained and untrained 
groups (Medeiros et al. 2004). Agrebi et al. (2015) suggested that endurance-trained adolescent 
males develop superior exercise performance before the cardiac remodeling of heart that is 
typically evident in trained adult athlete.  
1.5.3 Endurance exercise induced changes in cardiomyocytes  
Numerous studies report that exercise training alters cardiomyocyte morphology and induces 
hypertrophy in the rat heart (Hoydal et al. 2007; Mollova et al. 2013; Moore et al. 1993; Ramasamy 
et al. 2015; Waring et al. 2015; Wisloff et al. 2001). Cardiomyocyte volume increases by 17%-
32% after several weeks of endurance training (Ellison et al. 2012). In addition to cardiomyocyte 
hypertrophy, endurance training also induces functional changes to cardiomyocytes in relation to 
structure that contribute to the overall improved functioning of heart (Moore et al. 1993; Wisloff 
et al. 2002; Wisloff et al. 2001). For example, several weeks of endurance training in rat increases 
cardiomyocyte shortening and the degree of contraction-relaxation (Moore et al. 1993; Wisloff et 
al. 2002; Wisloff et al. 2001). Newly formed BrdU-positive cardiomyocytes (7%) were produced 
by intensity controlled exercise in the adult heart of rat (Waring et al. 2012). Endurance exercise 
improves cardiomyocyte volume, regeneration, and length and width that is required for better 
cardiac performance (Natali et al. 2001). The diameter of cardiomyocyte is reported to increase in 
rats trained for 4 weeks compared to the untrained control group (Waring et al. 2012). Waring et 
al. (2015) investigated the effects of exercise in adolescent rats and reported the endogenous 
regenrative capacity of the adult rat heart with the activation of cardiac stem progenitor cells 
(eCSCs). Trained rats can regenerate the heart with the new cardiomyocyte formation from already 
existed adult mature cardiomyocytes (Bostrom et al. 2010). Hence, there are evidences to support 
that physiological cardiac hypertrophy in response to endurance training in adolescent or adult 
rats. Therefore, it would be interesting to investigate and compare the effects of endurance exercise 
performed in the juvenile, adolescent and adult life exercise on the adult heart. 
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1.6 Cardiac Fibrosis 
Fibroblasts are found in connective tissue and collagen proteins. Collagen fibers help to maintain 
a proper framework for the tissue structure (Krenning et al. 2010). These cardiac fibers are believed 
to be involved in both cellular and molecular events which help to determine the heart structure 
and function (Krenning et al. 2010). Fibroblasts release different bioactive mediators influencing 
angiogenesis and myocyte proliferation in the heart (Krenning et al. 2010).  
1.6.1 Cardiac fibrosis in pathological hypertrophy 
An advanced degree of cardiac fibrosis is linked with increased CVD morbidity and mortality 
(Selvetella et al. 2004). It is usually associated with fibroblast proliferation in heart muscle and 
also with an irregular thickening of the heart valves due to the irregular proliferation of fibroblasts 
(Selvetella et al. 2004). Cardiac fibroblasts can impact molecular and cellular events that 
collectively determine cardiac structure and function (Krenning et al. 2010). Cardiac fibrosis is 
documented with intensive exercise training that is performed over years, with LV functional 
changes and adverse remodeling both in rats (Benito et al. 2011) and human (Whyte et al. 2008) 
studies. A reduced microvasculature and disrupted myocardial structures that result from increased 
deposition of extracellular matrix (ECM) is associated with fibrosis (Zeisberg et al. 2007). 
Fibroblasts are involved in inducing pathological changes in the heart structure by undergoing 
severe proliferation, depositing ECM proteins and by replacing myocytes with a scar tissue (Jalil 
et al. 1988). Fibroblast-induced remodeling leads to a stiffer and less compliant heart muscle and 
is accountable for increased myocardial stiffness and diastolic dysfunction leading towards cardiac 
failure (Jalil et al. 1988).  
1.6.2 Cardiac fibrosis in physiological hypertrophy 
There is not much association reported between cardiac fibrosis or cardiac dysfunction and 
physiological hypertrophy (Weeks et al. 2011). Fibroblasts are an important cellular component of 
cardiac tissue and have been investigated in relation with the effects of exercise in the heart 
(Anversa et al. 1986; Jacobs et al. 1984; Kwak et al. 2011; Mohlenkamp et al. 2008; Natali et al. 
2001; Waring et al. 2012). Cardiac fibrosis has an inverse relationship with exercise induced 
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changes in LV structure and function (Weeks et al. 2011). Physiological hypertrophy is not 
significantly linked with either reparative or interstitial fibrosis. For instance, increased collagen 
levels which may affect the collagen fibrotic matrix of the heart remained unchanged in the LV of 
endurance trained rats (Burgess et al. 1996; Jin et al. 2000). Likewise, the markers of myofibroblast 
activation associated with a pathological remodeling for example, smooth muscle α-actin were not 
detected in trained hearts of rat (Burgess et al. 1996). 
Low, moderate and high-intensity endurance training leads to decreased Angiotensin II (AngII), 
which is a known initiator of the fibrotic response in the heart (Fernandes et al. 2011a). There is 
no evidence of substantial modification for the presence of fibrosis among endurance athletes and 
sedentary control group (Rubinshtein et al. 2010). Although, fibrotic adverse remodeling as well 
as some arrhythmias occurs with high-intensity training and not with moderate or low-intensity 
exercise (O'Keefe et al. 2012) (Gerche et al. 2014). However, fibroblasts should be investigated 
while observing the effects of exercise in the heart. Cardiac fibrosis that occurs during exercise 
training with different intensities is provided in Table 1.3. 
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Table 1.3: Exercise and cardiac fibrosis 
 
 
 
 
 
 
 
 
 
Endurance exercise performed at low, moderate and high intensity for 30-120 minutes per day for 
few weeks-months which yielded into increase in number of cardiomyocytes and fibrosis (Anversa 
et al. 1986; Jacobs et al. 1984; Kwak et al. 2011; Mohlenkamp et al. 2008; Natali et al. 2001; 
Waring et al. 2012). 
  
VO2 max Cardiomyocytes Fibrosis 
Low Intensity 
 (55-60%) 
 
                    ↑ 
 
                ↑ 
Moderate Intensity  
(60-75%) 
 
                    ↑ 
 
                ↑ 
High Intensity  
(85-90%) 
 
                    ↑ 
 
                ↑ 
Duration 
(Minutes/day)                  60            30-120  
 
Time Period 
 
          4-13 weeks 
 
        4-16 Weeks 
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1.7 Animal model of exercise studies 
The understanding of molecular changes associated with exercise-induced cardiac hypertrophy is 
mostly due to laboratory studies using animal models. Rats and mice grow quickly to reach an 
adult age and are low-cost compared to other models such as dog, sheep and horses. There are 
developmental similarities between rodents and humans that allow translation of the age-specific 
changes of human life to adult rat models (Figure 1.5). Exercise training with several modes has 
been introduced to different genetic backgrounds in different animals including swim training, 
treadmill and voluntary wheel running. These models were measured at different levels such as 
the whole heart, ventricle, and individual cardiomyocyte and were quantified to initiate 
physiological hypertrophy (Kemi et al. 2010; McMullen et al. 2007a; Wisloff et al. 2002). 
Hypertrophy of cardiomyocytes occurs after swim training, treadmill running and voluntary wheel 
running programs in both rats and mice (Kemi et al. 2010; McMullen et al. 2007a; Wisloff et al. 
2002). Treadmill running is a favoured option for the precise study of effects of exercise training 
on heart structure, function and cardiomyocytes, despite it being labour demanding and having 
requirements for specialized equipment (Wang et al. 2010). Well-controlled speed, inclination, 
duration, and intensity can best be attained by the use of motorized treadmills (Boluyt et al. 2003). 
This also produces less variation within the experimental groups and hence allows for detection of 
even small changes.  
 
Figure 1.5: Comparison of age of rat and human  
Age of rats in weeks for juvenile, adolescent and adult life compared to years from childhood until 
adulthood in humans (Sengupta 2011; Andreollo 2012). 
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1.8 Time course of detraining 
Heart mass in adult rats following cessation of training reverts back to pre-training levels in as 
little as 2 weeks (Craig et al. 1991). On detraining, the training gained aerobic fitness achieved 
with a period of 2-3 months of training in adult rodents is lost in few weeks (Kemi et al. 2004) 
(Figure 1.6). For example, exercise-induced cardiac hypertrophy as measured by heart mass 
attained after several weeks of training was lost within 21 days after exercise termination (Craig 
et al. 1991; Lennon et al. 2004). In particular in adult rats, the enhanced cardiac functional and 
structural changes including LV wall thickness (Benito et al. 2011) and contractility (Benito et al. 
2011) were lost with 20 days detraining. In humans, LV mass and LVWT were back to sedentary 
levels with detraining periods of months to years (Pelliccia et al. 2002; Spence et al. 2011; Weiner 
et al. 2012). After 6 weeks of detraining, the improved aerobic fitness, LV mass and IVWT (except 
LVEDV that remained elevated) reversed back to the baseline values in young adults who 
performed the endurance training over a period of 6 months (Spence et al. 2013; Spence et al. 
2011).  
Most of the studies that have reported detraining back to the baseline levels in the heart have used 
adolescent or adult rats and humans (Benito et al. 2011; Bocalini et al. 2010; Craig et al. 1991; 
Kemi et al. 2004; Kemi et al. 2010; Waring et al. 2015). However, emerging evidence suggests 
that it might be different if exercise is performed in the juvenile or adolescent stage of life. The 
increased cardiomyocyte number and capillarisation from training was sustained in adolescent rats 
after 4 weeks of detraining (Waring et al. 2015). Moreover, a recent publication by our group with 
previous findings demonstrated that exercise training performed for only 4 weeks in juvenile life 
resulted in a 10% increase in heart mass which was sustained with exercise cessation until 
adulthood with no adverse effects (Wadley et al. 2016). Training at a specific age of development 
may have an important role in attaining the sustained improvement of cardiac performance. 
Juvenile life training sustained the improvement on the LVM of the adult heart. However, the 
exercise-induced effects of juvenile exercise on the structural, functional and cardiomyocyte 
changes were not investigated by Wadley et al. (2016) and require further investigation.  
 
 
Page | 27  
 
 
Figure 1.6: The reversibility of exercise training in the adult heart 
Exercise benefits of increased wall thickness, chamber size, contractility and capillarity that were 
achieved over period of months were lost within few days upon training cessation. The red line 
indicates wall thickness and chamber size, yellow line indicates contractility and the blue line 
indicates changes in capillarity (Benito et al. 2011; Craig et al. 1991; Kemi et al. 2004; Lennon et 
al. 2004). 
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1.9 Gene expression and cardiac hypertrophy 
There are distinct and different molecular mechanisms involved in inducing either physiological 
or pathological cardiac hypertrophy (Iemitsu et al. 2001; McMullen et al. 2007a). The following 
two sections of this thesis will discuss the molecular pathways and genes involved in pathological 
and physiological hypertrophies in detail. However, since pathological hypertrophy is not the 
primary focus of this study, this review will mostly discuss the physiological genes associated with 
endurance exercise training. 
1.9.1 Pathological regulation 
Cardiac hypertrophy of pathological models is associated with an upregulation of fetal genes 
(McKie et al. 2010; Stilli et al. 2006). These genes include the natriuretic peptide precursor A 
(nppa) and natriuretic peptide precursor B (nppb) encoding the atrial natriuretic peptide/factor 
(ANP/ANF) and the brain-type natriuretic peptide (BNP), and other contractile proteins (genes for 
fetal isoforms) such as myh6 and myh7 encoding the α-myosin heavy chain (α-MHC) and β-
myosin heavy chain (β-MHC) (Holtwick et al. 2003; Julie et al. 2005; McKie et al. 2010; Stilli et 
al. 2006). ANP/ANF is synthesized and released by the myocytes in the atria by responding to the 
distension of the atrias, stimulation of angiotensin II and sympathetic system activation (Sergeeva 
et al. 2014). ANP is primarily produced and deposited in cardiomyocytes as prepro-ANP, which 
is then cleaved to pro-ANP and lastly to ANP (Sergeeva et al. 2014).  Expression levels of nppa 
elevates during states of hypervolemia and, this occurs mostly in congestive HF (Benito et al. 
2011; Dewey et al. 2011). Such elevated levels of nppa are considered as a marker of asymptomatic 
LV dysfunction diagnosis (Sergeeva et al. 2014). Nppb is synthesized by the ventricles and in the 
brain. The nppb is first synthesized as prepro-nppb which is then cleaved to pro-nppb and later 
into nppb (Benito et al. 2011; Dewey et al. 2011). nppb is predominantly synthesized in the 
ventricle of the heart by responding to increased wall stress in heart muscle hypertrophy and to 
volume overload as well (Kinnunen et al. 1993). The gene expression of nppa and nppb marks the 
chamber myocardium in the embryo, and both genes serve as early and accurate markers for 
pathological hypertrophy and heart failure (Sergeeva et al. 2014).  
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In relation to pathological hypertrophy, fetal gene expression has been widely investigated (Park 
et al. 2011; Sheehy et al. 2009; Tanno et al. 2011; Zhao et al. 2004); and both nppa and nppb are 
linked to pathological hypertrophy (Holtwick et al. 2003; Julie et al. 2005; McKie et al. 2010; Stilli 
et al. 2006). Alterations in the contractile proteins such as a reduction in the expression of α-myosin 
heavy chain (αMHC) and an increase in the β-myosin heavy chain (βMHC) proteins are associated 
with pathological cardiac hypertrophy (Song et al. 2008). An important characteristic of 
pathological LV hypertrophy is the re-manifestation of fetal genes in the heart muscle (Grabowski 
et al. 2015; Rajabi et al. 2007; Wagner et al. 1999). For example, in rodent models, LV hypertrophy 
is marked by a switch from αMHC to MHC resulting in an enhanced economy of muscle 
contraction (Grabowski et al. 2015; Rajabi et al. 2007). The investigations of recapitulation of the 
communication of fetal genes during hypertrophy of the heart recognized numerous developmental 
genes that are re-expressed in the myocardium of hypertrophic mice (Wagner et al. 1999). α-
skeletal muscle actin, α-smooth muscle and myosin light chain-2 are also re-expressed in 
cardiomyocytes following exposure to pathological hypertrophic stimuli (Heineke et al. 2006).  
Myosin is a motor protein which is involved in the movement of cardiomyocytes. The myosin 
heavy chain (MHC) genes expression are important for the contraction of cardiac muscle (Gupta 
2007). The isotype of myosin contributes to the conduction velocity in cardiac muscle fibers. Myh6 
encoding the protein, α-myosin heavy chain (αMHC) is upregulated soon after birth. It has high 
ATPase activity which results in fast contractility but may downregulate in the failing heart 
(Fernandes et al. 2011b). Myh7 encoding the protein, β-myosin heavy chain (βMHC) has a 
low contractility and is mainly present in mononuclear cells (Soci et al. 2011). A switch from myh6 
to myh7 seems to be correlated with the switch from the adult expression program to the fetal gene 
program (Soci et al. 2011). This switch in the heart has a noticeable effect on heart contractility 
and function which is noticed during cardiac stress and CVD (Gupta 2007). In fetal hearts, both 
the myh6 isoform as well as the predominant myh7 isoform are expressed (Grabowski et al. 2015; 
Rajabi et al. 2007). βMHC upregulates in the developing heart and is downregulated after birth 
(Gupta 2007). An upregulation of mRNA nppa has expressed with a 6.1-fold increase during 
pathological hypertrophy and a 14.3-fold increase in heart failure (Kong et al. 2005). It is reported 
that nppa could increase in physiological hypertrophy by 2.3-fold (Kong et al. 2005), and a 3.0-
fold increase in the nppb mRNA level occurs during pathological hypertrophy but not during 
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physiological hypertrophy in rats (Chien et al. 1991; Kong et al. 2005). However, during the 
transition to decompensated heart failure, nppb mRNA levels downregulates to the baseline levels 
(Kong et al. 2005). These conflicting evidences may suggest that the expression of nppb is 
involved in the fetal gene programing of hypertrophy that often results in heart failure. Targets for 
the fetal gene program are proteins involved in contraction, calcium handling (SERCA 
downregulation) and metabolism (Miyamoto et al. 2000). Therefore, a switch to the fetal gene 
program can lead to a loss of function of these proteins (Ojamaa et al. 1994). A number of cardiac 
genes for their expression in both pathological and physiological models of cardiac hypertrophy 
was investigated and the levels of nppa and nppb, angiotensin converting enzyme (ACE), 
endothelin-1 and β-adrenergic receptor kinase mRNA transcripts were found to be significantly 
raised in pathological cardiac hypertrophic rats. However, the expression of these genes are not 
typically altered in acute or chronic exercise-trained rodents that undergo physiological 
hypertrophy (Bostrom et al. 2010; Iemitsu et al. 2005; Iemitsu et al. 2001; McMullen et al. 2007a). 
1.9.2 Physiological regulation 
Studies of physiological stimuli showed different signaling pathways and expression of genes that 
are related to changes in the heart structure, cell cycle, intracellular signaling, metabolism and the 
synthesis of proteins (Friddle et al. 2000; Kong et al. 2005; Liu et al. 2009; Liu et al. 2001; Mann 
et al. 2012). The identification of genes involved in physiological cardiac hypertrophy by exercise 
training represents an important component of the research presented in this thesis and is discussed 
in detail below. 
Differences in the signaling pathways mediating diseases and physiological hypertrophies were 
demonstrated by McMullen et al. (2004a) who showed that PI3-K (phosphoinositide 3-kinase) 
performs an important role in regulating physiological, but not a pathological hypertrophy 
(McMullen et al. 2004a; McMullen et al. 2003). Insulin like growth factor-1 (IGF-1) activates PI3-
K-p110α through a tyrosine kinase receptor called the IGF-1 receptor (IGF-1R) (Kong et al. 2005; 
McMullen et al. 2004a). IGF-1 and PI3-K were upregulated in rodent hearts in response to exercise 
training and are known to regulate regular growth of the heart during postnatal development 
(McMullen et al. 2004a; McMullen et al. 2003) (Figure 1.7). The mTOR-S6K-E1BP pathway is 
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downstream of PI3-K pathway and considered to be important for the biosynthesis of protein 
during exercise-induced hypertrophy (McMullen et al. 2004a). With the stimulation of the PI3K 
and Akt system (protein kinase B), the mTOR (mechanistic target of rapamycin) pathway supports 
regulating the alterations in the size of the cell (Kong et al. 2005). The mTOR pathway is critical 
in the regulation of cell growth and its activity is known to be altered during heart failure and 
pathological hypertrophy (Kong et al. 2005). Both AMPK and Akt are upstream of mTOR but 
neither Akt nor mTOR (ser2481) were significantly altered with treadmill training in rat heart 
(Dolinsky et al. 2006) (Figure 1.7).  
The major downstream effector of PI3-K is Akt1 which becomes activated by phosphorylation 
during exercise and helps in inducing physiological cardiac hypertrophy (Aoyagi et al. 2011; 
DeBosch et al. 2006). Akt1 is considered as an important factor because of its beneficial effects 
on the heart. These effects include the inhibition of cardiomyocyte death, improvement in calcium 
handling, helping in metabolism and in the growth of heart (Shiojima et al. 2005). In trained 
rodents, the genetic deletion of Akt1 resulted in a pathological cardiac hypertrophy in response to 
stress overload (Shiojima et al. 2005). This is suggestive of Akt1 being required for inducing 
physiological hypertrophy and inhibiting pathological hypertrophy (DeBosch et al. 2006). Also, 
Akt1 represses the transcription factor called C/EBPβ and by activating CITED4 and exerts pro-
proliferative effects on cardiomyocytes (Bostrom et al. 2010) (Figure 1.7).  
This project is not aiming to establish molecular pathways albeit as associated molecular markers. 
The review will be now discussing physiological genes associated with endurance exercise 
training. Physiological gene set including gata4, Tbx5, and nkx2.5 are regulated by C/EBPβ via 
interaction with serum response factor (SRF) (Figure 1.7). The expression levels of this gene set 
are altered following endurance exercise and are believed to be involved in hypertrophy and 
differentiation of cardiomyocytes (Bostrom et al. 2010; Liang et al. 2001; Waring et al. 2012; 
Warren et al. 2011). Also, C/EBPβ is considered to be essential in mediating cardiac exercise 
effects and inducing phenotypic physiological hypertrophy including cardiomyocyte hypertrophy 
and low levels of hyperplasia (Hu et al. 2011; Liang et al. 2001). Expression of foxo1 in 
cardiomyocytes attenuates calcineurin phosphatase activity and inhibits agonist-induced 
hypertrophic growth (Ni et al. 2006). 
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Figure 1.7: Key signaling pathways involved in physiological hypertrophy 
Exercise activated pathways in myocardium. Adopted from (Mann et al. 2012). 
  
Page | 33  
 
Given exercise increases these cardiac growth genes, investigating cardiac hypertrophy in the heart 
should examine gata4, nkx2.5, foxo1 and myh6. Also, the adult rat heart has a higher abundance 
of coxIV (Vijayasarathy et al. 1998) and is involved in nuclear and mitochondrial genomics in 
cardiac health and failure (Garnier et al. 2003). Therefore, it would be interesting to investigate 
coxIV in the adult heart with training during juvenile life. Recently, genes including spp1 
(osteopontin) and beta actin (Actb) were identified by Wadley et al. (2016) using gene array as 
being potentially upregulated in adult rat hearts exposed to juvenile exercise. spp1 is an 
extracellular matrix binding factor. The upregulation of spp1 is linked to cardiac hypertrophy in 
response to stress overload (Xie et al. 2013) and is considered as an important gene in the 
promotion of myoblast proliferation via repair of cardiac injury (Schunke et al. 2013). Thus, further 
investigation of these genes is required to examine if they are upregulated following juvenile 
exercise. 
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1.10 miRNAs 
miRNAs, small non-coding RNAs (Figure 1.8), controls gene regulation at the level of post-
transcription (Fernandes et al. 2015b; Notari et al. 2015). They play a key role in heart growth and 
development (Fernandes et al. 2011a; Notari et al. 2015; Soci et al. 2011). miRNAs bind to 3' 
untranslated regions (UTR) of their target genes which results in mRNA degradation (Lee et al. 
2004), or, suppression of protein translation (Kuersten et al. 2003). miRNA target the genes that 
encode for enzymes, proteins and nuclear factors that are associated with cardiac growth, 
differentiation, and development (Care et al. 2007). In physiological and pathological processes, 
miRNAs are considered to have therapeutic potential and may also be suitable as biomarkers in 
cardiovascular research (Devaux et al. 2015; Notari et al. 2015; Wong et al. 2016). Therefore, the 
identification of miRNAs involved in cardiac hypertrophy represents an important component of 
the research presented in this thesis. The objective of this section of the review is to highlight 
miRNA species associated with exercise-induced cardiac hypertrophy. 
1.10.1 miRNAs in physiological hypertrophy 
There are more than 200 miRNA species in the heart that are identified to be up or down regulated 
with endurance exercise (Dakhlallah et al. 2015; Fernandes et al. 2015b; Ramasamy et al. 2015). 
Approximately, 40 or more species are reported to induce cardiomyocyte proliferation in the 
neonatal heart (Eulalio et al. 2012). The expression of miRNAs being either cardiac enriched or 
cardiac-specific are miRNA-1, miRNA-133, miRNA-206 and miRNA-208 (Condorelli et al. 
2010). miRNA-1, miRNA-30e, miRNA-99b, miRNA-125b, miRNA-127, miRNA-133a, miRNA-
133b, miRNA-199a-3p, miRNA-204 and miRNA-208b are highly expressed in cardiac muscle in 
rats (Vacchi-Suzzi et al. 2013) (Figure 1.9). The identification of miRNAs involved in 
physiological cardiac hypertrophy, particularly in an endurance running trained rat model 
represents an important component of this thesis. This review will now further discuss the selected 
miRNAs playing an important role in cardiac hypertrophy are conserved miRNA signatures 
enriched in muscle structure including the heart-specific miRNA-1, miRNA-133b, miRNA-208b, 
miRNA-204 and miRNA-30, the cardiac valve-enriched miRNA-125b, miRNA-19b, and miRNA-
222. 
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Figure 1.8: Cellular gene control mechanism  
miRNA synthesis and function. Adopted from (Sluijter 2013). 
 
Figure 1.9: miRNA involved in physiological remodeling by exercise training 
miRNAs inducing changes in cardiomyocyte, fibroblast and epithelial cells in response to exercise 
trainings. Adopted from (Fernandes et al. 2015b). 
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miRNA-1 and miRNA-133b 
miRNA-1 is well established as a fundamental factor in cardiac development (Chen et al. 2006; 
Wystub et al. 2013). It is highly expressed in the heart and is connected to the control of cardiac 
growth and development (Liu et al. 2008). The upregulation of miRNA-1 is linked to cardiac 
hypertrophy in response to chronic pressure overload (Liu et al. 2008). The overexpression of 
miRNA-1 leads to enlarged ventricles and HF by causing developmental blockage (Han et al. 
2011). The down regulation of miRNA-1 is an initial change that is detected after increased 
pressure overload leads to changes in the expression of other miRNAs, increases heart mass and 
causes the dysfunction of regular heart contraction. miRNA-1 plays an important role in the 
pathogenesis of cardiac hypertrophy and the overexpression changes the cardiomyocyte 
hypertrophy (Da Costa Martins et al. 2012; Han et al. 2011). It also affects the growth of 
cardiomyocytes by inhibiting the signaling of calmodulin and NFAT in vitro (Notari et al. 2015). 
miRNA-1 targets the calmodulin, MEF2A and gata4 which are important in cardiomyocyte growth 
(Notari et al. 2015).  
In addition, an increased level of miRNA-1 in the developing heart targets the transcription factor 
Hand2 and reduces the pool of proliferating cardiomyocytes, thereby regulating cardiomyocyte 
differentiation and proliferation during heart formation (Ikeda et al. 2009). It is also been found 
that mice deficient in miRNA-1 exhibit an increase in the number of proliferating cardiomyocytes 
(Ikeda et al. 2009). An increase in miRNA-1 is associated with ischemic and non-ischemic dilated 
cardiomyopathy (Da Costa Martins et al. 2012). miRNA-1 is found to reduce in hypertrophy but 
returned back to normal or above normal during HF (Da Costa Martins et al. 2012). The decrease 
in miRNA-1 is one of the initial alterations reported after stress overload in the rat heart (Fu et al. 
2013; Miranda et al. 2006). miRNA-1 downregulates with exercise training (Care et al. 2007; 
Ramasamy et al. 2015), after 8 weeks of swimming training in adolescent rats (Ramasamy et al. 
2015). 
miRNA-133b is considered critical as it targets the IGF-1 pathway which plays an important role 
in heart development (Chen et al. 2006; Liu et al. 2008; Malizia et al. 2011; Wystub et al. 2013). 
It has also been shown to promote cardiac regeneration in aquatic animals such as zebrafish (Yin 
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et al. 2008). miRNA-133 plays a major role in regulating hypertrophy of the cardiomyocyte (Care 
et al. 2007; Fu et al. 2013). If overexpressed, it attenuates pathological cardiac hypertrophy while 
conversely, silencing or deleting miRNA-133 leads to excessive cardiac growth (Da Costa Martins 
et al. 2012). miRNA-133b plays a part considering its expression is inversely related to cardiac 
hypertrophy and sarcomere organization (Care et al. 2007). Ramasamy et al. (2015) reported an 
up regulation of miR133b in the hearts of adolescent trained rats. However, miR133b was lowered 
with exercise training in another exercise study in rodents (Soci et al. 2011).  
miRNA-99b and miRNA-30e 
miRNA-99b is involved in cell differentiation, proliferation, and chromatin remodeling 
(Ramasamy et al. 2015). mTOR is considered to help in different aspects of cellular function and 
miRNA-99b has been reported to target this pathway (Ramasamy et al. 2015). The miRNA-99 
family mainly targets the Akt/mTOR/IGF1 axis that leads to an advanced apoptosis and reduced 
protein synthesis during cancer (Turcatel et al. 2012). Also, TGF-β signaling is considered as an 
important pathway for epithelial and mesenchymal cell plasticity and miRNA-99b is investigated 
to target this pathway as well (Turcatel et al. 2012). miRNA-99b is downregulated in swim trained 
rats to possibly reduce apoptosis of cardiomyocytes (Ramasamy et al. 2015) while another study 
of wheel running in mice reported an upregulation of miRNA-99b in the heart (Martinelli et al. 
2014). miRNA-99b is found to target the same pathways that mainly control the proliferation and 
death of the cell including the pathways signaling chiefly via PI3K/Akt/mTOR and MAPK in the 
rat heart (Ramasamy et al. 2015) (Figure 1.10). 
Earlier studies indicated that miRNA-30e is an important marker for the diagnosis of pathological 
hypertrophy (Pan et al. 2013). miRNA-30e downregulates with an increase in angiotensin II which 
promotes myocardial hypertrophy via excessive autophagy (Pan et al. 2013). miRNA-30e plays 
an important role in cell differentiation and proliferation with possible involvement in cell division 
and growth. It is up-regulated in hypertrophy both in vitro and in vivo in rats, mice and human 
embryonic stem cells (Fernandes et al. 2015b; Ramasamy et al. 2015; Vacchi-Suzzi et al. 2013). 
miRNA-30 family upregulates during physiological hypertrophy in trained adolescent rats 
(Ramasamy et al. 2015). In hypertrophy models of the mouse heart and failing human hearts, the 
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expression of miRNA-30e is significantly down-regulated (Matkovich et al. 2009; Winter et al. 
2009). The reduced expression of miRNA-30 family triggers pathways of apoptosis, autophagy 
calcium signaling and TGF-beta induced-impaired endothelial cells function (Duan et al. 2015; 
Ramasamy et al. 2015).  
 
Figure 1.10: Schematic presentation of genes and miRNAs in cardiac hypertrophy.  
The red arrows indicate an up regulation and the green arrow indicate a down regulation. Adopted 
from (Ramasamy et al. 2015). 
miRNA -125b and miRNA-204 
miRNA-125b is reported to be important in several important cardiac developments such as 
differentiation, proliferation, metastasis, apoptosis and immune system via different pathways 
(Sun et al. 2013). miRNA-125b is a novel regulator of cardiac fibrosis, proliferation, and activation 
of cardiac fibroblasts (Nagpal et al. 2016). miRNA-204 is upregulated by endurance exercise 
training in rodent hearts (Ramasamy et al. 2015). miRNA-125b is a cardiac-miRNA which helps 
to protect the heart from ischemia reperfusion injury and also prevents the apoptosis of 
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cardiomyocytes (Wang et al. 2014). miRNA-125b acts as a strong repressor of multiple 
mechanisms of anti-fibrosis is required and crucial for the induction of cardiac fibrosis (Nagpal et 
al. 2016). The induction of miRNA-125b has been found in fibrotic models of humans and 
murines. miRNA-125b inhibits the induction of p53 and promotes fibroblast proliferation (Nagpal 
et al. 2016). Importantly, deletion or silencing of miRNA-125b rescues the angiotensin II-induced 
fibrosis including both perivascular and interstitial fibrosis (Nagpal et al. 2016). miRNA-125 
expression is increased during both cardiac development and iPS-derived cardiomyogenesis, 
suggestive of playing a pivotal role during muscle development (Lozano-Velasco et al. 
2015). miRNA-125b plays an essential role in cell differentiation and proliferation with possible 
involvement in cell division and growth. It has been shown to be up-regulated in hypertrophy in 
vitro and in vivo in rats and human embryonic stem cells (Huang et al. 2012; Lin et al. 2011; Wang 
et al. 2014; Wong et al. 2012; Yang et al. 2009). 
miRNA-204 drives cardiomyocyte proliferation in different periods of heart growth via the Jarid2 
signaling pathway (Liang et al. 2015) and plays a crucial role in cardiac myogenesis and plasticity 
(Sluijter 2013). It is expressed in cardiomyocytes and arterial smooth muscle cells and is encoded 
by the TRPM3 gene (Sluijter 2013). miRNA-204 targets Jarid 2 pathway which regulates cardiac 
hypertrophy (Liang et al. 2015). By overexpressing the miRNA-204 in cultured rat 
cardiomyocytes, the knockdown of Jarid2 represented the pro-proliferative effect of miRNA-204 
overexpression (Liang et al. 2015). While an enhanced expression of Jarid2 provides 
cardiomyocytes with resistance to proliferation (Liang et al. 2015). In rats, miRNA-204 plays a 
crucial role in controlling the autophagy of myocytes via autophagosomal marker called LC3-II 
protein during IR (ischemia reperfusion) (Xiao et al. 2011). Autophagy is programmed cell death 
which is considered essential for cell homeostasis and miRNA-204 plays a role in the survival of 
cell via necrosis and apoptosis (Melendez et al. 2003; Otto et al. 2003; Stromhaug et al. 2001). 
The level of autophagy is very low in physiological while high in pathological conditions 
(Gustafsson et al. 2008; Zhang et al. 2009). Earlier studies suggested that autophagy could be 
essential for the maintenance of cardiomyocyte homeostasis as cardiomyocytes are terminally 
differentiated cells with no capability of further division (Gustafsson et al. 2008; Zhang et al. 
2009). miRNA-204 upregulates following endurance training in rat hearts (Jian et al. 2011; Sluijter 
2013). 
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miRNA-208b and miRNA-222  
miRNA-208b is expressed in heart muscle as well as in skeletal muscle (van Rooij et al. 2009). It 
is encoded with an intron of the myh7 gene, the βMHC gene (Callis et al. 2009). miRNA-208b is 
involved in the myosin formation and activation of transcriptional genes (Notari et al. 2015). For 
instance, the overexpression of miRNA-208b leads to the repression of transcription factor gata4, 
the post-transcriptional genes including myostatin and TNF receptor-associated protein 1 (Trap1) 
(Notari et al. 2015). The deletion of miRNA-208b led to a reduction the contractility of the 
heart, possibly due to the perturbations in the conduction system of the heart (Callis et al. 2009). 
But it has also been indicated that deletion of miRNA-208b could improve the functions of heart 
and survival during heart failure (Montgomery et al. 2011). miRNA-208b significantly upregulates 
in trained rats with physiological cardiac hypertrophy (Ramasamy et al. 2015). 
In response to exercise, miRNA-222 regulates the short-term growth of the heart and 
cardiomyocytes (Liu et al. 2015). An increase in the expression of miRNA-222 is shown to induce 
physiological growth of cardiomyocytes in neonatal rodents (Liu et al. 2015) and regulates 
increased cardiomyocyte size after training in rodents (Liu et al. 2015). Liu et al. (2015) implicated 
miRNA222 to be important for endurance exercise induced growth and proliferation of 
cardiomyocyte in the adult heart and that it plays important role in protecting the heart against 
adverse remodeling after ischemic injury. Liu et al. (2015) showed that the inhibition of 
miRNA222 can completely block the heart and cardiomyocyte growth towards exercise response 
which indicates that miRNA222 may preserve cardiac structure and function (Liu et al. 2015). 
Given the novel finding of increased heart mass in the adult heart with only few weeks of exercise 
training in the juvenile life, the investigation of above mentioned miRNAs may have important 
role and may express with few weeks of juvenile life exercise training, hence, it is important to 
measure the expression of the above mentioned miRNAs in the hearts of the juvenile and adult 
endurance trained rats. 
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1.11 Project Rationale, Aims, and Hypothesis 
Cardiac hypertrophy is an increase in heart mass and occurs in response to specific stimuli that, 
depending on its nature, induces either physiological or pathological hypertrophy. There are 
striking molecular and structural differences between physiological cardiac hypertrophy following 
endurance exercise training and pathological hypertrophy induced by chronic pressure (such as 
hypertension) or volume overload (Chelliah et al. 2009; McMullen et al. 2007a). At a 
morphological level, the earliest stages of hypertrophy appear quite similar (Tardiff 2006) but later 
pathological cardiac hypertrophy leads to CVD, for example, heart failure and arrhythmia, while 
physiological hypertrophy does not (Hou et al. 2012; Tardiff 2006).Exercise training is beneficial 
for the health and normal functioning of the cardiovascular system (Elder et al. 2007; McMullen 
et al. 2007b; Scharhag et al. 2002; Torrent-Guasp et al. 2005). Exercise has been reported to induce 
beneficial effects by reducing CV disease risk. It directly affects the remodeling of the heart by 
inducing physiological, concentric or eccentric hypertrophy both at a molecular and cellular level 
(Ellison et al. 2012). The benefits of exercise for heart health are multifaceted, including important 
systemic effects as well as beneficial alterations within the muscle of the heart itself (McMullen 
et al. 2007b). These alterations include an increase in heart mass, structure, area, cardiomyocyte 
morphology and enhanced heart functions such as cardiac output. 
In humans, the physiological cardiac hypertrophy induced by endurance exercise results in normal 
systolic and diastolic cardiac function with increased LV wall thicknesses and LV internal 
diameter (Pluim et al. 2000). Exercise training increases ventricular compliance of the chamber by 
increasing wall thickness, which is attributed to a decrease in the diastolic stiffness of the 
myocardial wall (Woodiwiss et al. 1995). Numerous studies have reported the exercise-induced 
cardiomyocyte hypertrophy on the rat heart (Hoydal et al. 2007; Moore et al. 1993; Wisloff et al. 
2001). Endurance training induces hypertrophy in ventricular cardiomyocytes, improves 
cardiomyocyte shortening and rates of contraction-relaxation providing the cellular basis for the 
overall functioning of heart (Kemi et al. 2005; Kemi et al. 2010; Moore et al. 1993; Ramasamy et 
al. 2015; Wisloff et al. 2002; Wisloff et al. 2001).  
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According to earlier studies, the proliferative capacity of cardiomyocytes in the mammalian heart 
is dramatically decreased after birth, whereby much of the postnatal growth of the cardiac muscle 
is due to cardiomyocyte hypertrophy and extracellular matrix deposition (Bergmann et al. 2009; 
Bersell et al. 2009; Kajstura et al. 2010). Recent studies have established in rodents that endurance 
training can increase cardiomyocyte proliferation (Bostrom et al. 2010; Waring et al. 2015; Waring 
et al. 2012). By using BrdU to detect new myocyte formation, Waring et al. (2015) found that four 
weeks of endurance training in adolescent rats (10 weeks of age) led to a 7% increase in newly 
formed cardiomyocytes (Waring et al. 2015; Waring et al. 2012). The findings suggest that the 
rodent heart undergoes both cardiomyocyte hypertrophy and proliferation as an adaptation to 
endurance exercise (Waring et al. 2015; Waring et al. 2012). 
These functional and structural changes evidenced with exercise training lasts for few weeks in 
adult rats once training is stopped and then reverts back to pre-training levels (Benito et al. 2011; 
Kemi et al. 2005; Powers et al. 2002). However, recent work by Waring et al. (2015) in adolescent 
rats has shown that the exercise-induced increase in cardiomyocyte number and capillary density 
remain elevated for up to 4 weeks after training is stopped, despite cardiac function and heart mass 
returning to pre-training levels (Waring et al. 2015). These findings suggest that not all cardiac 
adaptions to exercise training are reversible, at least in the short-term. Recently, Wadley et al. 
(2016) reported a sustained 10% increase in heart mass of adult rats who underwent a few weeks 
of endurance training in juvenile life. Treadmill running was performed from 5 to 9 weeks of age 
for the juvenile trained rats, followed by detraining until 24 weeks of age. Another group of adult 
rats completed the same training protocol from 20 to 24 weeks of age (Wadley et al. 2016). Both 
juvenile and adult exercised rats displayed a 10% increase in heart mass in adulthood (Figure 1.1) 
with no adverse effects on blood pressure (Wadley et al. 2016). These findings suggest exercise 
interventions during a critical window of growth and development such as juvenile or even 
adolescent life, may elicit a ‘reprogramming’ effect in the heart when it is undergoing rapid growth 
and plasticity during these times. However, Wadley et al. (2016) did not explore the morphological 
and functional effects of juvenile exercise on the adult heart, which will be the focus of this thesis.  
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 Hence, the aims of this thesis are: 
Aim 1: To investigate if juvenile exercise (5-9 weeks of age) in male rats improves 
properties of the adult heart including heart structure, function, and morphology 
measured at 9 and 24 weeks of age. These properties include; 
i) LV wall mass, thicknesses, area and diameter for the heart structure 
ii) Contractility and cardiac output for heart function 
iii) Cardiomyocyte number, size and analysis of fibrosis for heart morphology 
Hypothesis: It is hypothesized that endurance training during juvenile life in male rats will 
improve LV mass, wall thicknesses, heart mass, dimensions and cardiomyocyte 
number and size without altering fibrosis in adulthood. 
Aim 2: To establish the juvenile period (5-9 weeks of age) compared to the adolescence 
(11-15 weeks of age) and adult (20-24 weeks of age) periods as a unique stage of 
development for short-term endurance exercise-induced physiological cardiac 
regeneration measured in the adulthood. 
Hypothesis: It is hypothesized that the juvenile period compared to the adolescence or the adult 
periods in rats is a unique stage of heart growth amenable to long-term cardiac 
programming by short-term endurance training. 
Aim 3: To quantify mRNA and miRNA expression to investigate the likely mediators of 
juvenile exercise-induced pathways in the juvenile and adult heart. 
Hypothesis: It is hypothesized that endurance training during juvenile development will result 
in an elevation in workload imposed on the heart can occur either by exercise training, 
which is transient and non- pathological or a sustained increase in the expression of 
mRNA and miRNA species in the heart involved with muscle growth and 
development. 
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CHAPTER 2 Methods 
2.1 Ethics and experimental protocol 
This study was approved by The Deakin University’s Ethics Committee Geelong (AEX 09-14) 
and The University of Melbourne’s Animal Experimentation Ethics Sub-Committee (AEC - ID # 
121675) prior to all experimental procedures performed on animals. Wistar-Kyoto (WKY) rats, 
aged 4 weeks, were obtained from the Australian Resource Centre (Murdoch, WA, Australia). The 
rats were housed in plastic cages. Humidity and temperature were kept constant at 19-22°C with a 
12-hour light-dark cycle, regularly cleaned and rats had access to standard rat chow and water ad 
libitum. Experimental protocol for all studies is given in Figure 2.1 (A - D). The four treatment 
groups including sedentary (n=48), juvenile exercise (n=48), adolescent exercise (n=12) and the 
adult exercise (n=23) were divided into two cohorts (Figure 2.2), which were needed to address 
the different aims of this project. The rats were randomly allocated into four experimental 
treatment groups involving different life-course exercise regimes as described below: 
1) Sedentary/Control: 
Sedentary are the control rats and did not perform any exercise. Some of the sedentary rats 
were killed at 9 weeks of age (n=15) while others were killed at 24 weeks of age (n=12). 
2) Juvenile exercise training: 
Juvenile rats were trained from 5-9 weeks of age. Some of the juvenile rats were killed at 
9 weeks of age (n=15) while others were killed at 24 weeks of age (n=23). 
3) Adolescent exercise training: 
Adolescent rats were trained from 11-15 weeks of age and were killed at 24 weeks of age 
(n=12).  
4) Adult exercise training 
Adult rats were trained from 20-24 weeks of age and were killed at 24 weeks of age (n=23). 
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Figure 2.1 outlines the two cohorts. Cohort 1 was designed to address aim 1 and 2 by analysing 
the perfusion fixed hearts for heart structure, function and morphology. Cohort 2 was designed to 
address aim 3 by analysing the frozen hearts for mRNA and miRNA expression.  
Figure 2.2 describes when measurements of 24-hour food intake, respiratory analysis and 
echocardiography and post mortem were conducted. Food intake over 24-hours was measured at 
7, 13, 16 and 24weeks of age. Indirect calorimetry and physical activity was measured by CLAMS 
(Comprehensive laboratory animal monitoring system) at 18 weeks of age. Echocardiography 
measurements were taken for all groups 48 hours prior to post mortem.  
Figure 2.3 outlines the process of how hearts from cohort 1 were randomly selected (n=8) and 
stereologically analysed to characterize the morphological changes.  
Figure 2.4 describes the measurements performed for cohort 2, which was similar to cohort 1 
except that they were not perfusion fixed and no CLAMS and echocardiography was performed.
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Figure 2.1: Sample size and grouping of rats in 2 cohorts 
Cohort 1: Designed to address aim 1 and 2 by investigating heart structure and function with echocardiography and rat hearts were 
perfusion fixed for histological analysis; Cohort 2: Designed to address aim 3 for the mRNA and miRNA analysis with rat hearts being 
quickly frozen in liquid nitrogen at post mortem. 
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Figure 2.2: Cohort 1 to achieve aims 1 and 2  
The treatment groups included were: Sedentary with no exercise training and Juvenile exercise training (5-9 weeks of age) with ECHO 
followed by necropsy at 9 or 24 weeks of age, whereby the rats were perfusion-fixed and hearts collected; Adolescent exercise training 
(11-15 weeks of age) and Adult exercise training (20-24 weeks of age) with ECHO followed by necropsy at 24 weeks of age, whereby 
the rats were perfusion-fixed and hearts collected. 
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Figure 2.3: Protocol for morphological analysis in Aims 1 and 2 
Hearts collected after post mortem were processed and stained for the stereological estimation of cardiomyocyte number, nuclearity, 
size and fibrosis. 
  
Page | 50  
 
 
Figure 2.4: Cohort 2 to achieve Aim 3 
The treatment groups included were: Sedentary with no exercise and Juvenile exercise training (5-9 weeks of age) weighed and post 
mortem at 9 or 24 weeks of age and Adult exercise training (20-24 weeks of age) weighed and post mortem at 24 weeks of age 
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2.2 Exercise training protocol 
The exercise training protocol was the same for all rats allocated to either the juvenile, adolescent 
or adult exercise training groups, such that all exercise groups performed the same absolute 
workload at their specific exercise training periods of life. Twenty-four hours after the last bout of 
exercise of the adult group, echocardiography was performed for all rats, followed by another 24 
hours when the rats were killed and hearts collected. For both cohorts, all the rats were killed 48 
hours following the last bout of exercise running in the adult exercise group.  
A motorised treadmill (Columbus Instruments, Columbus, OH, USA) exercised up to three rats 
simultaneously in individual lanes (Figure 2.5). For the purpose of acclimatisation, all rats 
allocated to the exercise groups were trained at 15 m/min for 20 mins on day 1 with an additional 
10 mins per day on subsequent days, increasing up to 60 mins for the first week. For the following 
three weeks of training, rats were exercised for one hour per day at a speed of 20 m/min. Rats were 
encouraged to run by blowing compressed air near the base of their tail (Laker et al. 2011; Wadley 
et al. 2016). Sedentary rats were housed in the same room and were placed in stationary treadmills 
during the allocated running times of the exercise groups and therefore, were subjected to the same 
environmental stimulation. 
 
Figure 2.5: Exercise training  
Rats training on a motorized treadmill at a speed of 20 m/min. 
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2.3 Body weight and food intake measurements  
Body weights were measured each day (5 days/week) during the exercise training period, for all 
animals. Twenty-four-hour food intake was measured for a single day at 7, 13, 16 and 21 weeks 
of age for all groups allocated to 9 or 24 weeks post mortem (Figure 2.2 and 2.4). For food intake 
measurement, rats were separated into individual cages with a known quantity of standard rat chow 
and water ad libitum. After 24 hours the remaining food, as well as any that had dropped into the 
box, was weighed and recorded. Food intake relative to body weight was subsequently calculated.  
2.4 Comprehensive lab animal monitoring system (CLAMS) 
Oxygen consumption (VO2) and carbon dioxide production (VCO2) were measured at 18 weeks 
of age for all rats using a Comprehensive Lab Animal Monitoring System; (CLAMS; Columbus 
Instruments, Columbus, OH, USA). CLAMS is an open circuit indirect calorimetry system that 
simultaneously calculates the animal activity, body mass and energy expenditure in the chamber. 
CLAMS also assessed the exchange of oxygen for carbon dioxide that occurs during the metabolic 
process. Respiratory exchange ratio (RER) was measured as VCO2/VO2. 
CLAMS cages were provided with tap water, food, paper bedding and fresh sawdust under 
chamber bottom, to absorb urine. Following a 30mins of gas equilibration in the interior of the 
chamber, four rats were measured simultaneously in separate cages. VO2 consumption and VCO2 
production were determined every 10mins over a 24hour period. Controlling software (7400 
Oxymax Single Chamber, Columbus Instruments, Columbus, OH, USA) provided specific 
calorimetric measurement and recording of VO2 and RER. Heat was derived by assessment of the 
exchange of oxygen for carbon dioxide that occurs during the metabolic process. The relationship 
between the VO2 consumption and VCO2 production revealed the calories of the foodstuff utilized 
by the animal. The ‘calorific value’ (CV) was then applied to the volume of gases exchanged to 
compute heat (CV * VO2). The following measurements were performed with CLAMS. 
  
Page | 53  
 
 VO2 = Rate of O2 consumption (ml/kg/hr) 
 DO2 = O2 concentration difference  
 AO2 = Accumulative O2 consumption (L) 
 VCO2 = Rate of CO2 production (ml/kg/hr) 
 DCO2 = CO2 concentration difference 
 ACO2 = Accumulative CO2 production (L) 
 RER = Respiratory exchange ratio (VCO2/VO2) 
 Heat = Rate of heat production (kcal/hr) 
 FLOW = Mass of air entering chamber (lpm) 
 X TOT = Total number of X-axis IR-beam breaks (counts) 
 X AMB = Number of ambulatory X-axis IR-beam breaks (counts) 
 X TOT = Number of vertical (rearing) motions (counts) 
The key parameters corresponding to the following 24hour period were split and averaged 
according to 12 hour light and 12hour dark phases, where 06:00 to 17:59 was the light phase and 
18:00 to 05:59 was the dark phase. Calculations were completed in real-time, as measurements 
were taken. 
  
Page | 54  
 
2.5 Echocardiography  
For the in vivo assessment of cardiac function, echocardiography was performed at 6 months of 
age (24 hours after the last exercise session). Rats were weighed and anaesthetized in the induction 
box with isoflurane (approximately 2-3 mins) using a Univentor 400 anaesthetic unit, with an 
induction concentration of 4% oxygen, (flow-rate at 1.5 L/min) (Figure 2.6 A and B). Upon visual 
observation, the unconscious rat was placed supinely onto a warming pad. This was followed by a 
maintenance concentration of 2.5% (isoflurane) delivered by a nose cone for about 30 mins. After 
checking pedal reflexes, the rat was then shaved antero-laterally from the mid-thorax extending 
beneath the axilla down to the mid-abdomen, ensuring maximum exposure of the left lateral chest 
wall and thus facilitating contact of the skin with the ultrasound probe. The rat was stabilized by 
taping the tail and extended right arm and electrocardiogram (ECG) clips applied (Figure 2.7 A). 
ECG clips were carefully positioned to measure surface potential (followed the propagation of 
electrical conductance along the heart; Lead I (top). The resulting ECG trace (bottom) assisted in 
determining stages in cardiac cycle when taking measurements in systole and diastole. The QRS 
segment represents left ventricular depolarization (systole) and the T wave represents ventricular 
relaxation (diastole) (Figure 2.7 B). 
2D-mode echocardiography was performed using a 7.5 mHz, linear array transducer and Vivid 7 
Echocardiography machine (GE Healthcare, Horten Norway) (Figure 2.6). Ultrasound gel 
(Comedical, Mattarella, Italy) was applied to the probe (transmission of ultrasound was optimized 
by applying copious quantities of transducer gel onto the imaging site). The probe was placed on 
the left anterior chest wall, at the 2nd - 4th intercostal spaces with gentle pressure. Angulation and 
rotation of the probe provided a parasternal short-axis view (PSAX) of the heart. The transducer 
position was adjusted until the septal and posterior endocardial walls were well defined. Settings 
were adjusted to maximise quality of the image and to define endocardial borders (imaging depth 
3cm).  
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Figure 2.6: 2D-echocardiagraphy setup 
ECHO Setup to take images using the panel by freezing images (a): The induction box and 
apparatus used to anaesthetize the rat (b). 
 
Figure 2.7: Echo-electrocardiogram 
Leads positions for ECHO to assess hear rate (a); heart rate during echocardiography is determined 
by electrocardiogram (b).  
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2.5.1 Left ventricle 
A well-defined view of the left ventricle was obtained to enable the view of cardiac cycles, 
permitting measurements to be taken at either systole or diastole. Measurements of the left 
ventricular internal diameter (LVID) and chamber wall thicknesses were obtained in PSAX, and 
used to calculate fractional area change (FAC) and fractional shortening (FS), respectively (Figure 
2.8 A). The parasternal long axis view (PLAX) was obtained by rotating the probe 90°, counter 
clockwise from the PSAX position. In this view, measurements were taken when the left atrium 
and mitral valve appeared posterior and the LV chamber was elongated, conical and not 
foreshortened in shape. Interventricular septum, posterior wall thicknesses and LV internal 
dimensions were measured (Figure 2.8 B). All measurements were made at end-diastole and if 
appropriate, end-systole, using criteria analogous to conventions recommended by the American 
Society of Echocardiography guidelines for clinical use in humans (Lang et al. 2005). 
Left ventricular area (LVA) and left ventricle internal dimension (LVID) were measured in both 
systole and diastole stages of the cardiac cycle (denoted by an ‘s’ or ‘d’ respectively, following 
the parameter abbreviation). Relative wall thickness (RWT) was determined at end-diastole (Tyagi 
2000) and left ventricular mass (LVM) was estimated using a geometric equation suitable for 
rodent models (Litwin et al. 1995). Contractility function of the heart was measured by regional 
left ventricular function and assessed by changes in fractional area change (FAC; determined by 
cavity area) and fractional shortening (FS; determined by cavity diameter) during systole and 
diastole (Figure 2.8 A and B). At least three recordings were taken for both PSAX and PLAX 
views, allowing for measurements to be taken multiple times and hence an accurate average 
(Mayet et al. 2000; Pawlush et al. 1993). 
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Summary of key echocardiographic parameters of the LV heart are as follows; 
LVA = Left ventricular area (cm2)  
PWT = Left ventricle posterior wall width (mm) 
RWT = Left ventricular relative wall thickness = (2 x PWT) / LVIDd 
IVS = Interventricular septum width (mm) 
LVID = Left ventricle internal dimension (cm) 
LVM = Left ventricular mass (g) = 1.04 * [(LVIDd+PWT+IVS) 3-LVIDd3] * 0.8+0.14 
FAC = Fractional area change (%) = [(LVAd-LVAs)/LVAd] * 100 
FS = Fractional shortening (%) = [(LVIDd-LVIDs)/LVIDd] * 100 
EF = Fractional shortening (%) = [(EDV-ESV)/EDV] * 100 
LVOT = LV Outflow Tract 
CO = Cardiac Output = SV x HR (SV = Stroke Volume (ml) and HR = Heart rate (bpm) 
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Figure 2.8: Echo-PSAX and PLAX Views 
Parasternal short axis view (SAX) (a) and Parasternal long axis view of the heart (PLAX) (b). 
Image retrieved from http://www.med.yale.edu/intmed/cardio/echo_atlas/contents/index.html 
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2.5.2 Right ventricle 
2D Echocardiography was also performed on the right ventricle (RV). RV linear dimensions were 
measured with a four chamber view by taking measurements of RV basal diameter (RV1), RV mid 
cavity diameter (RV2) and RV base to apex diameter (RV3) (Figure 2.9 A-C). RV Area was 
assessed by tracing the endocardial boarders (epicardium and endocardium) on the apical or 
subcostal four-chamber view (Figure 19 D and E). RV outflow tract (RVOT) diameters including 
RVOT proximal and RVOT distal were measured at the sub costal view (Figure 2.10 A and B). 
RV fractional area change (RVFAC) was obtained from a four-chamber view where the RV end-
diastolic (RVEDA) and end-systolic areas (RVESA) were measured, and the RVFAC was 
calculated as follows: RVFAC (%) = (RVEDA−RVESA)/RVEDA (Figure 2.10 C and D). To 
calculate right ventricular stroke volume, width of the pulmonary artery and the velocity time 
integral across the pulmonary valve / RVOT was measured using pulse doppler VTI (velocity time 
integral) images taken at the four-chamber view (Figure 2.10 E and F).  
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Figure 2.9: Echo-RV four chamber view 
Four-chamber view (a): RV basal diameter (RV1) (b), RV mid cavity diameter (RV2) and RV 
base to apex diameter (RV3) (c): RV epicardium (d) and RV endocardium (e). Images retrieved 
from https://web.stanford.edu/group/ccm_echocardio/cgi-bin/mediawiki/index.php 
Page | 61  
 
 
Figure 2.10: Echo-RV chamber views 
Proximal and distal diameters of the outflow tract (a and b): Apical four-chamber for area tracing 
of the endocardium at diastole (left; image c) and systole (right; image d) to determine the 
fractional area change (%): Width of the pulmonary artery and the velocity time integral across the 
pulmonary valve / RVOT was measured for stroke volume (e and f). Images retrieved from 
https://web.stanford.edu/group/ccm_echocardio/cgi-bin/mediawiki/index.php/Main_views 
  
Page | 62  
 
2.6 Perfusion fixation and post mortem tissue collection (Cohort 1) 
Twenty-four hours after echocardiography, animals were anaesthetized via an intraperitoneal 
injection of Ilium Xylazil-20 (30 mg/kg) and an intraperitoneal dose of Ketamine (100 mg/kg) 
(ketamine and xylazil from Troy Laboratories Pty Ltd, Smithfield, NSW, Australia) (Wlodek et 
al. 2007). A level of deep anaesthesia was confirmed by the absence of corneal and pedal reflexes 
and the rats were then perfusion fixed. Perfusion fixation involved an initial long midline incision 
with lateral extensions within the abdominal wall (Lim et al. 2011). An intravenous (IV) catheter 
(24 gauge x 19 mm Teflon tubing; CH2 Clifford Hallam Healthcare, Dandenong, VIC, Australia) 
was inserted into the abdominal aorta just above the iliac bifurcation; heparin (0.1 ml heparin 
sodium injection Mayne Pharma ltd, Mulgrave, VIC, Australia), papaverine hydrochloride (0.1ml 
papaverine hydrochloride pre-made at 120 mg.10 ml; Pickford Pharmacy, Carlton, VIC, Australia) 
and potassium chloride (0.1 ml/400 g body weight potassium chloride 1M; Merck Pty. Ltd., 
Kilsyth, VIC, Australia) were injected into the blood stream via the catheter to prevent the blood 
from clotting, to maximally dilate the vasculature and to arrest the heart in diastole, respectively 
(Gallo et al. 2012).  
Saline solution (0.9%; Baxter Healthcare Pty Ltd., Toongabbie, NSW, Australia) was then 
perfused via the abdominal aorta using a perfusion pump (Masterflex, Cole Parmer Instruments 
Co., Chicago, Illinois, USA) to clear the vasculature (300-500 ml). When the blood had cleared 
from the liver and the mesenteric vessels (indicated by a change in colour from dark red to pale 
pink) the perfusion pump was switched to 4% paraformaldehyde (PFA; Scharlab, Sentmenat, 
Spain) until the organs became stiff (300-500ml of PFA) (Black et al. 2012; Gallo et al. 2012). 
Once the animal was fixed, the heart was excised and weighed. The LV was then separated from 
the RV, and the atria and connective tissue excised. The LV was weighed and stored in 10% 
Neutral Buffer Formalin (NBF) until later stereological analysis (Bensley et al. 2010; Stacy et al. 
2009). Muscles, kidneys, eyes and brain were also collected from the animal at necropsy.  
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2.7 Post mortem tissue collection (Cohort 2) 
All the rats were anaesthetized via an intraperitoneal injection of Ilium Xylazil-20 (30 mg/kg) and 
Ketamine (100mg/kg) (ketamine and xylazil Troy Laboratories Pty Ltd, Smithfield, NSW, 
Australia) (Wlodek et al. 2007). A level of deep anaesthesia was confirmed by the absence of 
corneal and pedal reflexes. A midline incision was made and the chest cavity was opened (Lim et 
al. 2011). The whole heart was rapidly excised, washed with cold saline and weighed. The LV was 
then separated from the RV, and the atria and connective tissue excised, weighed and rapidly 
frozen in liquid nitrogen. The LV was crushed into a powder in liquid nitrogen and then stored at 
-80°C for later analysis (Section 2.10). 
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2.8 Stereological heart sampling 
The LV was cut into 1mm slices using dental sheet and a razor blade slicing device (Figure 2.11 
A - D) (Black et al, 2012; Corstius et al, 2005). LV slices were placed in 70% ethanol in preparation 
for tissue processing. Sampling of the LV for morphological and stereological analyses was 
performed using a smooth fractionator approach. six to ten pieces were sampled for embedding in 
glycolmethacrylate (for stereological analysis) and the consecutive six to ten  pieces were 
embedded in paraffin for assessment of cardiomyocyte nuclearity using confocal microscopy and 
cardiac fibrosis using image analysis.  
 
Figure 2.11: LV slicing for stereological analysis 
LV on the dental sheet (a); Razor blade slicing device (b); sliced LV heart on razor blade (c); sliced 
LV (d). 
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2.8.1 Glycolmethacrylate embedding 
Every second slice of the LV+S was embedded in glycolmethacrylate (GM). The heart tissue was 
dehydrated through grades of alcohols. The tissue was then left overnight in a GM infiltration 
embedding solution without hardener (Technovit 7100 resin without hardener 2; Heraeus Kulzer, 
Wehrheim, Germany). The heart tissue was then placed in a plastic embedding mould filled with 
GM infiltration embedding solution with hardener (Technovit 7100 kit; Heraeus Kulzer, 
Wehrheim, Germany) and allowed to set for 36hours. Once set, backing blocks were made using 
a Technovit 3040 resin (Heraeus Kulzer, Wehrheim, Germany) and were adhered to the GM 
blocks. The blocks were then left to sit at room temperature overnight. All tissue blocks were 
coded by an independent investigator so that the stereological and image analyses were performed 
in a blinded manner, to remove any bias during analyses (Figure 2.12 b and c). 
2.8.2 Glycolmethacrylate sectioning and staining 
The GM blocks were exhaustively serially sectioned at 20 µm on a Leica RM 2165 Microtome 
(Leica Microsystem GmbH, Nusstosh, Wetzlar Germany) using a Ralph glass knife (Knife Breaker 
LKB 2078, Linbrook International Pty. Ltd., Woolloongabba, QLD, Australia) (Figure 2.12 c). 
Every 10th section from the GM blocks was collected and mounted on glass slides (SuperFrost 
Plus® Menzel GmbH and Co. KG, Braunschweig, Lower Saxony, Germany) (Figure 2.12 d). The 
sections were stained with Haematoxylin for nuclei visualisation. Staining was carried out using a 
1000W microwave, to ensure full penetration of the Haematoxylin into the 20 µm resin section, at 
50% power for 4.5 mins. After heating, the slides were left to stand in the Haematoxylin for 2-3 
mins before rinsing in a container of lukewarm water to wash away excess stain for 5 mins (Figure 
2.12 d). Slides were then allowed to dry overnight at room temperature. Once dried, the slides 
were cover slipped with DPX mountant and left to air dry for at least 3 days before being analysed. 
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Figure 2.12: Blocks embedding, sectioning and staining 
Embedded blocks in resin (a): Embedded block coded by histology team (b): Block mounted on a 
microtome for sectioning (c): Hematoxylin stained section (slide) for stereological analysis (d). 
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2.8.3 Stereological estimation of cardiomyocyte number 
2.8.3.1 Optical disector/fractionator approach 
The total number of cardiomyocyte nuclei in the LV of each heart was determined using an optical 
dissector/fractionator approach in the Haematoxylin stained glycolmethacrylate embedded 
sections (Bensley et al. 2010; Corstius et al. 2005; Stacy et al. 2009). This method involved using 
an Olympus BX51 microscope fitted with a motorised stage (Olympus, Tokyo, Japan). Counting 
of cardiomyocyte nuclei was performed using the C.A.S.T. (Computer Aided Stereological 
Toolbox) stereological program (Olympus, Alberstand, Denmark). This method provides an 
unbiased estimate of cardiomyocyte number.  
Initially the sections mounted on slides were placed onto a microscope stage and viewed under 
1.25x magnification. The tissue was then traced and fields of view determined using a uniform 
systematic sampling method. Beginning from a random point the sections were then systematically 
sampled in the x-axis and y-axis using a step length of 1200 μm. To account for inconsistencies in 
cutting, only the middle 10µm (along the z-axis) of the tissue sections were counted. An unbiased 
counting frame (area 544.5 µm2) was superimposed over each field of view at 100x magnification. 
Cardiomyocyte nuclei were counted only if they came into focus within the counting frame, 
including cardiomyocyte nuclei that crossed the upper and right-hand edges of the counting frame 
(indicated by green lines, Figure 2.13), and were not counted if they touched the left or lower edges 
of the counting frame (indicated by red lines, Figure 2.13). Cardiomyocyte nuclei were identified 
from the nuclei of other cells by their elongated oval-shaped appearance, light purple stain and 
prominent nucleoli (Bruel et al. 2005). The total number of nuclei counted (Q-) was multiplied by 
the inverse of the sampling fractions to estimate the total number of cardiomyocyte nuclei in the 
left ventricle of the animal. 
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Figure 2.13: Cardiomyocyte counting 
An unbiased counting frame super imposed over cardiomyocytes in the field of view at 100x 
magnification. The green lines represent inclusion lines and the red lines are the exclusion lines. 
Cardiomyocyte nuclei were only counted if part or whole were within the counting frame or were 
touching the green lines when they came into focus within the middle 10 µms of the section. In 
this image only the nuclei indicated at by the yellow arrows would be counted. Note: The green 
lines are dashed here to make the lines more visible. 
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 2.8.3.2 Calculations 
The total number of cardiomyocyte nuclei within the LV was determined by multiplying the 
number of cardiomyocyte nuclei counted, using the optical dissector approach, by the reciprocal 
of the sampling fractions according to the formula:  
Total number of cardiomyocyte nuclei = Q- × 1/F1 ×1/F2 × 1/F3 × 1/F4 
Where, 
Q- = number of cardiomyocyte nuclei counted using the optical dissector 
f1 = the sampling fraction relating to the slices of LV sampled (every 2nd slice of LV was 
embedded) 
f2 = the sampling fraction relating to the sections collected and analysed (every 20th section was 
collected) 
f3 = sampling fraction relating to the depth of the section in which cardiomyocytes were counted 
(middle 10 µm in the 20 µm section) 
f4 = the fraction relating to the relative area of the counting frame within the sampled fields 
(544.5/1200x1200) 
The total number of cardiomyocytes in the LV was subsequently determined from the nuclear 
counts, by adjusting for the proportion of mononucleated, binucleated and trinucleated 
cardiomyocytes in the LV; this was determined using confocal microscopy (in section 2.10). 
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2.9 Paraffin embedding 
Tissues (mentioned in section 2.8) were processed for paraffin embedding. three to five tissue 
sections were then placed in an embedding mould and embedded in paraffin wax. A backing 
cassette was then adhered to the blocks and they were left to sit on a cold plate until set. For each 
heart, two blocks were prepared to be used for the analysis of cardiomyocyte nuclearity and size 
and for the estimation of fibrosis. 
2.9.1 Paraffin sectioning and staining for cardiomyocyte nuclearity and area 
To ensure the cardiac muscle was embedded in the correct orientation, an initial 5µm section was 
cut from all blocks and stained with Haematoxylin and Eosin. The tissues were then viewed under 
a light microscope at 60 x magnification and cardiomyocyte orientation was measured. In order 
for analysis, it was necessary for the cardiomyocytes to be oriented in a longitudinal and/or cross-
sectional plane. If cardiomyocytes were not oriented in these planes, the block was melted and 
tissue was re-oriented and embedded. Once optimum cardiomyocyte orientation was achieved, at 
least two full tissue face sections from each block (at least three to four blocks per heart) were cut 
at 40µm and mounted on Superfrost Plus microscope slides (Menzel Gläser 2004). In these thick 
40µm sections cardiomyocyte nuclearity, cross sectional and longitudinal area were measured. 
Paraffin embedded sections were incubated overnight in a solution of wheat germ agglutinin-Alexa 
Fluor 488 (Invitrogen) to stain cell membranes and 4’6-diamidino-2-phenylindole, 
dihydrochloride (DAPI-Invitrogen) to stain cell nuclei. This solution was made by placing 20ml 
of phosphate buffered saline (PBS) into a 50ml vial wrapped in aluminium foil to prevent light 
exposure. To the 50ml vial containing PBS, 1ml of wheat germ agglutinin-Alexa Fluor 488 was 
added. In a separate eppendorf tube 10µl of DAPI was diluted with 100µl of distilled water. This 
mixture was gently shaken. From this, 5µl of diluted DAPI was then added to the 50ml vial 
containing PBS and wheat germ agglutinin-Alexa Fluor 488. This mixture of DAPI, wheat germ 
agglutinin-Alexa Fluor 488 and PBS was then left to incubate for 24 hours on a shaker. Staining 
then proceeded in the following 24 hours.  
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The protocol of staining the paraffin sections initially involved the dewaxing of the sections. This 
was performed by firstly placing the paraffin sections in an oven set at 60°C for 30 mins. This was 
then followed by rinsing the sections three times for 2 mins each in 100% xylene, followed by 
three rinses for 2 mins each in 100% ethanol, before a final rinse in distilled water (for 30 secs). 
The slides were then placed into a plastic slide holder, wrapped with aluminium foil to create a 
light-proof incubation chamber. The dye solution was gently pipetted into the plastic slide holder 
and the slides were left to stand for 24 hours. Following the 24-hour staining period, the slides 
were then removed from the dye solution, placed into a clean plastic slide holder (wrapped with 
aluminium foil) and were washed with two rinses of PBS for 15 mins before being cover slipped 
with Moiwol (prepared by using Moiwol powder; Calbiochem, VIC). 
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2.10 Cardiomyocyte nuclearity, size, area and the number of 
cardiomyocytes per heart 
The proportion of mononucleated and binucleated cardiomyocytes in the LV was determined in 
the 40μm fluorescently labelled paraffin sections using confocal microscopy (Black et al. 2012; 
Lim et al. 2010). Utilising three-dimensional software (Imaris Version 6.1/6.2, Bitplane, AG, 
Zurich, Switzerland), the number of nuclei within at least 200 cardiomyocytes in each heart were 
examined. The percentage of mononucleated, binucleated or trinucleated cardiomyocytes was then 
determined (Black et al. 2012; Lim et al. 2010). The total number of cardiomyocytes within the 
LV was subsequently determined from the initial cardiomyocyte nuclei counts (as described above 
in section 2.8.3) by adjusting for the relative proportions of mononucleated and multinucleated 
cardiomyocytes. 
In addition, the 40 μm paraffin sections stained with wheat germ agglutinin-Alexa Fluor 488 
(Invitrogen, Mulgrave, Victoria, Australia) were also used to trace the cell boundaries of 
cardiomyocytes in longitudinal and cross-sections (NIS-Elements, Nikon, Kawasaki, Kanagawa, 
Japan) (Figure 2.14 A and B). Only cardiomyocytes in the respective sections, where the nuclei 
could be seen in the centre of the cell were analysed (Figure 2.14 C and D). The longitudinal and 
cross-sectional area of approximately 200 cardiomyocytes from each heart were measured. 
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Figure 2.14: Confocal images 
Confocal image of longitudinal cardiomyocytes (a): Mononucleated and binucleated 
cardiomyocyte (b): Confocal image of cross sectional cardiomyocytes (c): Cardiomyocytes were 
only traced (Natali et al. 2001) for cross sectional area if they contained a central nucleus (d). Note: 
To make the nuclei and boundaries more visible in this figure, the cell boundaries are highlighted 
with thick marker tracing. 
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2.11 Fibrosis 
Paraffin-embedded tissues sectioned at 5 μm and stained with a 0.001% Sirius red diluted in picric 
acid were used to assess the levels of fibrosis (interstitial, perivascular and reparative) within the 
myocardium. The sections were viewed under a light microscope at 20 x magnification and 
projected onto a monitor screen with the aid of a CCD camera (Sony XC-77CE CCD, Japan) 
interfaced with a computer. The percentage of collagen within the interstitium was then quantified 
using image analysis (Bensley et al. 2010) (Image-Pro Plus Version 6.0, Media Cybernetics). Each 
sampled field of view was displayed on the monitor and the amount of red staining collagen area 
per total tissue area was measured using the colour analysis tool. A systematic uniform random 
sample of eight fields per section (16 fields from the LV for each heart) was undertaken to analyse 
the levels of interstitial/reparative fibrosis. Collagen area was determined by measuring the area 
of red-stained tissue within a given field and the relative proportion of interstitial/reparative 
fibrosis subsequently determined. 
To measure the perivascular fibrosis, myocardial arteries within each LV section with a diameter 
ranging from approximately 150 to 500 μm were counted. Five to eight intramyocardial arteries 
per tissue were then randomly selected for analysis (Bensley et al. 2010). To determine the area of 
the lumen and adventitia of each artery, the outline of the lumen was traced and by applying color 
tool, the adventitia was measured under 20x magnification using image analysis. The cross-
sectional area of the media of the same vessels was also measured. The areas of the lumen, media, 
and adventitia were subsequently calculated using Image-Pro Plus Version 6.0 (Media 
Cybernetics). The area of adventitia was taken as a measure of perivascular fibrosis. To account 
for differences in the size of arteries sampled, the adventitia:lumen ratio was calculated as a relative 
measure of perivascular fibrosis. The area of the media and media:lumen ratio were also 
determined (Bensley et al. 2010). 
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2.12 Cohort 2 Analyses 
2.12.1 Protein extraction 
For enzyme activity, approximately 30mg of tissue was homogenized in ice‐cold lysis buffer 
(20 μL buffer/mg muscle; 50 mmol/L Tris at pH 7.5 containing 1 mmol/L EDTA, 10% vol/vol 
glycerol, 1% vol/vol Triton X‐100, 50 mmol/L NaF, 5 mmol/L Na4P2O7, 1 mmol/L DTT, 
1 mmol/L PMSF, and 5 µl/mL protease inhibitor cocktail (P8340; Sigma, St. Louis, MO). Tissue 
lysates were then incubated on ice for 20 min and then spun at 10,000 x g for 20 minutes at 4°C.  
2.12.1.1 BCA assay 
The protein concentration of homogenized tissue samples was determined using the bicinchoninic 
acid protein assay (BCA; Pierce Biotechnology, Rockford, IL). Protein homogenate in the diluted 
supernatant (1:10) were compared to known BSA concentrations as a standard (Wadley et al. 
2013). Serial dilutions for a standard curve were prepared as described in Technical Manual (Smith 
et. al. 1985, Thermo Scientific Pierce 2009). 10 µl of each standard and each sample was added to 
a 96-well microplate in replicates of three. Working reagent was prepared using a ratio of 1:50 
(Reagent A: Reagent B) and a green solution was formed. 200 µl of working reagent was added to 
each well using a multichannel pipette. The microplate was placed in an incubator for an hour at 
37°C. Absorbance of each well was read at 595 nm using a microplate reader. The amount of 
protein in each well was calculated by plotting a standard curve by averaging the blank-corrected 
reading for each BSA standard vs. its concentration in μg/ml. By using the standard curve, the 
protein concentration was determined for each sample. 
2.12.1.2 COX activity 
For the determination of cytochrome c oxidase activity in the mitochondria of the sample tissues, 
the COX Assay Kit (Sigma-Aldrich Co. LL) was used. The samples were diluted with enzyme 
dilution buffer with a ratio of 1:100. Ferrocytochrome c Substrate solution (0.22 mM) was reduced 
by adding 5 µl of the 0.1 M DTT solution to a final concentration of 0.5 mM, gently mixed and 
incubated for 15 mins. The 1×Assay Buffer was used to zero the spectrophotometer. For each 
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samples’ activity measurement, 25 µl of the sample + 25 µl of the Ferro C solution + 500 µl of 1 
× Assay buffer was added to a cuvette: covered with parafilm, mixed and quickly placed into the 
spectrophotometer for reading. The decrease in absorption at 550 nm was recorded every 10th 
second for 1 min. The data obtained was normalized to total protein content and the activity 
(µmol/min/g protein) was measured by using the below formula: 
Units/ml = [∆ A/min × 0.55/ (21.84)] dil × / mg protein × 1000 
Where, 
∆ A/min = A/minute (sample)-A/minute (blank) 
A/minute (blank) 
dil = dilution factor of enzyme or sample = 10 
0.025 = sample volume 
mg protein = (protein) × 25/1000 
vol of enzyme = volume of enzyme or sample in ml 
21.84 = ΔƐmM between ferrocytochrome c and ferricytochrome c at 550 nm 
Unit definition: One unit will oxidize 1.0 mM of ferrocytochrome c per min at 25 °C, pH 7.0. 
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2.12.2 Gene expression analysis 
2.12.2.1 RNA extraction for mRNA and miRNA analysis  
Approximately 25-30 mg of the crushed heart tissue was used for RNA extraction using TRIzol® 
reagent (Invitrogen, Mulgrave, VIC) and extracted by using silica-membrane RNeasy spin 
columns and DNase on-column digestion (Qiagen miRNeasy kit) according to the manufacturer's 
protocol. The RNA concentration was assessed using the Nanodrop 1000 Spectrophotometer 
(Thermo Fisher Scientific, MA, USA). The ratio between A260/A280 was 1.5-2.0 for all samples. 
2.12.2.2 Reverse transcription (mRNA analysis) 
First-strand cDNA was generated from 1 μg RNA in 20 μl reaction buffer using the High Capacity 
RT-kit (Applied Biosystems, Carlsbad, CA, USA), 1 × RT buffer and random primers, 8 mM 
dNTP and 2.5 Uμl−1 MultiScribeTM RT enzyme. The RT protocol consisted of 10 min at 25°C, 
120 min at 37°C, 5 min at 85°C then cooled to 4°C. The cDNA was stored at −20°C until further 
analysis. 
2.12.2.3. Optimization (mRNA analysis) 
A serial dilution on the cDNA was performed for each gene and ran real-time polymerase chain 
reaction (RT-PCR) to make a standard curve and checked efficiency. The dilutions of cDNA used 
were 1:10, 1:20, 1:40 and 1:80 and ran in duplicates. All of the genes were found to be efficiently 
expressed in 1:50 dilution. The efficiency curves for each gene are provided in appendix-1. 
2.12.2.4 Real-time PCR (mRNA analysis) 
RT-PCR was carried out using a Stratagene MX3000 thermal cycler to measure mRNA levels. 
mRNA levels were measured using primer sets for the gene of interest (Table 2.1), 1 × SYBR® 
Green PCR MasterMix (Agilent Technologies, Valencia, CA, USA) and 5 µl of cDNA. The PCR 
conditions were 1 cycle of 10 min at 95°C:40 cycles of 30 secs at 95°C, 60 secs at 60°C, 60 secs 
at 72°C: 1 cycle of 60 secs at 95°C, 30 secs at 55°C, 30 secs at 95°C. RT-PCR analyses were 
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conducted in triplicate. Ct values were obtained from the MxPro QPCR software (Agilent 
Technologies, Santa Clara, CA, USA). Mean Ct values and their standard error of the mean (SEM) 
were calculated for each of the samples. Ct values were logarithmically transformed and mean log 
transformed Ct values. The relative quantification of gene expression was performed by the 
comparative CT (ΔΔCT) method using the house-keeping gene ribosomal 18s as the endogenous 
control. The primer sequences used were obtained from gene sequences (GeneBank) (Table 2.1). 
Relative quantification of gene expression was performed by the comparative CT (ΔΔCT) method 
using the housekeeping gene ribosomal 18s. 
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Table 2.1: Primer and sequences 
Accession No. Gene Forward Primer Reverse Primer Primer 
Concentration 
(nM) 
NM_031144 Actb 5’-GACGGAATTTACGGCTCAACAT-3’  5’-AATTAGGAAAGTTGAGCCAATAATTACG-3’  200 
NM_012530.1 ckm 5’-ACAGCAAAGACAGACACTCAGG-3’  5’-GAACTTGTTGTGGGTGTTGC-3’ 200 
NM_017202.1 coxIV  5’-GTGCTGATCTGGGAGAAGAGCTA-
3’  
5’-GGTTGACCTTCATGTCCAGCAT-3’ 200 
NM_001191846.2 foxo1   5’-AAGAGTTAGTGAGCAGGCAAC-3’   5’-CAGAGCACAGGCAGTACACA-3’ 200 
NM_144730.1 gata4  5’-CTCTTCGTCCTTCGCTGGAG-3’  5’-GACTGGTCTCGAACACCCTG-3’ 200 
NM_017239.2 myh6  5’-AAGAGTGACAGGATGACGGA-3’  5’-GTCACCGTCTTGCCGTTTTC-3’ 200 
NM_053651.1 nkx2.5  5’-CCTCGGATTTCACACCCACA-3’  5’-CCGAGGCATCAGGTTAGGTC-3’ 200 
NM_012612.2 nppa 5’-GAAGCGGGGGCGGCACTTAG-3’  5’-TTCGGTACCGGAAGCTGTTGCA-3’  200 
NM_031545.1 nppb 5’-AACAATCCACGATGCAGAAGC-3’  5’-GGCGCTGTCTTGAGACCTAA-3’ 200 
V01270.1 r18s  5’-GCATGGCCGTTCTTAGTTGG-3’  5’-TGCCAGAGTCTCGTTCGTTA-3’ 200 
 
Actb (Beta-actin); ckm (Creatine kinase, muscle); coxIV (Cytochrome C Oxidase IV); foxo1 (Forkhead Box O1); gata4 (GATA 
transcription factor 4); myh6 (Myosin heavy Chain 6); nkx2.5 (Nk2 homeobox 5); nppa (natriuretic peptide A); nppb (Brain natriuretic 
peptide); r18s (Ribosomal 18s) 
Page | 80  
 
2.12.3 miRNA analysis   
2.12.3.1 Reverse transcription (miRNA analysis) 
RNA (5 ng) was reverse transcribed using the Taqman microRNA Reverse Transcription (RT) kit 
(Applied Biosystems). A RT primer pool was prepared by pooling all miRNA-specific primers (1 
μl) of interest. The reaction mix containing 0.3 μl 100 mM dNTP, 3 μl enzyme (50 U/μl), 1.5 μl 
10× RT buffer and 0.2 μl RNase inhibitor (20 U/μl) was added to the pool. A final volume of 15 
μl (11μl + 4 μl of the RNA) was reverse-transcribed with the following conditions: 30 min at 16°C 
to anneal primers, 30 min at 42°C for the extension phase, 5 min at 85°C to stop the reaction. 
cDNA was then stored at -20°C for optimization and further analysis.  
2.12.3.2 Optimization (miRNA analysis) 
A serial dilution on the cDNA was performed for each miRNA and RT-PCR to make a standard 
curve and check efficiency. The dilutions used were 1:10, 1:20, 1:40 and 1:80. All of the miRNAs 
were found to be efficiently expressed in 1:15 cDNA dilution. The efficiency curves for each 
miRNA are provided in appendix-1. 
2.12.3.3 Real-time PCR (miRNA analysis) 
RT-PCR was carried out using a Stratagene MX3000 thermal cycler to measure miRNA levels. 
miRNAs were reverse-transcribed using the 1×Taqman Universal Master Mix II, no UNG kit 
(Applied Biosystems; no. 4440047). miRNA levels were measured using specific primer and 
probes sets as per the manufacturer’s instructions (Applied Biosystems, Carlsbad, CA, USA, Table 
2.2) using the 1×Taqman Universal MasterMix II, no UNG kit. PCR conditions consisted of 1 
cycle of 10 mins at 95°C; 40 cycles of 15 secs at 95°C, 60 secs at 60°C. U6 was used as an 
endogenous control. The primer sequences used were obtained from Applied Biosystems (Table 
2.2). All samples were run in triplicate for all miRNA targets measured. All analysis was 
performed using the Stratagene MX3000 thermal cycler dedicated software and employed the 
comparative CT (ΔΔCT) method.
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Table 2.2: miRNA Probe sequences and assay number 
This table presents miRNAs of interest with probe sequences and assay numbers.  
Assay ID Assay Name Sequence 
001973 U6 snRNA GTGCTCGCTTCGGCAGCACATATACTAAAATTGGAACGATACAGAGAAGA
TTAGCATGGCCCCTGCGCAAGGATGACACGCAAATTCGTGAAGCGTTCCA
TATTTT 
002222 miRNA-1 UGGAAUGUAAAGAAGUAUGUAU 
002223 miRNA-30e UGUAAACAUCCUUGACUGGAAG 
000436 miRNA-99b CACCCGUAGAACCGACCUUGCG 
002074 miRNA-125b ACAAGUCAGGCUCUUGGGACCU 
002247 miRNA-133b UUUGGUCCCCUUCAACCAGCUA 
000508 miRNA-204 UUCCCUUUGUCAUCCUAUGCCU 
461846 miRNA-208b AAGCUUUUUGCUCGCGUUAU 
002097 miRNA-222 CUCAGUAGCCAGUGUAGAUCCU 
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2.13 Statistical analysis 
All data were analysed using GraphPad Prism 6.01 (GraphPad Software, Inc. La Jolla, CA, USA). 
The statistical significance was set at P<0.05.  Data for the rats killed at 9 weeks (sedentary and 
juvenile exercise groups) was compared using an unpaired t-test. Data for rats killed at 24 weeks 
(sedentary, juvenile exercise, adolescent exercise and adult exercise) was compared using one-
way ANOVA. Post-Hoc Newman-Keuls was used for multiple comparison tests. A two-way 
ANOVA (between factor “Group”, within factor “Time”) was also used for the analysis of body 
weight over time for the different groups. Significant differences were indicated by different 
symbols such as * P<0.05 vs Sedentary, # P<0.05 vs Juvenile exercise and + P<0.05 vs Adolescent 
exercise. 
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CHAPTER 3 Results 
3.1 Body weight and growth 
The overall body weight at 9 weeks of age was not significantly different between the juvenile 
exercise group and the sedentary group (Figure 3.1 A). Body weight at 24 weeks of age was not 
significantly different between the sedentary and the juvenile and adult exercise groups (P<0.05, 
Figure 3.2 B). However, at 24 weeks of age the adolescent exercise group had a significantly higher 
body weight compared to all other groups (P<0.05, Figure 3.1 B). 
Similarly, juvenile exercise did not significantly change the body weight between weeks 7-9 when 
compared to the sedentary group (Figure 3.2 A). At 24 weeks of age, two-way ANOVA did not 
reveal any significant differences for body weight measurements recorded at week age 13, 16, 18, 
21 and 24 including all groups (Figure 3.2). 
 
S e d e n ta ry J u v e n ile
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
E x e rc ise
B
o
d
y
 w
ei
g
h
t 
(g
)
at
 p
o
st
 m
o
rt
em
S e d e n ta ry J u v e n ile A d o le s c e n t A d u lt
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
B
o
d
y
 w
ei
g
h
t 
(g
)
at
 p
o
st
 m
o
rt
em
# +
E x e rc ise
2 4  W e e k s  o f  a g e9  W e e k s  o f  a g e
BA
 
Figure 3.1: Body weight of rats allocated to either 9 or 24 weeks’ post mortem 
Body weight measurements were recorded for sedentary (n=20), juvenile (n=22), adolescent 
(n=14) and adult (n=13) rats on daily basis. Data presented as mean ± SEM. Significant differences 
are indicated by different symbols. * P<0.05 vs Sedentary, # P<0.05 vs Juvenile and + P<0.05 vs 
Adolescent. 
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Figure 3.2: Body mass measured at different time intervals at 9 or 24 weeks of age   
Body weight measured during exercise and resting period between 5 to 24 weeks of age for sedentary (n=20), juvenile (n=22; trained 
from 5-9 weeks of age), adolescent (n=14; trained from 11-13 weeks of age) and adult (n=13; trained from 20-24 weeks of age). Data 
presented as mean ± SEM.  
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3.2 Food intake 
Measurements for twenty-four-hour food intake recorded during weeks 7, 13, 16 and 21 of age 
did not reveal any significant difference for any of the treatment groups (Figure 3.3 A-D). 
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Figure 3.3: Food intake at week age 7, 13, 16 and 21 
Twenty four hour food intake measurement was recorded at 7, 13, 16 and 21 weeks of age for 
sedentary (n=20), juvenile (n=22), adolescent (n=14) and adult (n=13). Data presented as mean ± 
SEM.  
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3.3 Respiratory measurements 
Oxygen consumption (VO2) and carbon dioxide production (VCO2) were measured at 18 weeks 
of age as no groups were doing any exercise during this period. During the light and dark cycles, 
there was no significant difference in VO2 or VCO2 in the juvenile exercise or adult exercise 
groups compared to the sedentary groups (Figure 3.4 A-D). VCO2 was a significantly higher in 
the adolescence exercise group during the dark cycle compared to other groups (P<0.05, Figure 
3.4 D). However, during the light cycle there was not any difference between the adolescence and 
the remaining groups (Figure 3.4 C). In all groups the respiratory exchange ratio (RER) remained 
unchanged throughout the 24hr period, regardless of light-dark cycle (Figure 3.4 E and F) and was 
not different for any of the groups.   
Heat production during the light cycle was significantly higher only for the adolescent exercise 
group compared to other groups (Figure 3.5 A) and remained higher during the dark cycle (P<0.05, 
Figure 3.5 B). Heat production during the light cycle for the juvenile was not significantly 
different. However, there was more production of heat in dark cycle for the juvenile exercise 
compared to the adult exercise and sedentary groups (P<0.05, Figure 3.5 B).  
Total activity during the light and dark cycles was also assessed with IR-Beams at 18 weeks of 
age. There were no significant differences between the experimental groups in any of the activity 
measurements assessed, including total activity (X-beam), ambulation (X-ambulatory) and rearing 
(Z-beam) (Figure 3.6 A-F). 
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Figure 3.4: Respiratory measurements at week age 18 
Oxygen consumption (VO2), carbon dioxide elimination (VCO2), and respiratory exchange ratio 
(RER) were calculated at week age 18 during light and dark cycle were measured at week age 18 
by using CLAMS. Data presented as mean ± SEM. [n=sedentary (n=9), juvenile (n=11), 
adolescent (n=14) and adult (n=13)]. Significant differences are indicated by different symbols. * 
P<0.05 vs Sedentary, # P<0.05 vs Juveniles and + P<0.05 vs Adolescents. 
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Figure 3.5: Heat production during light and dark cycle 
Heat production during light and dark cycle was measured at week age 18 by using CLAMS. Data 
presented as mean ± SEM. [n=sedentary (n=9), juvenile (n=11), adolescent (n=14) and adult 
(n=13)]. Significant differences are indicated by different symbols. * P<0.05 vs Sedentary, # 
P<0.05 vs Juveniles and + P<0.05 vs Adolescents.
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Figure 3.6: Activity measurements 
Activity was measured at week age 18 by using CLAMS. Data presented as mean ± SEM. 
[n=sedentary (n=9), juvenile (n=11), adolescent (n=14) and adult (n=13)]. Significant differences 
are indicated by different symbols.  
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3.4 Echocardiography 
3.4.1 Left ventricle 
3.4.1.1 Left Ventricular geometry 
Both at 9 and 24 weeks of age, juvenile exercise significantly increased several aspects of LV 
geometry including mass, wall thickness, septum thickness and LV cross sections that were 
assessed with 2D echocardiography.  
At 9 weeks of age, when compared to sedentary rats, juvenile exercise increased the left ventricle 
mass (LVM) by 25% (P<0.05, Figure 3.7 A). The wall thicknesses including posterior wall 
thickness (PWT) and relative wall thickness (RWT) increased by 17% and 11% respectively 
(P<0.05, Figure 3.8 A and C) and the interventricular septum thickness at diastole (IVSd) by 7% 
(Figure 3.8 E). 
When measured at 24 weeks of age, the LVM of rats who completed juvenile exercise was still 
significantly higher by ~18% (P<0.05, Figure 3.7 B). Rats who completed adolescent or adult 
exercise also increased LVM by 20% and 12% (P<0.05, Figure 3.7 B) compared to the sedentary 
group. Exercise performed by the juvenile, adolescent and adult exercise groups increased the 
PWT by 18%, 15% and 6% respectively, (P<0.05, Figure 3.8 B) and RWT by 8%, 11% and 5%  
respectively (P<0.05, Figure 3.8 D) compared to the sedentary group. The interventricular septum 
thickness also increased in the hearts of the exercise rats compared to sedentary rats (Figure 3.8 
F).
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Figure 3.7: Left ventricle mass  
Left ventricle mass (LVM) measured with 2D-echocardiography. Data presented as mean ± SEM. 
[n=sedentary (n=9), juvenile (n=11), adolescent (n=14) and adult (n=13)]. Significant differences 
are indicated by different symbols. * P<0.05 vs Sedentary, # P<0.05 vs Juveniles and + P<0.05 vs 
Adolescents. 
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Figure 3.8: LV posterior, relative and septal wall thicknesses  
Left ventricle posterior wall thickness (LVPWT), Left ventricle relative wall thickness (LVRWT) 
and Left ventricle interventricular septum (LVISD) measured with 2D-echocardiography. Data 
presented as mean ± SEM. [n=sedentary (n=9), juvenile (n=11), adolescent (n=14) and adult 
(n=13)]. Significant differences are indicated by different symbols. * P<0.05 vs Sedentary, # 
P<0.05 vs Juveniles and + P<0.05 vs Adolescents. 
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3.4.1.2 Left ventricular size 
LV size or cavity during end-diastole and end-systole was assessed by measuring LV area/cavity 
at diastole (LVAd), LV area/cavity at systole (LVAs), LV internal diameter at diastole (LVIDd) 
and LV internal diameter at systole (LVIDs). Exercise intervention at juvenile, adolescent and 
adult life did not affect the LV systolic or diastolic cavity at 9 and 24 weeks of age (Figure 3.9 A-
D).  
When compared to sedentary rats, juvenile exercise increased LVIDd by 7% and LVIDs by 10% 
at 9 weeks of age (P<0.05; Figure 3.10 A and C). At 24 weeks of age, the increase in LV internal 
diameter at diastole (LVIDd) did not significantly changed for any of the exercise groups (Figure 
3.9 A). However, there was a tendency for an increase in LVIDd for the adolescent rats by 4% 
compared to sedentary and adult counterparts (P= 0.059; Figure 3.10 D). At 24 weeks of age, the 
LVIDs was significantly higher for the juvenile and adolescent groups (P<0.05; Figure 3.10 B).  
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Figure 3.9: LV area at systole and diastole  
LV area at diastole (LVAd) and at systole (LVAs) measured with 2D-echocardiography. Data 
presented as mean ± SEM. [n=sedentary (n=9), juvenile (n=11), adolescent (n=14) and adult 
(n=13)]. 
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Figure 3.10: LV internal diameter at diastole and systole 
LV internal diameter at diastole (LVIDd) and at systole (LVIDs) measured with 2D-
echocardiography. Data presented as mean ± SEM. [n=sedentary (n=9), juvenile (n=11), 
adolescent (n=14) and adult (n=13)]. Significant differences are indicated by different symbols. * 
P<0.05 vs Sedentary. 
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3.4.1.3 Left ventricular systolic function 
Systolic function was assessed from measurements taken in the parasternal short axis (PSAX) and 
parasternal long axis (PLAX) view of the left ventricle during end-diastole and end-systole.  
At 9 weeks of age, there was no significant difference in the fractional area (FA), fractional 
shortening (FS) and ejection fraction (EF) between sedentary and juvenile exercise rats (Figure 
3.11 A and C; Figure 3.12 A). Cardiac output (CO) was significantly increased (18%) in the 
juvenile exercise group when compared to the sedentary group (P<0.05, Figure 3.12 G). CO is the 
product of heart rate (HR) and stroke volume (SV) and here the increase in the CO was because of 
an increase in HR and not SV. 
At 24 weeks of age, fractional area change (FAC) was not significantly different between any of 
the treatment groups (Figure 3.11 B). However, FS was significantly lower in the juvenile exercise 
rats compared to the sedentary and the adult exercise groups (Figure 3.11 D). Furthermore, 
although the ejection fraction (EF) was not significantly altered following juvenile and adult 
exercise, the adolescent exercise group had a significantly higher EF compared to sedentary rats 
(Figure 3.12 B). CO was higher for the adolescent exercise group compared to sedentary (Figure 
3.12 D) and this was due to a higher resting HR (Figure 3.12 D). 
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Figure 3.11: Fractional area change and fractional shortening  
Fractional area change (FAC) and fractional shortening (FS) measured with 2D-echocardiography. 
Data presented as mean ± SEM. [n=sedentary (n=9), juvenile (n=11), adolescent (n=14) and adult 
(n=13)]. Significant differences are indicated by different symbols. * P<0.05 vs Sedentary, # 
P<0.05 vs Juveniles. 
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Figure 3.12: Ejection fraction, heart rate, stroke volume and cardiac output 
Ejection fraction (EF); Heart rate (HR); Stroke volume (SV); Cardiac output (CO); measured with 
2D Echocardiography. Data presented as mean ± SEM. [n=sedentary (n=9), juvenile (n=11), 
adolescent (n=14) and adult (n=13)]. Significant differences are indicated by different symbols. * 
P<0.05 vs Sedentary, # P<0.05 vs Juveniles.
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3.4.2 Right ventricle echocardiography measurements 
Echocardiographic measurements for the right ventricle did not reveal any significant changes 
for the structure and function of right ventricle for any of the experimental groups both in 9 
weeks and 24 weeks old hearts (Table 3.1).  
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Table 3. 1: Effects of endurance exercise on RV measurements 
 
RV end-diastolic and end-systolic area (EDA and ESA); RV fractional area change (FAC); RV 
outflow tract (RVOT diameters including RVOT proximal and RVOT distal); Pulmonary 
artery (PA); Relative wall thickness (RVWT); RV epicardium and endocardium (EPI and 
ENDO); Aortic cross section area (CSA); Pulmonary artery velocity time integral (PAVTI); 
Pulmonary valve flow acceleration time (PAAT); Pulmonary artery heart rate (PAHR); RV 
cardiac output (CO); RV stroke volume (SV); RV linear dimensions (RV1 to RV4): Data 
presented as mean ± SEM.  [n=sedentary (n=9), juvenile (n=11), adolescent (n=14) and adult 
(n=13)].  
RV measurements              9 weeks old            24 weeks old 
  Sedentary Juvenile Sedentary Juvenile Adolescent Adult 
EDA (cm) 0.386±0.016 0.379±0.011 0.437±0.018 0.406±0.025 0.437±0.022 0.443±0.021 
ESA (cm) 0.168±0.011 0.161±0.009 0.209±0.016 0.188±0.013 0.197±0.016 0.201±0.010 
FAC (%) 0.569 0.017 0.569±0.018 0.528±0.030 0.525±0.025 0.568±0.021 0.550±0.029 
RVOT Prox (cm) 0.333±0.013 0.353±0.008 0.384±0.010 0.386±0.006 0.384±0.011 0.383±0.008 
RVOT Distal (cm) 0.305±0.010 0.302±0.006 0.331±0.009 0.337±0.006 0.335±0.009 0.334±0.006 
PA (cm) 0.223±0.014 0.241±0.002 0.276±0.012 0.269±0.007 0.256±0.002 0.256±0.004 
RVWT (cm) 0.045±0.001 0.047±0.001 0.059±0.002 0.058±0.002 0.054±0.001 0.057±0.003 
RV EPI (cm) 0.315±0.018 0.287±0.010 0.325±0.003 0.315±0.011 0.326±0.012 0.310±0.010 
RV ENDO (cm) 0.216±0.015 0.238±0.040 0.224±0.005 0.214±0.009 0.237±0.014 0.216±0.007 
Aortic CSA (cm) 0.051±0.001 0.052±0.001 0.054±0.001 0.060±0.001 0.061±0.001 0.053±0.001 
PA VTI (cm) 3.558±0.198 3.193±0.130 5.827±0.366 5.419±0.269 5.581±0.367 5.697±0.333 
PAAT (cm) 28.29±1.231 29.10±1.291 28.09±1.571 29.67±0.870 30.60±1.251 30.76±1.021 
PA HR (bmp) 375.5 ± 10.91 355.4±9.101 305.4±35.07 329.1±31.67 329.1±32.06 288.8±30.04 
RV CO (ml/min) 65.50±3.593 60.22±3.578 134.9±3.360 141.6±3.859 139.7±2.088 127.6±3.107 
RV1 (cm) 0.410±0.005 0.404±0.004 0.411±0.015 0.409±0.013 0.428±0.009 0.411±0.011 
RV2 (cm) 0.358±0.005 0.352±0.003 0.378±0.016 0.376±0.016 0.399±0.012 0.388±0.009 
RV3 (cm) 0.790±0.016 0.803±0.017 0.951±0.031 0.844±0.049 0.860±0.025 0.926±0.031 
RV4 (cm) 0.350±0.008 0.346±0.006 0.379±0.006 0.385±0.006 0.385±0.007 0.382±0.008 
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3.5 Post mortem weights  
 
At 9 weeks of age, the juvenile exercise significantly increased the relative heart weight by 
22% and LV mass by 27% compared to sedentary rats (P<0.05, Table 3.2). RV mass, dorsal 
body fat, liver and kidney mass, soleus and gastrocnemius muscle and tibia measurements were 
not significantly different among the groups. The skeletal muscle mass of the left and right 
EDL normalized to body weight were significantly increased for the juvenile exercise group, 
however the total muscle mass was not significantly different compared to the sedentary rats 
(Table 3.3). Body weight at 9 weeks of age was not significantly changed for both groups. 
These results were, therefore, not due to altered body mass at adulthood since relative whole 
heart and LV mass were still significantly higher following juvenile exercise (Table 3.2). 
At 24 weeks of age adult exercise led to a significantly higher whole heart, LV and RV mass 
(P<0.05, Table 3.2). Dorsal body fat, liver, kidney and skeletal muscle mass including EDL, 
soleus and gastrocnemius muscle were not significantly different for the juvenile and adult 
exercise groups. However, right tibia measurement of the adult exercise group was 
significantly different compared to the sedentary rats. Body weight and LV to body weight was 
also not changed (Table 3.3). 
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Table 3.2: Post mortem weights 
Data presented as mean ± SEM. [n=sedentary (n=9), juvenile (n=11), adolescent (n=14) and 
adult (n=13)]. Significant differences are indicated by * P<0.05 vs Sedentary. 
  
 9 weeks old  24 weeks old  
 Sedentary Juveniles Sedentary Juveniles Adult 
Body weight (g) 190.06±3.19 184.08±3.00 368.50±4.48 375.78±8.38 373.04±4.48 
Heart (g) 0.714±0.013 0.854±0.025* 1.144 ±0.025 1.366±0.041 1.534±0.116* 
Heart / Body weight 0.373±0.010 0.465±0.014* 0.310±0.005 0.336±0.016 0.411±0.003* 
LV (g) 0.517±0.006 0.664±0.019* 0.900±0.020 0.998±0.025 1.016±0.065 
LV / Body weight 0.270±0.006 0.362±0.012* 0.244±0.007 0.265±0.010 0.248±0.029 
LV / Tibia (g/mm) 1.574±0.031 2.036±0.012* 2.283±0.047 2.526±0.055 2.267±0.280 
RV (g) 0.123±0.010 0.133±0.009 0.149±0.007 0.161±0.006 0.183±0.012* 
RV / Tibia (g/mm) 0.375±0.031 0.406±0.028 0.381±0.018 0.408±0.015 0.454±0.034 
Kidney Left (g) 0.696±0.011 0.674±0.012 1.213±0.045 1.213±0.045 1.103±0.039 
Kidney left / Body weight 0.366±0.006 0.368±0.006 0.305±0.008 0.323±0.011 0.294±0.007 
Kidney Right (g) 0.700±0.019 0.666±0.012 1.119±0.029 1.186±0.038 1.098±0.032 
Kidney right / Body weight 0.368±0.009 0.363±0.005 0.303±0.006 0.316±0.009 0.294±0.006 
Total Kid (g) 0.702±0.031 0.732±0.009 2.247±0.065 2.400±0.082 2.207±0.074 
Total Kidney / Body weight 0.374±0.018 0.364±0.037 0.609±0.013 0.639±0.204 0.589±0.014 
Liver weight (g) 6.714±0.130 6.521±0.150 9.972±0.153 10.67±0.221 10.26±0.225 
Liver/ Body weight 3.479±0.121 3.548±0.058 2.479±0.252 2.846±0.049 2.749±0.040 
Dorsol Fat (g) 0.862±0.054 0.738±0.076 4.966±0.144 4.324±0.165 4.743±0.233 
Dorsol Fat / Body weight 0.413±0.050 0.400±0.039 1.217±0.125 1.038±0.111 1.272±0.061 
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Table 3.3: Skeletal muscle weight/tibia length 
Data presented as mean ± SEM. [n=sedentary (n=9), juvenile (n=11), adolescent (n=14) and 
adult (n=13)]. Significant differences are indicated by * P<0.05 vs Sedentary. 
  
 9 weeks old  24 weeks old  
 Sedentary Juveniles Sedentary Juveniles Adult 
Soleus Left (g) 0.101±0.004 0.102±0.004 0.168±0.009 0.149±0.002 0.175±0.007 
Soleus Left /Body weight 0.053±0.002 0.057±0.004 0.045±0.002 0.040±0.002 0.047±0.001 
Soleus Right (g) 0.117±0.010 0.092±0.010 0.168±0.010 0.148±0.007 0.166±0.009 
Soleus Right / Body weight 0.062±0.005 0.050±0.006 0.045±0.003 0.039±0.002 0.044±0.002 
Extensor digitorum longus Left (g) 0.077±0.004 0.090±0.005 0.163±0.008 0.187±0.003 0.142±0.026 
Extensor digitorum longus Left / Body 
weight 
0.041±0.002 0.049±0.024* 0.044±0.022 0.051±0.001 0.038±0.003 
Extensor digitorum longus Right (g) 0.076±0.004 0.091±0.003* 0.154±0.008 0.187±0.003 0.146±0.009 
Extensor digitorum longus Right / 
Body weight 
0.037±0.001 0.049±0.002* 0.041±0.002 0.050±0.001 0.038±0.003 
Gastrocnemius Left (g) 0.803±0.016 0.763±0.018 1.538±0.039 1.637±0.032 1.555±0.041 
Gastrocnemius Left / Body weight 0.423±0.010 0.415±0.009 0.417±0.010 0.437±0.011 0.416±0.008 
Gastrocnemius Right (g) 0.794±0.026 0.719±0.025 1.541±0.044 1.536±0.039 1.545±0.035 
Gastrocnemius Right / Body weight 0.416±0.014 1.876 ±0.04 0.418±0.011 0.411±0.014 0.414±0.007 
Tibia Left (mm) 32.99±0.316 33.31±0.405 39.20±0.139 39.68±0.292 40.9±0.603* 
Tibia Right (mm) 32.73±0.380 32.32±0.440 39.23±0.243 39.56±0.213 40.40±0.550 
Tibia Average 32.85±0.329 32.81±0.407 39.56±0.253 39.62±0.247 40.65±0.550 
Total Muscle weight (g) 1.953±0.050 1.876±0.047 3.733±0.090 3.846±0.055 3.718±0.070 
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3.6 LV cardiomyocytes  
3.6.1 Cardiomyocyte number 
At 9 weeks of age, the total number of cardiomyocytes within the LV was 40% higher in the 
rats that had undergone the juvenile exercise training program compared to the sedentary group 
(P<0.001, Figure 3.13A).  
At 24 weeks of age, the number of cardiomyocytes in the LV was 36% higher in the rats that 
underwent juvenile exercise training compared to the rats that remained sedentary throughout 
life. In addition, the total number of cardiomyocytes was 35% higher than in the juvenile 
exercise group compared to the sedentary group (P<0.01, Figure 3.13 B). The number of 
cardiomyocytes in the adolescent exercise group was not significantly different  to other 
groups(Figure 3.13 B).  
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Figure 3.13: LV Cardiomyocyte number 
Data presented as mean ± SEM. [n=sedentary (n=8), juvenile (n=8), adolescent (n=8) and adult 
(n=8)]. Significant differences are indicated by different symbols: * P<0.05 vs Sedentary, # 
P<0.05 vs Juveniles 
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3.6.2 Cardiomyocyte nuclearity 
At 9 weeks of age, the proportion of mononucleated cardiomyocytes in the juvenile exercise 
heart was doubled compared to the sedentary heart (14% vs 8%, respectively, P<0.05, Figure 
3.14 A). Accordingly, the proportion of binucleated cardiomyocytes in the juvenile exercise 
heart was significantly lower (86% vs 92% respectively, P<0.05, Figure 3.14 C) compared to 
the sedentary group.  
At 24 weeks of age, the proportion of binucleated cardiomyocytes in the juvenile exercise heart 
remained significantly lower than the sedentary group (89% vs 94% respectively, P<0.05, 
Figure 3.14 B) and accordingly the proportion of mononucleated cardiomyocytes in the 
juvenile exercise heart was significantly higher compared to the sedentary group (11% vs 6%, 
respectively, P<0.05, Figure 3.14 B and D). The adolescent exercise also increased the 
percentage of mononucleated cardiomyocytes compared to sedentary and adult exercise. Adult 
exercise, however, did not increase in the number of mononucleated cardiomyocytes (Figure 
3.14 B). For the percentage of binucleated cardiomyocytes in the LV, the juvenile and 
adolescent exercise groups have lowered the cardiomyocyte proportion compared to sedentary 
and adult exercise groups (Figure 3.14 D).  
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Figure 3.14: Proportion of mono and binucleated LV cardiomyocyte  
Data presented as mean ± SEM. [n=sedentary (n=8), juvenile (n=8), adolescent (n=8) and adult 
(n=8)]. Significant differences are indicated by different symbols. * P<0.05 vs Sedentary, # 
P<0.05 vs Juveniles and + P<0.05 vs Adolescents. 
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3.6.3.1 Cross sectional and longitudinal area of cardiomyocytes 
At 9 weeks of age, juvenile exercise increased the cardiomyocyte cross sectional area (CSA) 
and longitudinal area (LA) in the heart (12% and 16%, respectively) compared to the sedentary 
heart (Figure 3.15 A and C).  
At 24 weeks of age, a significant increase was measured in the CSA and LA of cardiomyocytes 
in the hearts of all exercise groups including juvenile and adult exercise groups compared to 
the sedentary group (P<0.05; Figure 3.15 B and D). While adolescent exercise only increased 
LA of cardiomyocytes compared to the juvenile and adult exercise and the sedentary groups 
(Figure 3.15 B and D). 
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Figure 3.15: LV cross sectional and longitudinal area of cardiomyocyte 
Data presented as mean ± SEM. [n=sedentary (n=8), juvenile (n=8), adolescent (n=8) and adult 
(n=8)]. Significant differences are indicated by different symbols: * P<0.05 vs Sedentary, # 
P<0.05 vs Juveniles and + P<0.05 vs Adolescents. 
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3.6.3.2 Longitudinal area of mononucleated and binucleated cardiomyocytes  
At 9 weeks of age, the LA of mononucleated cardiomyocytes was not significantly different 
following juvenile exercise compared to the sedentary rats (Figure 3.16 A). However, there 
was a significant increase in the binucleated cardiomyocyte LA in the juvenile exercised heart 
(18%) compared to the sedentary group (P<0.05, Figure 3.16 C).  
At 24 weeks of age, only adolescent exercise increased the LA of mononucleated 
cardiomyocytes compared to other groups (Figure 3.16 B). However, the LA of binucleated 
cardiomyocytes was increased for all the exercise groups compared to the sedentary group 
(P<0.05, Figure 3.16 D).  
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Figure 3.16: LV longitudinal area of mono and binucleated cardiomyocyte  
Data presented as mean ± SEM. [n=sedentary (n=8), juvenile (n=8), adolescent (n=8) and adult 
(n=8)]. Significant differences are indicated by different symbols: * P<0.05 vs Sedentary, # 
P<0.05 vs Juveniles and + P<0.05 vs Adolescents. 
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 3.6.4 Cardiomyocyte number relative to heart and LV weight 
At 9 weeks of age, juvenile exercise led to a significantly higher number of cardiomyocytes 
relative to heart weight by 44% compared to the sedentary group (P<0.05, Figure 3.17 A). The 
number of cardiomyocytes relative to LV mass was significantly higher by 15% for the juvenile 
exercise group compared to the sedentary group (P<0.05, Figure 3.17 C).  
At 24 weeks of age, number of cardiomyocytes relative to heart weight was not altered for the 
juvenile and adolescent groups but was lower for the adult exercise group compared to the 
juveniles (P<0.05, Figure 3.17 B). Also, juvenile life exercise increased the number of 
cardiomyocytes relative to LV by 22% compared to the adolescent and adult exercise groups 
and the sedentary group (Figure 3.17 D). 
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Figure 3.17: LV cardiomyocyte number relative to heart and LV weight 
Data presented as mean ± SEM. [n=sedentary (n=8), juvenile (n=8), adolescent (n=8) and adult 
(n=8)]. Significant differences are indicated by different symbols: * P<0.05 vs Sedentary, # 
P<0.05 vs Juveniles. 
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3.7 Myocardial fibrosis 
Fibrosis levels were assessed by picrosirius red staining in hearts at 24 weeks of age. There 
was no significant difference in the levels of collagen in the left ventricular myocardium 
between any of the treatment groups (Figure 3.18 A - C). There were no differences in the 
levels of interstitial or perivascular collagen in the hearts of trained exercise groups compared 
to the sedentary group. 
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Figure 3.18: Levels of cardiac fibrosis  
Fibrosis at interstitial, perivascular and reparative level. Data presented as mean ± SEM. 
[n=sedentary (n=8), juvenile (n=8), adolescent (n=8) and adult (n=8)]. 
Page | 111  
 
3.8 Cytochrome c oxidase (COX) activity 
 
Juvenile exercise significantly increased COX activity at 9 weeks of age compared to sedentary 
rats (P<0.05; Figure 3.19 A). At 24 week of age, COX activity was increased only for the adult 
exercise group (P<0.05; Figure 3.19 B).  
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Figure 3.19: Cytochrome c oxidase activity  
Cytochrome c oxidase activity at 9 and 24 weeks of age. Data presented as mean ± SEM. 
[n=sedentary (n=11), juvenile (n=11) and adult (n=11)]. Significant differences are indicated 
by different symbols. * P<0.05 vs Sedentary, # P<0.05 vs Juveniles.
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3.9 Gene analysis 
 
The expression of the house keeping gene, r18s was not altered at 9 or 24 weeks of age among 
any of the groups (Figure 3.20 A and B). 
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Figure 3.20: Housekeeping gene Ribosomal 18s  
Ribosomal 18s mRNA expression at 9 and 24 weeks of age. Data presented as mean ± SEM. 
[n=sedentary (n=11), juvenile (n=11) and adult (n=11)]. 
At 9 weeks of age, juvenile exercise decreased the mRNA levels of nppa while it increased the 
nppb expression compared to sedentary rats (P<0.05; Figure 3.21 A and C). At 24 weeks of 
age, juvenile and adult exercise did not change the mRNA expression of nppa and nppb (Fig. 
3.21 B and D).  
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Figure 3.21: nppa and nppb  
mRNA expression of nppa and nppb at 9 and 24 weeks of age. Data presented as mean ± SEM. 
[n=sedentary (n=11), juvenile (n=11) and adult (n=11)]. Sinificant differences are indicated by 
different symbols: * P<0.05 vs Sedentary 
 
At 9 weeks of age, gata4, nkx2.5, foxo1 and myh6 were not significantly altered by juvenile 
exercise compared to sedentary rats (Figure 3.22 A, C, E and G). At 24 weeks of age, there 
was also no change in the mRNA levels of gata4, nkx2.5, foxo1 and myh6 following juvenile 
and adult exercise (Figure 3.22 B, D, F and H).   
At 9 weeks of age, Actb, spp1 and ckm were not changed, however, coxIV was expressed with 
juvenile exercise training (Figure 3.23 A, C, E and G). Similarly, at 24 weeks of age, Actb, 
spp1 and ckm was not altered for any group, however, coxIV significantly increased in the 
juvenile exercise group compared to the adult exercise and sedentary groups (Figure 3.23 B, 
D, F and H). 
Page | 114  
 
S e d e n ta ry J u v e n ile
0 .0
0 .5
1 .0
1 .5
g a t a 4
m
R
N
A
(A
rb
it
ra
ry
 u
n
it
s)
E xerc ise
S e d e n ta ry J u v e n ile A d u lt
0 .0
0 .5
1 .0
1 .5
g a t a 4
E xerc ise
m
R
N
A
(A
rb
it
ra
ry
 u
n
it
s)
S e d e n ta ry J u v e n ile
0 .0
0 .5
1 .0
1 .5
n k x 2 .5
m
R
N
A
(A
rb
it
ra
ry
 u
n
it
s)
E xerc ise
S e d e n ta ry J u v e n ile A d u lt
0 .0
0 .5
1 .0
1 .5
n k x 2 .5
E xerc ise
m
R
N
A
(A
rb
it
ra
ry
 u
n
it
s)
S e d e n ta ry J u v e n ile
0 .0
0 .1
0 .2
0 .3
0 .4
fo x o 1
m
R
N
A
(A
rb
it
ra
ry
 u
n
it
s)
E xerc ise
S e d e n ta ry J u v e n ile A d u lt
0 .0
0 .1
0 .2
0 .3
0 .4
fo x o 1
E xerc ise
m
R
N
A
(A
rb
it
ra
ry
 u
n
it
s)
BA
DC
FE
HG
9  W e e k s  o f  a g e 2 4  W e e k s  o f  a g e
S e d e n ta ry J u v e n ile
0 .0
0 .5
1 .0
1 .5
m yh 6
m
R
N
A
(A
rb
it
ra
ry
 u
n
it
s)
E xerc ise
S e d e n ta ry J u v e n ile A d u lt
0 .0
0 .5
1 .0
1 .5
m yh 6
E xerc ise
m
R
N
A
(A
rb
it
ra
ry
 u
n
it
s)
 
Figure 3.22: gata4; nkx2.5; foxo1; myh6  
mRNA expression of gata4, nkx2.5, foxo1 and myh6 at 9 and 24 weeks of age. Data presented 
as mean ± SEM. [n=sedentary (n=11), juvenile (n=11) and adult (n=11)].  
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Figure 3.23: coxIV, ckm, Actb and spp1 
mRNA expression of coxIV, Actb and spp1 at 9 and 24 weeks of age. Data presented as mean 
± SEM. [n=sedentary (n=11), juvenile (n=11) and adult (n=11)]. Significant differences are 
indicated by different symbol: * P<0.05 vs Sedentary. 
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3.10 miRNA analysis 
The expression of U6 was not altered at 9 or 24 weeks of age for any treatment group (Figure 
3.24 A and B). 
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Figure 3.24: U6 expression at 9 and 24 weeks of age 
U6 sRNA expression at 9 and 24 weeks of age. Data presented as mean ± SEM. [n=sedentary 
(n=11), juvenile (n=11) and adult (n=11)].  
At 9 weeks of age, the expression of miRNA-1 was significantly reduced following juvenile 
exercise training compared to sedentary group (P<0.05, Figure 3.25 A). At 24 weeks of age, 
the expression of miRNA-1 was significantly increased following adult exercise training 
compared to juvenile exercise and sedentary groups (P<0.05, Figure 3.25 B). At 9 weeks of 
age, miRNA-133b was upregulated in rats following juvenile exercise compared to sedentary 
rats (P<0.05, Figure 3.25 C). At 24 weeks of age, the expression of miRNA-133b was not 
changed for any of the groups (Figure 3.25 D).  
At 9 weeks of age, juvenile exercise did not change the miRNA-208b expression (Figure 3.25 
E). However, at 24 weeks of age, there was a significant downregulation in rats following the 
adult exercise compared to juvenile exercise and sedentary groups (P<0.05, Figure 3.25 F). At 
9 weeks of age, miRNA-222 expression did not change with juvenile exercise (Figure 3.25 G). 
However, at 24 weeks of age, there was a significant downregulation in the adult exercise group 
compared to both juvenile and sedentary groups (P<0.05, Figure 3.25 H). At 9 and 24 weeks 
of age, juvenile and adult exercise did not change the expression of miRNA-30e, miRNA-99b, 
miRNA-125b and miRNA-204 (Figure 3.26 A-H, respectively)
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Figure 3.25: miRNA-1, miRNA-133b, miRNA-208b and miRNA-222  
Expression of miRNA-1, mRNA0133b, miRNA-208b and miRNA-222 at 9 and 24 weeks of 
age Data presented as mean ± SEM. [n=sedentary (n=11), juvenile (n=11) and adult (n=11)]. 
Significant differences are indicated by different symbols. * P<0.05 vs Sedentary, # P<0.05 vs 
Juveniles. 
Page | 118  
 
2 4  W e e k s  o f  a g e9  W e e k s  o f  a g e
A B
C D
E F
G H
S e d e n ta ry J u v e n ile A d u lt
0 .0
0 .5
1 .0
1 .5
m iR N A 30e
E x e r c is e
m
ii
R
N
A
 r
el
at
iv
e 
to
 U
6 
sn
R
N
A
 
(A
rb
it
ra
ry
 u
ni
ts
)
S e d e n ta ry J u v e n ile
0 .0
0 .5
1 .0
1 .5
m iR N A -30e
E x e r c is e
m
ii
R
N
A
 r
el
at
iv
e 
to
 U
6 
sn
R
N
A
 
(A
rb
it
ra
ry
 u
ni
ts
)
S e d e n ta ry J u v e n ile
0 .0
0 .2
0 .4
0 .6
0 .8
m iR N A -204
E x e r c is e
m
ii
R
N
A
 r
el
at
iv
e 
to
 U
6 
sn
R
N
A
 
(A
rb
it
ra
ry
 u
ni
ts
)
S e d e n ta ry J u v e n ile A d u lt
0 .0
0 .5
1 .0
1 .5
m iR N A -99b
E x e r c is e
m
ii
R
N
A
 r
el
at
iv
e 
to
 U
6 
sn
R
N
A
 
(A
rb
it
ra
ry
 u
ni
ts
)
S e d e n ta ry J u v e n ile
0 .0
0 .5
1 .0
1 .5
m iR N A -99b
E x e r c is e
m
ii
R
N
A
 r
el
at
iv
e 
to
 U
6 
sn
R
N
A
 
(A
rb
it
ra
ry
 u
ni
ts
)
S e d e n ta ry J u v e n ile A d u lt
0 .0
0 .5
1 .0
1 .5
m iR N A -125b
E x e r c is e
m
ii
R
N
A
 r
el
at
iv
e 
to
 U
6 
sn
R
N
A
 
(A
rb
it
ra
ry
 u
ni
ts
)
S e d e n ta ry J u v e n ile A d u lt
0 .0
0 .2
0 .4
0 .6
0 .8
m iR N A -204
E x e r c is e
m
ii
R
N
A
 r
el
at
iv
e 
to
 U
6 
sn
R
N
A
 
(A
rb
it
ra
ry
 u
ni
ts
)
S e d e n ta ry J u v e n ile
0 .0
0 .5
1 .0
1 .5
E x e r c is e
m iR N A -125b
m
ii
R
N
A
 r
el
at
iv
e 
to
 U
6 
sn
R
N
A
 
(A
rb
it
ra
ry
 u
ni
ts
)
 
Figure 3.26: miRNA-30e, miRNA-99b, miRNA-125b and miRNA-204 
Expression of miRNA-30e, miRNA-99b, miRNA-125b and miRNA-204 at 9 and 24 weeks 
of age. Data presented as mean ± SEM. [n=sedentary (n=11), juvenile (n=11) and adult 
(n=11)]. 
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CHAPTER 4 Discussion 
The findings of this thesis are in agreement with the hypothesis that endurance training during 
juvenile life in male rat increases heart mass, LV wall thickness, cardiomyocyte number and 
size without altering fibrosis in adulthood. However, there was no increase in heart function, 
since it was maintained at normal levels in the adult heart following juvenile exercise. The size 
of longitudinal binucleated cardiomyocytes and the proportion of mononucleated 
cardiomyocytes increased in the juvenile exercise group. Furthermore, adolescent exercise 
increased heart mass, wall thickness and heart function, but it did not significantly increase the 
cardiomyocyte number in adulthood. The size of longitudinal binucleated cardiomyocytes and 
the proportion of mononucleated cardiomyocytes increased in the adolescent exercise group. 
As expected, adult exercise training increased heart mass, wall thickness, and cardiomyocyte 
size despite no change in cardiomyocyte number. The findings are also in agreement with the 
hypothesis, that the juvenile period in rats appears to be a unique stage of heart growth that is 
amenable to long-term cardiac programming by short-term endurance training. This study 
found that only juvenile exercise training led to sustained increases in heart mass and 
cardiomyocyte number into adulthood despite a 15week period of detraining. Lastly, the 
hypothesis that endurance training during juvenile development would result in sustained 
increases in the expression of selected mRNA and miRNA species in the heart involved with 
muscle growth and development was not demonstrated. The results obtained are contrary as 
juvenile exercise did not reveal any specific gene or miRNA species that were examined to be 
differentially regulated in the adult heart. However, juvenile exercise at 9 weeks of age does 
differentially regulate the expression of miR-1 and miR-133b, which are both regulators of 
cardiac growth. 
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4.1 Endurance exercise improved the adult cardiac structure 
changes 
4.1.1 LVM increases in the heart with endurance exercise 
Heart mass typically increases 15-30% following several weeks of endurance exercise training 
in rodents (Fenning et al. 2003; Medeiros et al. 2004; Wisloff et al. 2002; Wisloff et al. 2001). 
In adult rats the increases in heart mass are typically lost following several weeks of detraining 
(Fenning et al. 2003; Hoydal et al. 2007; Kemi et al. 2004; Waring et al. 2015; Wisloff et al. 
2009; Wisloff et al. 2002). Exercise training in the current study increased left ventricle mass 
(LVM) in all exercise groups but the novel findings of this study was that the 25% increase in 
LVM following juvenile exercise at 9 weeks of age was sustained into adulthood at 18% despite 
15 weeks of detraining. This is consistent with a recent study from our group that demonstrated 
an identical juvenile exercise training program led to a 10% increase in heart mass in adulthood 
with no adverse effects (Wadley et al. 2016). Adolescent exercise (11-15 weeks of age) training 
in this study increased LVM by 20% after 9 weeks of detraining. In contrast, Waring et al. 
(2015) found a 29% increased LVM in the adolescent exercise trained rats, although upon four 
weeks of detraining LVM was only 8% higher, which was no longer significantly different 
(Waring et al. 2015). The reason for this discrepancy could be due to different statistical power. 
The non significant 8% increase in the LVM of the adolescent rats who were detrained for four 
weeks could possibly be due to a lower sample size (n=6 rats) of Waring and colleagues 
(Waring et al. 2015). However, the adolescent exercise group in the present study had a much 
larger sample size (n=14) and so perhaps with 10-12 rats per group Waring et al. (2015) may 
have reported an 8% increase in LVM to be statistically significant. Another reason for the 
discrepancies in the results could be due to the use of different strains of rats as the present 
study used WKY rats while Waring et al. (2015) used Wistar strain of rats. This might have 
led to different results in different strain of rats though at the same age. Although the post 
mortem body weight data in the present study did not reveal significant changes for most of 
the parameters (Table 3.2 and 3.3). LV post mortem weight was significantly different for the 
juvenile exercise group compared to sedentary while t-test was applied, however, after 
applying ANOVA to all groups no significance was found for LV weight. Therefore, it is 
possible that heart weight measurements were under powered to detect differences in the LV 
when using multiple groups. 
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4.1.2 LV wall thicknesses increases with endurance exercise 
The exercise treatments in the present study increased LV wall thicknesses in all groups 
compared to the sedentary group, which is consistent with a number of studies reported in rats 
following training (Bocalini et al. 2010; Fenning et al. 2003; Kemi et al. 2002; Pluim et al. 
2000; Spence et al. 2013; Urhausen et al. 1996; Waring et al. 2015). An increase in the left 
ventricle wall thicknesses (posterior wall, relative wall and septal) along with the increase in 
LVM is related to the physiological hypertrophy following endurance training (Baggish et al. 
2008; Fernandes et al. 2011b; Sturgeon et al. 2015). At 24 weeks of age juvenile, adolescent 
and adult exercise all significantly increased the wall thickness of the LV as measured by the 
posterior, relative and septal wall thicknesses using echocardiography. The current model of 
endurance treadmill running increased posterior and relative wall thicknesses in the juvenile 
exercised rats at 9 weeks of age by 17% and 11% respectively. Interestingly, these increases in 
posterior and relative wall thicknesses were sustained by 15% and 8%, respectively at 24 week 
of age despite 15 weeks of detraining. The adolescent and adult exercise groups had a 
significant increase in posterior wall thickness (15% and 6% respectively) and relative wall 
thickness (11% and 5% respectively). As a result of the increase in after-load during endurance 
exercise, intraventricular pressure in the ejection phase may increase stress on the myocardium 
wall which increases the heart wall thicknesses (Anversa et al. 1990; Ellison et al. 2012), 
causing concentric hypertrophy (Fernandes et al. 2011b; Gaasch et al. 2011; Mihl et al. 2008; 
Spence et al. 2011). The cardiovascular adaptation of increased wall thickness in the trained 
rat hearts in the present study is similar to that measured in previous exercise studies (Baggish 
et al. 2008; Iemitsu et al. 2005; Jin et al. 2001; Kemi et al. 2002; Waring et al. 2015; Waring 
et al. 2012; Weiner et al. 2012). Although the endurance training protocols vary between 
studies, the present findings are in line with previous studies that have reported concentric 
hypertrophy in the hearts of trained rats and mice (Fernandes et al. 2011b; Gaasch et al. 2011; 
Mihl et al. 2008; Spence et al. 2011).  
Physiological concentric cardiac hypertrophy along with increased wall thicknesses has been 
shown to occur in a number of rodent exercise training studies of several weeks in duration 
using either low, moderate and even exhaustive treadmill running protocols (Evangelista et al. 
2006; Iemitsu et al. 2005; Kemi et al. 2002; Sun et al. 2008; Waring et al. 2015; Woodiwiss et 
al. 1995). Therefore, endurance exercise training protocol used in the current study promoted 
cardiac growth compatible with physiological cardiac hypertrophy. Moreover, the hypertrophy 
Page | 123  
 
that occurred was concentric in all the exercise groups including juvenile, adolescent and adult. 
The finding of concentric hypertrophy in adult rats in the current study might be contrary to 
the concept of developing eccentric hypertrophy (volume overload hypertrophy) with 
endurance training. However, recent long-term endurance training studies in humans suggest 
that concentric cardiac hypertrophy occurs prior to eccentric hypertrophy (Arbab-Zadeh et al. 
2014). Indeed, after a 1year period of endurance training in adult humans, concentric 
hypertrophy of the heart was found to occur for the first few months, followed by eccentric 
hypertrophy at a much later stage following several months of training (Arbab-Zadeh et al. 
2014). Considering this finding, it is possible that the trained rats in the present study would 
need a much longer training period to develop eccentric hypertrophy. According to Laplace’s 
law, the left ventricle may respond to exercise with initial concentric hypertrophy suggesting a 
primary pressure overload stimulus or perhaps an adaptive response to the increased cardiac 
work during training as a function of increased HR. Later, the left ventricle may dilate and 
restore the baseline mass-to-volume ratio. Similar to Arbab-Zadeh et al. (2014), the endurance 
exercise training may not be a primary left ventricle volume overload stimulus; rather, the 
pattern of left ventricle remodeling depends on the duration of the exercise performed (Arbab-
Zadeh et al. 2014). Long-term training studies are now required to determine if concentric 
cardiac hypertrophy precedes eccentric hypertrophy in rodents like it does in humans. 
4.1.3 LV size and diameter changes with endurance exercise 
Exercise training in the current study did not change the left ventricle area in any of the exercise 
groups, which is consistent with findings of several previous studies in rodents (Douglas 1989; 
McGavock et al. 2003; Meyer et al. 2015). With respect to left ventricle internal diameters, 
only juvenile exercise increased the internal diameter at end diastole (LVIDd) at 9 weeks of 
age, with this effect being lost by 24 weeks of age. Left ventricle internal diameter at end 
systole (LVIDs) was not changed at 9 weeks of age but significantly increased by 8% and 5% 
at 24 weeks of age in the juvenile and adolescent exercise groups, respectively. The load on 
any region of the myocardium follows LaPlace’s Law: (pressure×radius) / (2×wall thickness); 
thus, an increase in pressure can be offset by an increase in wall thickness. Systolic stress is a 
major determinant of ejection performance, where the normalization of systolic stress helps to 
maintain a normal ejection fraction even when needing to generate high levels of systolic 
pressure (Lorell et al. 2000). As concentric hypertrophy is characterized by an increase in wall 
thickness and with minimal changes in chamber size, the findings pertaining to LV cavity and 
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internal diameter in the present study suggest concentric hypertrophy of the hearts of exercised 
trained rats.  
Unlike LVIDd, the effect of endurance exercise on LVIDs is less defined, with some studies 
reporting a decrease (Jin et al. 2000; Spence et al. 2011; Waring et al. 2015), while others show 
an increase in LVIDs with endurance exercise (Baggish et al. 2008; Bocalini et al. 2010). There 
was a significant increase in the LVIDs in the juvenile and adolescent exercise rats compared 
to sedentary rats, which is not in agreement with findings reported in adolescent endurance 
trained rats (Waring et al. 2015; Waring et al. 2012), and also to previous investigations (Dayan 
et al. 2005; Groban et al. 2008; Hydock et al. 2007, 2008; Wisloff et al. 2002; Wisloff et al. 
2001). LV systolic dysfunction is a strong predictor of changes in cardiac events (Prada-
Delgado et al. 2015). The present study did not measure blood pressure as the resting blood 
pressure, was normal in our previous investigation (Wadley et al. 2016). In terms of 
myocardium mechanics, changes in LV volume reflects changes in LV muscle fiber 
dimensions which affects the quantification of diastolic and systolic volume filling or emptying 
during the cardiac cycle. LV internal diameters and the changes in LV volume are closely 
related as the LV cavity dimensions would allow the required LV volume filling or emptying 
with each cardiac stroke (Bishop et al. 1970). The changes in LVIDs in the present study could 
be due to changes in the LV systolic emptying and it may be the reason to have a reduced 
fractional shortening due to reduced LVIDs. The present study did not measure the LV end 
diastolic or systolic volume. It is therefore important to investigate the changes in internal 
diameters in relation with whole LV volume measurements in future studies. Using 2D-
echocardiographic measurement for LV volumes is not preferred due to in accurate 
measurements, however, 3D-echocardiography (Ram et al. 2011; Scherrer-Crosbie et al. 1999) 
and CMR (cardiac magnetic resonance imaging) (Arias et al. 2013) are validated to provide 
more accurate measurements in the rat heart. 
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4.2 Functional changes in the heart with endurance exercise in 
juvenile, adolescent and adult stages of life 
4.2.1 Endurance exercise increased the cardiac output  
At 9 weeks of age, juvenile exercise increased resting cardiac output (CO). However, this effect 
on resting cardiac function was mostly lost by 24 weeks of age. Furthermore, the increase in 
CO with juvenile exercise at 9 weeks of age was due to an increase in resting HR and not a 
change in resting SV. Similarly, the adolescent exercise increased resting CO in adulthood and 
this was also due to a small but significant increase in resting HR. The finding that resting CO 
was not altered following adult exercise training is in contrast with previous studies who 
reported an increased CO with a decrease or no change in HR (Barlow et al. 2012; Bocalini et 
al. 2010; Da Silva et al. 2012). However, the findings of the juvenile and adolescent exercise 
training relating to increased CO at rest due to a higher resting HR in the present study are 
unexpected. A number of studies report reductions in resting HR following endurance exercise 
(Barlow et al. 2012; Bocalini et al. 2010; D’Souza et al. 2014; Da Silva et al. 2012; Evangelista 
et al. 2006). There are however, studies that report no reduction in resting HR in both rat and 
human exercise models (Almeida et al. 2003; Barnard et al. 1976; Pluim et al. 2000).  
Moderate intensity exercise training is responsible for structural and hemodynamic adaptations 
in the cardiovascular system and promotes adjustments in autonomic nervous system 
(Rodrigues et al. 2014). Resting bradycardia is considered to be a hallmark of exercise training 
adaptation in both animals and humans (De Angelis et al. 2004; Evangelista et al. 2005; Katona 
et al. 1982). Exercise training leads to an improvement of cardiovascular capacity, which is 
associated with lower resting and submaximal HR (Almeida et al. 2003). Bradycardia due to 
exercise training is associated with reduced O2 uptake and increased SV (Wisloff et al. 2001). 
The dynamic balance between the sympathetic and parasympathetic (vagal) influences on 
sinoatrial (SA) node activity primarily determines the actual HR at a given physiological state 
(Carnevali et al. 2014). Bradycardia occurs due to an increase in cardiac parasympathetic 
activity and a decrease in intrinsic rate of pacemaker cells (Opthof 2000). The mechanisms 
underlying the resting bradycardia is widely studied and reported to occur due to increased 
cardiac vagal activity (Catai et al. 2002; De Angelis et al. 2004), reduced cardiac sympathetic 
activity (De Angelis et al. 2004) and, lower intrinsic HR (IHR; the rate at which the heart 
beats when all cardiac neural and hormonal inputs are removed) (Katona et al. 1982; Negrão 
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et al. 1992; Scott et al. 2004). The findings of this study could relate to a previous study that 
reported the reversibility of resting HR with detraining and its association with changes in 
intrinsic HR and contribution of the vagal and sympathetic control of resting HR after 
detraining (Evangelista et al. 2006). Indeed, Evangelista et al. (2005) evidenced the IHR-
mediated loss of resting bradycardia with detraining in adolescent rats. Resting HR was 
significantly lower with one week of detraining in rats (8 weeks old) that trained on a treadmill 
for 8 weeks (Evangelista et al. 2005). However, two weeks of detraining reversed the resting 
HR due to an increased IHR (Evangelista et al. 2005). Changes in IHR are involved in resting 
bradycardia, and that IHR is associated with the effects of detraining on resting HR. There are 
interrelations of vagal and sympathetic effects on cardiac rate (Opthof 2000) however, resting 
HR reversibility with detraining is at least in part IHR-mediated. The increased resting HR in 
the exercise groups in the present study needs further investigation to understand the cardiac 
mechanics behind these changes. Perhaps, measuring the vagal and sympathetic tone and, IHR 
may answer the somewhat unexpected findings. The vagal and sympathetic tone estimate the 
maximal tachycardic and bradycardic response to methylatropine and propranolol (Hassan 
1991). This could be a future direction for research and measurement of sympathovagal balance 
can be employed by HR/HR0 (HR=m.n.HR0 in which HR is heart rate (beats/min), m is 
sympathetic influence (m≥1), n is vagal influence (0<n≤1) and HR0 is intrinsic heart rate 
(beats/min) (Evangelista et al. 2005). Intrinsic heart rate can be assessed with in vivo 
pharmacological tools and surgical interventions, or in vitro after isolation of the whole heart 
(Langendorff perfusion) or the right atrium (Evangelista et al. 2005). Langendorff perfusion of 
hearts or isolated perfused hearts assay is an in vitro technique that allows accurate 
measurement of contractile strength and HR of an intact rodent (Fernandes et al. 2015a; 
Huggins et al. 2003). It is extensively used for physiological, pharmacological, biochemical 
and molecular studies and reliably measures the phenotype of the heart (Aksentijević et al. 
2016). Sympathetic nerve activity in relation to cardiovascular system represents important 
modulations in  respiration that lead to rhythmic oscillations in BP (Menuet et al. 2016). WHBP 
(working heart-brainstem preparation) could be utilized to record the respiratory, sympathetic 
and cardiovascular activities (Menuet et al. 2016). By employing these techniques in future 
studies will help to better understand the reasons for HR changes induced by endurance 
exercise training.  
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4.2.2 Heart contractility increases with endurance training 
Fractional shortening (FS; change in LV short axis diameter during systole) and fractional area 
change in LV (FAC) are the measurements to assess the heart contraction and are associated 
with ventricular preload and afterload changes (Anversa et al. 1985). Exercise training did not 
change the FAC in any of the groups, and suggests a normal LV area as there was no reduction 
in the chamber size (LVAs and LVAd) as discussed in section 4.1.3. These results are in line 
with some previous findings of exercise studies that reported no changes in the LV of trained 
hearts (Hayward et al. 2011; Hydock et al. 2007, 2008; Wisloff et al. 2002; Wisloff et al. 2001). 
Juvenile exercise did not change FS at 9 weeks of age however, it was significantly reduced, 
but only by 5% at 24 weeks of age. The internal diameter changes suggest alterations in heart 
contractility which is termed fractional shortening (FS). An increase in LVIDs here indicates a 
reduction in the FS, indicating a small reduction in LV function, which could reflect a reduction 
in the pumping of blood associated with reduced cavity or size. FS is typically 40-55% in 
normal healthy rats (Waring et al. 2012; Weytjens et al. 2006). In the current study at 24 weeks 
of age, the sedentary group had a FS of ~50%, while the juvenile exercise group had a 
significantly lower FS of 45%. Despite a small but significant reduction in FS this lower level 
in the juvenile exercise group was still within the normal healthy range (Weytjens et al. 2006). 
Like the FAC and FS, ejection fraction (EF) is a measure of the heart muscle contractility. EF 
reflects the basal level of contractility, provided that the loading conditions are constant 
(Fisman et al. 1990). Alteration in EF could occur with a decrease in the contractile capacity 
of the affected region due to the loss of contractile elements and the normal architecture of the 
ventricular wall (Pabis et al. 2008; Thomas et al. 2006). This may lead to an impairment of 
systolic function. This study however, did not observe any changes in EF for the juvenile and 
adult exercise groups at 24 weeks of age. The adolescent exercise group displayed a normal EF 
(80%) despite it being significantly reduced compared to the sedentary group (85%) at 24 
weeks of age. However, it is within a normal range of the reported EF values in a 24 week old 
rat heart (70-86%). A possible mechanism to this reduced EF relates to volume overload of the 
LV measured to occur in athletes (Lorell et al. 2000; Maron et al. 2006). In the initial phase of 
this condition, the preload is increased, with near maximal use of the Frank-Starling 
mechanism, and some increase in systolic aortic pressure is apparent (which was not measured 
in this study). These two changes affect EF in opposite ways, so that it remains the same 
(Fisman et al. 1990). Afterward, the ventricle dilates and becomes hypertrophic. In a later 
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phase, chronic overload produces further elongation of myocardial fibres when the muscle can 
no longer maintain a match between preload and afterload, and EF declines (Fisman et al. 
1990). The adolescent group also had significant increases in LVIDs, LVPWT, CO and EF 
(albeit within normal ranges), which may suggest concentric remodeling and not eccentric 
hypertrophy since there is no dilatation as evident by no change in LVIDd. While EF changed 
in the adolescent group, it did not change in the other exercise groups. A possible reason for 
these discrepant findings is that EF is considered to be not accurate at measuring LV systolic 
function (Baggish et al. 2008; Legaz Arrese et al. 2005; McMurray et al. 2012). A reduced or 
normal EF in trained humans is characterized as a secondary effect of LV dilation and has been 
reported previously to have limitations as a degree of LV systolic function to be unable to 
account for LV geometric changes in LV chamber (Baggish et al. 2008; Legaz Arrese et al. 
2005; McMurray et al. 2012). 
One of the reasons for reduced FS is that the juvenile group had reduced LVIDs at 24 weeks 
of age. A reduction in the internal diameter at systole would require a greater exertion of 
pressure to ejaculate the blood, which is why they had a reduced FS. The current study 
however, did not find a reduction in the LV cavity size and also the resting systolic blood 
pressure was normal in the trained rats in our previous study (Wadley et al. 2016). The 
significant changes in FS at 24 weeks of age in the juvenile exercise group could be justified 
with having an increased resting HR which may be for the compensation to the changes in LV 
and to account for the reduced LVIDs and FS. In summary, given no changes in EF in the 
juvenile exercise group and minor reduction in FS, and changes in the EF for adolescent 
exercise group appears to be mostly minor and are within normal range still for healthy rats. 
The overall findings suggest that resting cardiac function is not impaired in exercise groups. 
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4.3 RV did not change with juvenile endurance exercise 
Endurance exercise training results in an increased volume load on the heart, a condition in 
which an additional but identical work demand is applied to both ventricles. There is increasing 
interest in the RV function which may be impaired as a result of pressure or volume overload 
(Gopalan 2011). Often secondary to right heart valve or muscle pathology, right‐to‐left 
shunting may lead to RV dilatation (Ho et al. 2006). RV function also plays an important role 
in the pathogenesis and outcome of CVD (Ho et al. 2006). Measuring RV structure and function 
might be challenging because of the position, having thin walls and due to a crescentic shape 
of the RV wrapping around the LV (Ho et al. 2006). A number of echocardiographic 
measurements of the RV assessing mass, chamber size and function were performed in the 
present study which did not reveal any significant changes to the structure and function of the 
RV for any of the experimental groups at either 9 or 24 weeks of age. The RV investigations 
of the present study are in line with an earlier study during which adult rats who undertook a 
moderate treadmill running program for few weeks did not develop hypertrophy of the RV as 
assessed by RV area and RV mass (Dowell et al. 1976). Similarly, WKY rats at 5 weeks of age 
were subjected to a daily moderate treadmill running that lasted for 7 weeks with no 
development of RV hypertrophy (Anversa et al. 1983). The investigations made in the current 
study do not agree with most of the previous findings where significant effects of exercise are 
detected on RV mass and volume (Erol et al. 2002; Kasikcioglu et al. 2005; Perseghin et al. 
2007; Scharhag et al. 2002). In previous animal studies, the exercised trained hearts in 
comparison to the sedentary animals showed RV hypertrophy out of proportion to the LV (21-
31% increase in RV mass and 7 - 12% increase in LV mass), as well as an increase in RV and 
septal cardiomyocyte length of approximately 26% (Anversa et al. 1982; Anversa et al. 1985; 
Anversa et al. 1983; Wisloff et al. 2001). The mode of exercise training was resistance training 
and the training period of these studies were for months which could be the reason that the 
present did not find significant changes in the RV as measured by echocardiography of the 
exercise groups. The RV post mortem data revealed that the adult exercise group at 24 weeks 
of age increased RV mass was not detected with the echocardiographic measurement. The 
findings of RV post mortem weight agrees with the previous studies (Erol et al. 2002; 
Kasikcioglu et al. 2005; Perseghin et al. 2007; Scharhag et al. 2002) but echocardiography did 
not detect the difference in RV and it appears that juvenile exercise still is not altered even 
when the direct weighing method was employed. 
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In human studies, young endurance trained male athletes present with physiologic hypertrophy 
of both RV and LV when training has been performed over the course of a year (Erol et al. 
2002; Kasikcioglu et al. 2005; Perseghin et al. 2007; Scharhag et al. 2002). Similarly, active 
young humans were reported to have a 22-37% increase in RV mass and a 13-25% increase in 
RV end-diastolic volume (RVEDV) compared with sedentary subjects (Perseghin et al. 2007; 
Scharhag et al. 2002). Untrained obese adults were reported with a 12% increase in RV mass 
and 4% increase in RVEDV after 8 weeks of training (Vogelsang et al. 2008) which was similar 
with the findings of exercise induced changes in the RV of athletes (Baggish et al. 2008). One 
of the reasons that could be made towards the different results of the RV findings of this current 
study with the previous studies is that previous studies had an intense exercise regime and were 
not a moderate training intensity like the one employed here. This has been shown previously 
that increased RV mass and volumes have a nonlinear association with higher levels of 
intentional exercise (Aaron et al. 2011), and that the association with mass of RV is 
independent of LV mass (Aaron et al. 2011).  
RV structure and function are complicated to measure with standard methods of 
echocardiography and MRI (Aaron et al. 2011). Imaging the RV has been a challenge for a 
long time, due to the complex geometry (Gopalan 2011). Because of the shape and position of 
RV lies behind the sternum restricts the parasternal views accessed with the ultrasound beam 
via echocardiography. Therefore, it needs to be imaged from several echocardiographic views 
to provide several cross sectional planes (Gopalan 2011; Ho et al. 2006). The present study 
used only apical and sub costal four chamber views.  Therefore, further studies are required to 
determine the mechanisms and implications of exercise in RV morphology (Aaron et al. 2011). 
Nevertheless, it does not appear that juvenile exercise alters RV mass, although adult exercise 
significantly increased RV mass by 20% when using the more sensitive RV measure of direct 
weighing compared to echocardiography.  
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4.4 Indirect calorimetry and physical activity levels with 
endurance exercise training 
Respiratory exchange ratio (RER), heat production and ambulation activity were recorded at 
18 weeks of age. By that time, only the juvenile (5-9 weeks of age) and adolescent (11-15 
weeks of age) groups had completed exercise training. Only the adolescent group was found to 
have a higher VCO2 during the dark cycle compared to the rest of the groups. However, RER 
(VCO2/VO2) was similar between all groups including the sedentary rats. There were no 
changes in the levels of physical activity among the groups. Adolescent exercised rats had 
higher body heat production during both cycles (day and night) while juvenile exercise 
produced more heat only during the dark cycle. In contrast, the adults and sedentary rats did 
not increase their heat production. The most likely reason for the increased heat production in 
the adolescent exercise group was that this group were significantly heavier than all the other 
groups and this may have led to increased heat production. Food intake and energy expenditure 
are linked by a complex bio-behavioural control system that responds to the utilization and 
availability of metabolic energy in a process that favours energy homeostasis (Speakman et al. 
2011). However, the food intake measured in the present study was similar in all groups so the 
heat produced by the juvenile and adolescent may not be due to energy intake. Despite no 
changes in the fat mass or total muscle mass, the body weight of adolescent exercise rats was 
significantly higher which may suggest that having a bigger area of the body surface could also 
be one of the reason to release more heat during light and dark cycle.  
The dominant factor that could influence the levels of energy expenditure (EE) or heat 
production through a large body surface is body weight, which is a limitation towards correctly 
measuring the indirect calorimetry (Arch et al. 2006). Although indirect calorimetry offers the 
possibility to obtain more precise information such as the rate of oxidation of carbohydrates, 
lipids and proteins, measurement of energetic cost of physical activity and thermic effect of 
food in the rodent (Even et al. 1994). However, studies have pointed out significant limitations 
when using EE and RER obtained by open-circuit indirect calorimetry in rodents. Factors 
including oscillation in the interconversion of macronutrients or lack of stability in pool sizes 
of CO2 and O2 make it difficult to interpret short-term changes in RER (Arch et al. 2006). 
Hence, the transient changes in RER particularly present in exercise performed with intensity 
or intermittently could be undetected by this system, because of the delay between collection 
and analysis of the air collected from the chamber (Arch et al. 2006). Therefore, the present 
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study may not have been able to found significant differences for the RER changes among the 
groups.  
A potential reason attributed to the sustained increase in heart mass following juvenile exercise 
could be the increased levels of daily physical activity. The rats might have remained active 
until adulthood while they were in cages. To support this, it has been shown in earlier studies 
that spontaneous physical activities leads to changes in physiological changes such as heart 
rate (Garland et al. 2011; Nicklas et al. 2014). Perhaps, spontaneous physical activities may 
lead to increase in heart mass. Although, spontaneous physical activity levels measured with 
CLAMS in this study were not different among the groups. However, the increased heart mass 
in adulthood following juvenile exercise could be unlikely due to increased spontaneous 
activity.  
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4.5 Cardiomyocyte morphology and nuclearity with endurance 
training 
4.5.1 Cardiomyocyte number increases with endurance exercise 
The major finding for this thesis was that at 9 weeks of age, juvenile exercise increased the 
total number of LV cardiomyocytes by 40% compared to the sedentary group. Importantly, this 
increase in cardiomyocyte number was sustained by 36% at adulthood, despite the juvenile 
exercised rats being sedentary for 15 weeks. This impact of juvenile exercise on the LV 
cardiomyocyte number in the adult heart is highly novel, since as far as can be determined, no 
previous study have reported such sustained changes of endurance training on the adult heart. 
This is particularly the case with respect to cardiomyocyte number. However, these findings 
are at least partly supported by Waring et al. (2015) as they demonstrated total cardiomyocyte 
number to significantly increase by 7% following four weeks of training in adolescent rats, an 
effect that was sustained by four weeks of detraining. The novelty of the current study is that 
this effect on cardiomyocyte number is sustained well into adulthood and may potentially be 
permanent. However, to confirm if this effect really is permanent the juvenile exercise rats 
would need to be kept for much longer, such as until 12-18 months of age to confirm the 
permanence of the increase in cardiomyocyte number in later life. While the juveniles exercised 
rats had significantly increased cardiomyocyte number, the adolescent and adult exercised rats 
were not significantly different to the sedentary rats. This indicates that with ageing, a reduction 
in the exercise effects on increasing cardiomyocyte number occurs. This may suggest that the 
juvenile period is a unique stage of development and programing the regenerative capacity of 
the heart for later life. In comparison to the study by Waring et al. (2015), the present study 
found that cardiomyocyte number was not significantly increased with endurance exercise 
during the adolescent period of life. However, the possibility cannot be ruled out that a sample 
size of eight rats per group in the present study was not sufficient to detect the much smaller 
(approximately 15%) increase in cardiomyocyte number in the adolescent exercise rats 
compared to the significant increase found in the juvenile exercise group (36%).  
While in recent years the potential of cardiomyocytes to proliferate in response to endurance 
exercise has been shown (Bostrom et al. 2010; Waring et al. 2015; Waring et al. 2012), the 
increase in cardiomyocyte number in the juvenile exercise rats of the present study could be 
due to increased proliferation or decreased apoptosis of cardiomyocytes. Wulfsohn et al. (2004) 
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showed that fibers and connective tissue continue to grow in the LV from day 5 after birth until 
young rats of 125 days (Mattfeldt et al. 1987; Wulfsohn et al. 2004). To support these findings, 
it has been shown that physical exercise determines cardiac growth through new cardiomyocyte 
formation and that exercise training activates circulating, as well as resident tissue-specific 
cardiac, stem or progenitor cells (Ellison et al. 2011). The new cardiomyocytes predominantly 
originate from resident endogenous cardiac stem or progenitor cells (Ellison et al. 2013; Hsieh 
et al. 2007; Loffredo et al. 2011). After administration of BrdU to track new cell generation, 
newly formed mononucleated, BrdUpos LV cardiomyocytes appeared with the double staining 
of BrdU in trained rats compared to sedentary rats (Waring et al. 2015). Further investigations 
were made to confirm the presence of these new cardiomyocytes and a subpopulation of 
cycling cardiomyocytes, called Ki67pos (cells that are still in the cell cycle or had recently 
completed cycling) were found as well, and their incidences was higher in the trained rats 
compared to sedentary rats (Waring et al. 2015). Furthermore, BrdUpos LV cardiomyocytes 
were higher than Ki67pos LV cardiomyocytes with exercise training (Waring et al. 2015), with 
the increments in number of both of these cells implying an increase in cardiomyocyte number. 
However, the period of detraining lost the increase in Ki67pos cells (Waring et al. 2015) which 
suggests that exercise was the stimulus for the formation of Ki67pos cells and once the training 
was stopped, the increase was lost. Given the sustained increase of cardiomyocyte number in 
the juvenile exercise group (detrained for 15 weeks) in the present study and the reported loss 
of cardiomyocyte number and decrease in Ki67pos cells in trained adolescent rats (detrained for 
weeks) by Waring et al. (2015), it could be suggested that the juvenile exercise may have a 
sustained increase in Ki67pos cells. Therefore, it could be a future direction to detect the 
formation and increase in the Ki67pos number. 
To compare and support the findings of the present study in the juvenile exercise group with 
that of humans, cardiomyocyte proliferation is shown to contribute to developmental heart 
growth in young humans. It has been shown in humans that between the first year and age 20, 
the number of cardiomyocytes in the LV increases 3.4-fold due to cell cycle activity (Mollova 
et al. 2013). The percentages of cardiomyocytes in mitosis and cytokinesis were reported to be 
highest in infants, decreasing to low levels by 20 years of age (Mollova et al. 2013). A similar 
finding of increasing cardiomyocyte number is reported in rats (Wulfsohn et al. 2004). 
Although cardiomyocyte mitosis is detectable throughout life, cardiomyocyte cytokinesis was 
not evident after 20 years of age in humans that may suggest myocardium may have 
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regenerative capabilities in children and adolescents (Mollova et al. 2013). Exercise increases 
certain key growth activating factors which stimulates c-kitpos eCSCs and enhances 
multiplication and differentiation of cardiomyocyte and endothelial lineage (Waring et al. 
2012). However, these changes were lost with detraining and eCSCs return to normal 
homeostasis. Waring et al. (2015) suggested that 4 weeks of detraining reversed the training 
induced adaptations such as capillarisation and proliferation of cardiomyocytes, this may have 
important implications for physical inactivity as being a major risk factor for CVD and HF. 
Perhaps as Waring et al. (2015) suggested, it would bring more insight to these findings if a 
second period of training and detraining was employed to investigate the heart muscle for 
changes in the formation of cardiac cells. As the present study did not investigate the cell 
cycling of the newly formed cells in detail, future studies are now required to confirm the 
increase in cardiomyocyte number in the juvenile trained rats was due to increased 
proliferation, perhaps by examining changes in the population of BrdUpos LV cardiomyocytes 
and Ki67pos cardiomyocytes. 
4.5.2 Cardiomyocyte nuclearity increased with endurance exercise 
Another novel finding of this study was that the juvenile and adolescent exercise groups 
increased the percentage of mononucleated cardiomyocytes at 24 weeks of age. At 9 weeks of 
age following juvenile exercise, the proportion of mononucleated cardiomyocytes was double 
that of sedentary rats (14% vs 7%) and binucleated cardiomyocytes was lowered (86% vs 92% 
respectively) compared to the sedentary group. Furthermore, by 24 weeks of age, the 
proportion of binucleated cardiomyocytes in the juvenile exercise group remained significantly 
lower (89% vs 94% respectively) and mononucleated cardiomyocytes were significantly higher 
in comparison with the sedentary group (11% vs 6%). These findings demonstrate that juvenile 
exercise induces long-term changes in the proportion of mono and binucleated cardiomyocytes 
which could be due to increased proliferation. As discussed in the previous section (4.5.1), 
juvenile exercise group had a significantly higher cardiomyocyte number compared to other 
groups which could be due to this increase in the number of mononucleated cardiomyocytes. 
To support this, recent studies reported that a small number of cardiomyocytes can complete 
mitosis at postnatal or adult stages in both rodents and humans (Bersell et al. 2009; Eulalio et 
al. 2012; Mollova et al. 2013; Senyo et al. 2014). In the postnatal life of rats, hyperplasia 
continues in the first few weeks with only a small proportion of binucleated cardiomyocytes at 
birth (Corstius et al. 2005). Mononucleated cells are proliferative, whereas binucleated cells 
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exit the cell cycle and no longer proliferate in early postnatal life (Paradis et al. 2014). It has 
been demonstrated that mononucleated cardiomyocytes are more likely to undergo cytokinesis 
than binucleated myocytes (Matz et al. 1998). By measuring mitosis in mono and binucleated 
cardiomyocytes in newts and recording the process of mitosis with time-lapse video 
microscopy, Matz et al. (1998) revealed that mononucleated cardiomyocytes produced 
mononucleated daughter cells in 80% of the cases, while 20% were single, binucleated 
cardiomyocytes. Only 32% of binucleated cardiomyocytes underwent complete cytokinesis to 
produce two binucleated daughter cells and resulted in 68% variably in nucleated myocytes 
(Matz et al. 1998). Mono- and binucleated cardiomyocytes that underwent mitosis, had a 
similar time interval for the period from the breakdown of nuclear material (prometaphase) to 
the start of anaphase, but the period between anaphase and midbody formation was 
significantly shorter in binucleated than in mononucleated myocytes. This present study found 
a comparatively lower number of binucleated cardiomyocytes and increased the proportion of 
mononucleated cardiomyocytes which may have led to increased cardiomyocyte number in the 
juvenile exercise group. To support this, in cultured binculeated cardiomyocytes, mitosis 
resulted into variably nucleated daughter cells, while monoucleated cardiomyocytes produced 
predominantly mononucleated daughter cells (Matz et al. 1998). Certainly, given the findings 
in this study, it is possible that the increased population of mononucleated cells in the juvenile 
exercise group might be capable of proliferating postnatally or, have recently undergone 
proliferation, perhaps due to the endurance training. However, there may be some difference 
in the percentage of mono- versus binucleated cardiomyocytes between species (Clubb et al. 
1984; Olivetti et al. 1996; Schmid et al. 1985; Soonpaa et al. 1996) which may account for 
some of the differences in potential for cell cycle entry that have been reported across studies.  
 
There are two possible outcomes for a mononucleated cardiomyocyte that duplicates its DNA 
(Thornburg et al. 2011). It may undergo cytokinesis and completion, yielding two 
mononucleated daughter cardiomyocytes or it may form a binucleated cell with approximately 
twice the volume of a mononucleated cardiomyocyte. Such a binucleated cell rarely enters the 
cell cycle (Thornburg et al. 2011). In first few days of the neonatal life of mammals, 
cardiomyocytes experience division cycling phases of karyokinesis (nuclear division) which is 
immediately followed by cytokinesis (cell division), and then again by karyokinesis without 
cytokinesis (also known as acytokinetic mitosis or endoreduplication) which leads to the 
formation of binucleated cardiomyocytes (Li et al. 1997; Soonpaa et al. 1996; Zebrowski et al. 
2013). Cardiomyocyte binucleation and ploidy are natural outcomes of postnatal 
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cardiomyocyte proliferation events (Zebrowski and Engel, 2013). Cardiomyocyte hypertrophy, 
polyploidy, binucleation and cell cycle withdrawal are all due to changes in the differentiated 
state of adult cardiomyocytes (Ahuja et al. 2007; Naqvi et al. 2014; Zebrowski et al. 2013). In 
order to divide, dedifferentiated cardiomyocyte disassemble their sarcomeres (Yahalom-Ronen 
et al. 2015). The cardiac regeneration in neonatal mice and zebra fish accompanied by the loss 
of sarcomeric structures and re-acquisition of division of cell, attributed to cardiomyocyte 
dedifferentiation (Jopling et al. 2010; Porrello et al. 2011). Thus, in future studies, it would be 
worth assessing the ultrastructural features of cardiomyocytes in the juvenile, adolescent and 
adult exercise group to measure the phenotype of the myofilaments (and thus maturity) of the 
mononucleated cardiomyocytes by using electron microscopy. The present study however, did 
not measure the ploidy, terminal differentiation or proliferation as this would require an 
additional cohort of rats and therefore, it could be a future direction to employ these 
measurements towards the findings of this present study. 
It is likely that upon reaching terminal differentiation (complete withdrawal of cardiomyocyte 
from cell cycle), binucleated cardiomyocytes are incapable of further proliferation as this 
would compromise their contractile function (Naqvi et al. 2014). Alternatively, mononucleated 
cardiomyocytes may also be terminally differentiated but have remained mononucleated. 
Terminal differentiation of mammalian cardiomyocytes appears to activate various cell cycle 
checkpoints so that even if there is a stimulus to divide, cell division is prevented (Herget et al. 
1997; Soonpaa et al. 1997a; Soonpaa et al. 1996; Soonpaa et al. 1997b). To define the 
developmental cues that may lead to terminal differentiation, the role for the c-kit in 
cardiomyocyte terminal differentiation is important and has been studied (Naqvi et al. 2014). 
This study did not incorporate BrdU to assess whether the increase in number of 
cardiomyocytes following juvenile exercise is due to newly formed cardiomyocytes via 
proliferation. Therefore, future research should aim to confirm the relative importance of 
proliferation in such increases in cardiomyocyte number detected. 
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4.5.3 Relevance of cardiomyocyte proliferation or apoptosis to the findings of juvenile 
exercise induced changes 
Cardiomyocyte number represents a balance between cardiomyocyte renewal (proliferation 
and differentiation) and loss (apoptosis). The central dogma relating to postnatal 
cardiomyocyte growth is that cardiomyocytes have limited capacity to proliferate after birth. 
Although cardiomyocytes do divide following birth, their proliferative capacity is markedly 
reduced (Beltrami et al. 2001). However, recent studies have shown that a few weeks of 
endurance training increases cardiomyocyte proliferation in rodent hearts (Bostrom et al. 2010; 
Waring et al. 2015; Waring et al. 2012). Therefore, as discussed in this thesis, it is highly likely 
that the 40% increased cardiomyocyte number by juvenile exercise training in the present study 
is at least partly due to cardiomyocyte proliferation. There are three possible pathways for the 
generation of new cardiomyocytes and these include the division of already existing mature 
cardiomyocytes (Kajstura et al. 1998), progenitor cells differentiation (Hsieh et al. 2007) and 
dedifferentiated cardiomyocyte amplification (Jopling et al. 2010; Kikuchi et al. 2010). Cell 
cycle regulators are differentially expressed within the mononucleate versus binucleate state. 
Cardiomyocytes exit the cell cycle as they become binucleated and as such are terminally 
differentiated. Cell cycle phases include gap phase 1 (G1), synthesis phase (S), gap phase 2 
(G2) and mitosis (M). The G0 phase provides an exit route from the cell cycle in which the 
cells remain in an indefinite quiescent state (Paradis et al. 2014). Molecules that determine the 
rate of growth and proliferation include cyclin-dependent kinases (CDKs) and their inhibitors 
(CDKIs). CDKs promote the cell cycle whereas CDKIs are known to inhibit the cell cycle 
(Brooks et al. 1998). In rodents, cardiomyocyte transition occurs during the first two weeks of 
postnatal life. The majority of cardiomyocyte are binucleated by postnatal day 7 (Li et al. 1996). 
The remaining cardiomyocyte are mononucleated and it is perhaps those that have the capacity 
to proliferate and increase cardiomyocyte number with training. Actin, myosin and myomesin 
in mitotic cardiomyocytes help to make the contractile ring which is required cytokinesis 
(Ahuja et al. 2004; Li et al. 1997; Miller 2011). Changes in the organization and distribution 
of actin, myosin and myomesin affects the process of cytokinesis (Ahuja et al. 2004; Li et al. 
1997; Miller 2011). With the enzymatic isolation of cardiomyocytes by using anti-myomesin, 
phalloidin and isoform-specific anti-myosin, the actin-myosin contractile ring was reformed in 
the binucleation process of cardiomyocytes (Ahuja et al. 2004; Li et al. 1997). The mitosis 
process was similar in all phases and only sarcomeric myosin and myomesin were partially 
disassembled. It was concluded that molecules that are involved in later stages of cytokinesis 
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could be responsible for incomplete cytokinesis during binucleation process (Li et al. 1997). 
Potential sources of the proliferating cardiomyocytes in an adult heart could be due to post-
mitotic terminally differentiated cardiomyocytes that can enter cell cycle and are able to divide 
(Care et al. 2007), cardiomyocyte growth from HSCs (hematopoietic stem cells) (Leri et al. 
2014), or dedifferentiation of cardiomyocytes (Ogawa et al. 1992). Proliferation could occur 
by the constitution of the progeny of CSCs (cardiac stem cells) or due to the combination of all 
these mechanisms (Leri et al. 2014). In the present study, the increased number of 
cardiomyocytes in the juvenile exercise group could be due to already existing cells, stem cells 
or due to apoptosis is unknown however, given the evidence of proliferation and increased cell 
cycle activity in the cardiomyocytes of adolescent trained rats (Bostrom et al. 2010; Waring et 
al. 2015), the cardiomyocyte in juvenile life may have a higher cell cycle activity and they are 
more likely to proliferate. The labelling experiments by using tritiated thymidine or BrdU 
indicates the number of cardiomyocytes entering cell cycle in the heart (Ahuja et al. 2007). Rb 
(Retinoblastoma susceptibility gene (Rb)) proteins is identified to play a critical role in 
regulating cell cycle exit and that deleting Rb prior to myogenic differentiation resulted in a 
severe defect in differentiation and apoptosis (Ahuja et al. 2007). IGF-1 and MAPK regulates 
cardiomyocyte proliferation and growth in response to diverse developmental signals (Ahuja 
et al. 2007). Cyclin B1-CDC2 and knock down of p21/p27 are shown to increase cell cycle 
activity of cardiomyocytes (BICKNELL et al. 2004; Di Stefano et al. 2011). Video microscopic 
documentation of cultured cradiomyocytes is helpful in understanding the cell cycle activities 
(Senyo et al. 2014). To investigate the processes of cytokinesis and karyokinesis in relation 
with exercise trainings in the juvenile exercise groups, it would be worth employing these 
techniques for future research. 
Cardiomyocyte number represents a balance between cardiomyocyte renewal (proliferation 
and differentiation) and loss (apoptosis). Apoptosis is considered an important mechanism 
during heart development (Poelmann et al. 2005). During embryogenesis, the importance of 
cardiomyocyte apoptosis has been well documented but there isn’t much documentation about 
the role of apoptosis in late gestation and early postnatal life. In this study, the increased number 
of cardiomyocytes in the juvenile exercise group could also be due to changes in apoptosis. 
Waring et al. (2012) assessed apoptosis in the cardiomyocytes of trained rats and only a single 
apoptotic cardiomyocyte nuclei was detected in the heart of one rat in the high intensity trained 
group. Hence, Waring et al. (2012), showed that apoptosis does not trigger the new myocyte 
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formation during exercise training and therefore, the juvenile exercise group in the present 
study may not have apoptotic cardiomyocytes. However, apoptosis is an important homeostatic 
phenomenon and therefore studies are required to measure both proliferation and apoptosis in 
the cardiomyocytes of the juvenile trained hearts. 
4.5.4 Cardiomyocyte size: cross sectional and longitudinal area increases with 
endurance exercise  
At 24 weeks of age, juvenile, adolescent and adult exercise increased cardiomyocyte 
hypertrophy, However, there were distinct differences between the exercise groups, with 
juvenile and adult exercise increasing both cross sectional (CSA) and longitudinal area (LA), 
whereas adolescent exercise only increased LA. A number of studies have reported exercise-
induced cardiomyocyte hypertrophy in rats (Anversa et al. 1982; Hoydal et al. 2007; Moore et 
al. 1993; Wisloff et al. 2002; Wisloff et al. 2001). Furthermore, endurance exercise improves 
cardiomyocyte volume, length and width, which are required for improved cardiac 
performance (Natali et al. 2001). The present study detected an increase in the CSA and LA of 
cardiomyocytes in the juvenile exercise group at 9 weeks of age (12% and 16%, respectively) 
in comparison with sedentary rats. Consistent with the findings of previous studies (Kemi et 
al. 2002; Kolwicz et al. 2009; Waring et al. 2015; Wisloff et al. 2001), hypertrophy of 
cardiomyocytes in the adult heart via an increase in both CSA and LA is expected in rats who 
have recently completed endurance training, such as the adult exercise group in the present 
study. Indeed, previous studies have shown endurance exercise increases cardiomyocyte LA 
and CSA in adolescent and adult rats with moderate exercise training of 4 to 12 weeks (Kemi 
et al. 2002; Kolwicz et al. 2009; Waring et al. 2015; Wisloff et al. 2009). Similarly, despite the 
loss or a decrease in the exercise induced changes including angiogenesis (increased density of 
capillaries), new cardiomyocyte formation including both BrdUpos and Ki67pos (Waring et al. 
2015), a prescursor-product relationship between CD45neg eCSCs and c-kitpos eCSC activation 
and proliferation, and newly formed differentiated cell progeny in the adolescent rats (Bostrom 
et al. 2010; Ellison et al. 2013; van Berlo et al. 2014; Waring et al. 2012). Waring et al. (2015) 
found a hypertrophic response as the newly formed cells, BrdUpos cardiomyocytes were larger 
in both trained and detrained adolescent rats. Hence, it is suggestive that exercise induces 
cardiomyocyte hypertrophy and given the findings in the present study, juvenile as well as 
adolescent exercise hypertrophied the cardiomyocytes. 
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The present study measured the LA of the mono- and binucleated cardiomyocytes in the LV of 
the exercised trained groups. However, the most common approach in the field is to assess 
cardiomyocyte dimensions to measure the CSA of the cardiomyocyte (Bensley et al. 2010; 
Campbell et al. 1991; Sorenson et al. 1985). However, there are limitations with the use of 
CSA as this measurement is around the short axis of the cardiomyocyte represents only a 2-
dimensional picture of a 3-dimensional cell. Also, it ignores the length of the cardiomyocyte 
which can vary considerably within the same heart (Bensley et al. 2010; Campbell et al. 1991; 
Sorenson et al. 1985). Hence, the present study only measured the LA and not the CSA, for the 
mononucleated and binucleated cells. At 9 weeks of age there was no difference in the LA of 
the mononucleated cardiomyocytes, but there was an 18% increase in the LA of binucleated 
cardiomyocyte in the juvenile exercised group compared to the sedentary group. This suggests 
that the mononucleated cardiomyocytes have a relatively normal size and that even if they are 
newly formed, they have not undergone hypertrophy. In contrast, it may be the existing 
binucleated cardiomyocytes that have undergone cardiomyocyte hypertrophy. Indeed, given 
approximately 90% of cardiomyocytes are binucleated, the increased CSA and LA that was 
initially measured in all cardiomyocytes, prior to them being classified according to nuclearity 
is mostly in the binucleated cardiomyocytes. This also suggests that the juvenile exercise does 
induce hypertrophy however, it is mostly due to hypertrophy of the binucleated 
cardiomyocytes. Although juvenile exercise increased the number of mononucleated 
cardiomyocytes, this occurred without any increase in mononucleated LA, suggesting that there 
was little hypertrophy in these fibers. However, juvenile exercise did induce hypertrophy in 
binucleated fibers, as evidenced by a significant increase in the binucleated LA, which was 
maintained into adulthood. Thus, juvenile exercise training leads to an increase in heart mass 
and LV wall thickness in adulthood via an increase in the number of mononucleated 
cardiomyocytes and also by hypertrophy of existing binucleated cardiomyocytes. A schematic 
illustration of the impact of juvenile, adolescent and adult life exercise is shown in figure 4.1. 
Adolescent trained rats increased LA in both mononucleated and binucleated fibers. The 
juvenile and adult exercise groups however, increased only the LA of binucleated fibers. 
Adolescent exercise also led to a sustained increase in the proportion of mononucleated 
cardiomyocytes into adulthood. However, unlike the juvenile exercise rats, these 
mononucleated cardiomyocytes underwent hypertrophy, as evidenced by an increase in LA. 
This finding could be related to the investigations reported Waring et al. (2015), whose data 
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showed in adolescent rats that the newly formed cardiomyocytes as a result of endurance 
training have an increased diameter and thus underwent some hypertrophy (Waring et al. 2015). 
Therefore, it appears that adolescent exercise leads to a sustained increase in heart mass and 
wall thickness in adulthood due to an increase in both the number and size of mononucleated 
cardiomyocytes and also by hypertrophy of existing binucleated cardiomyocytes. In contrast, 
adult exercise only increased the size of existing binucleated cardiomyocytes. It is unclear why 
the LA of mononucleated cardiomyocytes in the adolescent group underwent hypertrophy at 
24 weeks of age but juvenile exercise rats did not. One reason could be that the present study 
assessed the size of cardiomyocytes using CSA and LA measurements of cardiomyocytes, 
which is different to what Waring et al. (2015) reported in their adolescent trained rats. Perhaps, 
the timings of measurements made this difference as Waring et al. (2015) measured the 
cardiomyocyte after 4weeks of detraining, while the present study measured after 9 weeks of 
detraining. 
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Figure 4.1: A schematic presentation of results 
Schematic illustration of the impact of short-term endurance training in the juvenile, adolescent 
and adult life on the adult heart. 
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4.6 COX activity increased in the heart with endurance exercise 
 
COX plays an important role in cellular energy transformation in the mitochondrial respiratory 
chain (Taanman 1997). In the present study, COX activity significantly increased following 
juvenile exercise at 9 week of age. However, this increase was not maintained through to 24 
weeks of age. Adult exercise also increased COX activity in 24 week old hearts compared to 
the juvenile exercise and sedentary groups. These results are in line with previous studies that 
also reported an increase in COX activity in the heart when measured a few hours to a couple 
of days after the last bout of training in rats (Freimann et al. 2005; Hüttemann et al. 2012; Tate 
et al. 1996; van Breda et al. 1992). The fact that COX did not remain elevated in the hearts of 
the 24 weeks old juvenile exercise group suggests that the adaptation of this key mitochondrial 
protein to exercise is unlike cardiomyocyte number, not programmable but likely returns to 
pretraining levels in the 15 week period of detraining. 
  
Page | 145  
 
4.7 Cardiac gene expression and endurance exercise 
4.7.1 Physiological genes and endurance exercise  
Endurance training increases the expression of genes involved in the regulation of cardiac 
growth and development, including gata4, nkx2.5, foxo1 and myh6 (Bostrom et al. 2010; 
Diffee et al. 2003; Friddle et al. 2000). However, juvenile and adult exercise training did not 
change the expression of gata4, nkx2.5, foxo1 and myh6 either at 9 or 24 weeks of age in the 
present study. The findings are in conflict with several studies showing increases in cardiac 
gata4, foxo1 and nkx2.5 with endurance training in rodents (Akazawa et al. 2003; Bisping et 
al. 2006; Iemitsu et al. 2006; Jin et al. 2001; Kikuchi et al. 2010). In cardiomyocytes, gata4 
regulates the transcription of nppa, nppb, nkx2.5 (Evans et al. 1995; Warren et al. 2011), α- 
and β-myosin heavy chain composition and hence, it is essential for important adaptive 
responses such as cardiomyocyte survival, hypertrophy in response to pressure overload and 
exercise, and protection against ischemic insult (Bisping et al. 2006; Liang et al. 2001; Suzuki 
et al. 2004). gata4 is a proliferative marker as investigated in the regeneration of heart in 
zebrafish (Kikuchi et al. 2010). C/EBPβ controls gata4 expression by binding to SRF and 
sequestering from the direct binding to gata4 and α-mhc promoters. The reduction in C/EBPβ 
in the zebrafish embryo induced significant proliferation of cardiomyocytes (Akazawa et al. 
2003). Similarly, C/EBPβ downregulated with exercise training in mice and, this reduction led 
to increased proliferation and physiological hypertrophy of cardiomyocytes (Bostrom et al. 
2010). gata4 levels markedly reduce during pathological conditions as marked reduction in the 
expression of gata4 is reported in failing rat hearts (Kobayashi et al. 2007; Oka et al. 2006). 
The present study did not find an increased expression of gata4, nkx2.5 and myh6, however it 
was not reduced and therefore these result indicates no pathological events in the hearts of the 
exercise groups. However, it would be worth examining genes like C/EBPβ and CITED4 which 
are not measured in the present study and were reported earlier to be involved in cardiomyocyte 
proliferation (Bostrom et al. 2010). The findings of unchanged expression of foxo1 in the 
present study can be supported by some earlier findings. Over the last decade, foxo1 proteins 
appeared to modulate cardiomyocyte proliferation during development and, is believed to 
negatively regulate cardiomyocyte growth as the overexpression of foxo1 blocks 
cardiomyocyte proliferation but expression of dominant negative foxo1 leads to enhanced 
cardiomyocyte growth (Evans-Anderson et al. 2008; Hannenhalli et al. 2006) both in human 
as well as murine models of cardiac failure. Also, activated foxo1 suppress angiogenesis in 
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endothelial cells and inhibit excessive growth in cardio-myocytes (Cavalcante et al. 2011). 
foxo1 expression increased the activation of AKT-eNOS and Ref-1 in aorta of rats with 
resistance exercise training (Qi et al. 2014). Similarly, resistance exercise decreased foxo1 
phosphorylation but did not affect foxo1 expression which indicated that resistance exercise 
may inhibit foxo1 translocation from the nucleus into the cytosol (Li et al. 2015). Increased 
expression of foxo1 results in decreased cardiomyocyte cell size and activation of autophagic 
vacuole formation and autophagy pathway gene expression (Sengupta et al. 2009). In addition, 
using dominant negative foxo1 adenovirus, foxo1 activity is shown to be required to regulate 
the cell size in rat neonatal cardiomyocytes (Sengupta et al. 2009). Sengupta et al. (2009) found 
that an increase in the foxo1 expression reduces cardiomyocyte cell size and activates the 
autophagic pathway by activating phagocytic formation of vacuoles and they showed that by 
using adenovirus (dominant negative foxo1), the cardiomyocyte size can be regulated by foxo1 
activation in rats. However, foxo1 gene expression did not change in the present study in 
exercise rats. Perhaps, foxo1 is more expressive in pathophysiological models as discussed 
above.  Fathi (2016) trained adolescent rats on a motorised treadmill for 14 weeks to investigate 
the effect of moderate endurance activity on the expression of myh6. They performed the 
analysis 48 hours after the last bout of exercise and reported a significant increased expression 
of myh6 in the adult heart of trained rat compared to controls. The authors concluded that the 
increase in myh6 was responsible for the increase in heart contractility power.  Similarly, high 
intensity exercise training in rats are reported with an increase expression of myh6 but not with 
low to moderate intensity exercise (Rocha et al. 2012). One of the reason could be that the 
exercise training period in the present study was only 4 weeks and the exercise mode was 
moderate so based on the above discussion, the duration was not long and intensity was not 
high enough to increase the expression level of myh6. 
Endurance training also increases the expression of genes in the heart involved in the regulation 
of cardiomyocyte cell cycle, structure and metabolism, such as Actb, ckm, spp1 and coxIV 
(Wadley et al. 2016). However, the present study did not find any change in the expression of 
these genes either at 9 or 24 weeks of age except for coxIV. The results could be supported by 
a previous study of Golden et al. (1994), exercise did not induce significant changes in ckm 
(isozyme including CK-MB and CK-BB) expression after 2 and 10 months of swim training in 
WKY rats, (Golden et al. 1994). Actb and spp1 was increased in our previous investigation 
(Wadley et al. 2016) but did not change in the present study. However, coxIV increased 
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expression in both studies but only in the adult exercise group and not in the juvenile exercise 
group ((Wadley et al. 2016). To support the findings of coxIV, Freimann et al. (2005) showed 
that COX nuclear and mitochondrial encoded subunits and COX mRNAs were highly 
expressed in exercise trained hearts by array analysis (Freimann et al. 2005). In this study, 
juvenile exercise increased mRNA levels of coxIV at 9 and 24 week of age compared to the 
adult exercise and sedentary groups. The findings are supported by earlier findings of increased 
expression of coxIV in trained rats at adulthood, despite being trained on a motorized treadmill 
for a few weeks (Kemi et al. 2007). It is also confirmed with the findings of COX activity in 
the present study discussed previously in section 4.6 which suggest that there is no decrement 
in the enzyme activity with age in the juvenile exercise group.  
Another reason to explain a lack of effect of exercise in many of the genes measured is that 
studies in both heart and skeletal muscle showed that some genes upregulated within 3 hours 
of finishing exercise but return to baseline levels within 24 hours of exercise, whilst other genes 
do not increase expression until after several days or a few weeks of training (Perry et al. 2010; 
Radom-Aizik et al. 2009; Stepto et al. 2012). Most of the exercise responsive genes examined 
in the present study have been shown by other investigators to be elevated 24-48 hours after 
exercise (Akazawa et al. 2003; Gluckman et al. 2009; Liang et al. 2001; Wadley et al. 2016; 
Zhang et al. 2010). However, the present study found changes in the expression levels of coxIV, 
nppa and nppb and not in the other genes of interest. Perhaps, sampling the hearts 48 hours 
after last bout of exercise might not have allowed, presumably, the detection of earlier events 
in the response to juvenile and adult exercise that could have matched the findings with 
previous studies in the literature. Hence, it would be worth examining the changes in gene 
expression a few hours after the last bout of exercise in both juvenile and adult exercise groups. 
4.7.2 Pathological genes and endurance exercise  
Pathological hypertrophy induces increased expression of fetal genes including nppa and nppb 
(Jin et al. 2001; Suo et al. 2002). At 9 weeks of age, there was a decrease in nppa, but an 
increase in the expression of mRNA expression of nppb . A large 6.1-fold upregulation of nppa 
and nppb mRNA expression may occur in response to pathological hypertrophy (Chien et al. 
1991; Kong et al. 2005). However, the expression of nppa and nppb were not differentially 
expressed by 24 weeks of age in any of the group, which is similar to the findings of earlier 
studies reported in the adult heart. Azizi et al. (1995) did not detect a change in ventricular 
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nppa gene expression in run-trained adult rats. Consistent with another investigation, Iemitsu 
et al. (2001) analysed the expression of important cardiac genes in both pathological and 
physiological models of hypertrophy. The level of nppb was found to be significantly elevated 
in pathological cardiac hypertrophic rats, but not control or swim-trained physiological 
hypertrophic rats (Iemitsu et al. 2001). The findings in this thesis are consistent with previous 
studies that have investigated the expression of nppa and nppb in physiological and 
pathological cardiac hypertrophy (Chien et al. 1991; Iemitsu et al. 2001; Jin et al. 2000; Kong 
et al. 2005). There are several other fetal genes including myh7, foxo3, murf1 that were not 
explored. However, since nppa and nppb were not increased at 24 weeks of age, there was no 
need to measure the other pathological genes. Given pathological hypertrophy is associated 
with an upregulation of nppa and nppb and that fibrosis and cardiac function were also not 
reduced in the current model, these findings suggest that the increased heart mass investigated 
following juvenile and adult exercise was physiological and not pathological hypertrophy. 
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4.8 miRNAs and endurance exercise 
4.8.1 miRNA-1 and 133b 
miRNA-1, and miRNA-133, are key regulators of cardiac hypertrophy (Care et al. 2007). In 
the current study, juvenile exercise significantly reduced miRNA-1 and increased miRNA-
133b at 9 weeks of age, which suggests a potential role for these miRNA species in exercise-
induced cardiac hypertrophy at adulthood. Consistent with the findings of this study, 
Ramasamy et al. (2015) and Care et al. (2007) also found a down regulation of miRNA-1 and 
an up regulation of miR133b (Ramasamy et al. 2015) in the hearts of adolescent trained rats. 
A similar downregulation of cardiac miRNA-1 was reported by another rodent exercise study 
(Soci et al. 2011) however, in contrast to the findings of the present study, miR133b was 
lowered with exercise training in trained rodents (Soci et al. 2011). The reason for the different 
results could be that the mode of exercise was swimming and the investigations by (Soci et al. 
2011) were made in female rats who performed high intensity exercise. miRNA-133b 
expression is inversely related to cardiac hypertrophy and sarcomere organisation (Care et al. 
2007). The downregulation of miR133b is reported to be involved in the development of 
apoptosis, fibrosis and prolongation of the QT interval (Abdellatif 2010). Both miRNA-1 and 
miRNA-133b targets the insulin-like growth factor (IGF-1), which is considered as an 
important modulator of growth, survival and differentiation (Gielen et al. 2010; Soci et al. 
2011). Ramasamy et al. (2015) indicated a regulatory mechanism for the decreased expression 
of miRNA-1 and upregulation of miRNA-133 following endurance training (Ramasamy et al. 
2015). This also indicates that miRNA-1, being antihypertrophic, was downregulated at 9 
weeks of age which may have allowed for increased expression of IGF-1 and the structural 
hypertrophy of heart in the trained hearts of the juvenile at 24 weeks of age. To support this, 
miRNA-1 is reported to downregulate at the onset of pressure/volume overload on the heart 
that appears to be sufficient to account for the changes in gene expression underlying the 
initiation and progression of physiological cardiac hypertrophy (Sayed et al. 2007). 
Unexpectedly, miRNA-1 was increased in the 24 weeks old hearts following adult exercise and 
not juvenile exercise group. The reasons are unclear and have not been reported previously in 
adult male rats. miRNA-1 targets the IGF-1 pathway which plays an important role in heart 
development (Chen et al. 2006; Liu et al. 2008; Malizia et al. 2011; Wystub et al. 2013). It is 
well known that IGF-1 is upregulated following exercise and has been implicated in myocardial 
hypertrophy (Catalucci et al. 2008). In mice, IGF-1 myocardial expression is reported to 
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modulate the eCSC survival and function, preventing eCSC ageing and cardiac dysfunction 
(Torella et al. 2004). IGF-1 is a modulator of growth, survival and differentiation (Loya et al. 
2009) , and is demonstrated to boost cardiac repair and regeneration in a porcine model of 
myocardial infarction via intracoronary injection of small doses of IGF-1 (Ellison et al. 2011). 
Given these findings, further study of the IGF1-1 pathway is now warranted to examine if it is 
upregulated by juvenile exercise. 
4.8.2 miRNA-30e 
The current study did not observe any significant changes in miRNA-30e expression for any 
of the study groups at 9 or 24 weeks of age. Ramasamy et al. (2015) detected a down regulation 
of miRNA-30e in cardiomyocytes following endurance training, which in turn is though to 
promote myocardial hypertrophy through excessive autophagy. This finding was considered 
logical as during pathological hypertrophy, the downregulated expression of miRNA-30 family 
activates pathways of apoptosis, calcium signaling and autophagy (Ramasamy et al. 2015). 
Ramasamy et al. (2015) made the observations in swim-trained adolescent rats and which is 
different to the rats and training model used in the current study. Nevertheless, the lack of 
change in miRNA-30e expression by juvenile training at 9 weeks of age suggests that miRNA-
30e is not involved in the sustained increase of cardiomyocyte number or heart mass in the 
present study. 
4.8.3 miRNA-99b, miRNA-125b and miRNA-204 
miRNA-99b, miRNA-125b and miRNA-204 are reported to play important roles in cell 
differentiation, proliferation and chromatin remodeling (Chaudhuri et al. 2011; Cui et al. 2012; 
Fernandes et al. 2015b; Kim et al. 2012; Turcatel et al. 2012; Wang et al. 2014; Xiao et al. 
2012). miRNA-99b is considered to target the same pathways that primarily regulate the 
proliferation and death of the cell via PI3K/Akt/mTOR and MAPK in the rat heart (Ramasamy 
et al. 2015). miRNA-99b is also significantly up regulated in the hearts of swim-trained 
adolescent rats (Ramasamy et al. 2015). In contrast, this study did not observe any altered 
expression of miRNA-99b and miRNA-125b with juvenile or adult exercise training at 24 
weeks of age. miRNA-125b is considered a cardio-miR, which helps to protect the heart from 
ischemia reperfusion injury and also prevents the cardiomyocyte apoptosis (Wang et al. 2014). 
Also, miR-125b is considered as critical for the induction of fibrosis in heart and acts as a 
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potent repressor of multiple anti-fibrotic mechanisms (Nagpal et al. 2016). In humans, a 
decrease in miRNA-125b was reported in trained human heart which was downregulated by 
pro-inflammatory factors including LPS and TNF-α, respectively (Radom-Aizik et al. 2010). 
miR-125b is shown to induce cardiac fibrosis in both human heart and murine models. It has 
been recently found that miR-125b inhibits p53 to induce fibroblast proliferation (Nagpal et al. 
2016). In vivo silencing of miR-125b by reduced Angiotensin II-induced perivascular and 
interstitial fibrosis (Nagpal et al. 2016). RNA-sequencing analysis established that miR-125b 
alters the gene expression profiles of the key fibrosis-related genes and is a core component of 
fibrogenesis in the heart (Nagpal et al. 2016). Using a combination of in vitro and in 
vivo studies, Nagpal et al. (2016) found miR-125b to be a novel regulator of cardiac fibrosis, 
proliferation and differentiation of cardiac fibroblasts (Nagpal et al. 2016). The present study 
measured the levels of interestitial and perivascular fibrosis as well as the media to lumen ratio 
but did not find any significant difference for the exercise groups compared to the sedentary 
group. Given the present study did not find any fibrosis in any of the exercise group, the 
expression level of miRNA-125b was not altered. miRNA-204 regulates cardiomyocyte 
proliferation via the Jarid2 signaling pathway in rat hearts (Liang et al. 2015) and miRNA-204 
is significantly increased in cardiac hypertrophy following endurance exercise in the adolescent 
rat heart (Ramasamy et al. 2015). However, the expression of miRNA-99b, miRNA-125b and 
miRNA-204 expression was not altered in trained rats at 9 or 24 weeks of age. Therefore 
miRNA-99b, miR125b and miRNA-204 do not appear to be involved in the sustained increases 
in heart mass and cardiomyocyte number following juvenile exercise in the current study. 
4.8.4 miRNA-208b and miRNA-222 
miRNA-208b is cardiac specific (Callis et al. 2009; van Rooij et al. 2009) and is necessary for 
the induction of cardiomyocyte hypertrophy (Callis et al. 2009). At 9 weeks of age, juvenile 
exercise did not alter the expression of miRNA-208b and miRNA-222. However, at 24weeks 
of age both miRNA-208b and miRNA-222 were significantly downregulated following adult 
exercise. The findings of miRNA-208b are similar with a recent study who reported that high 
intensity swim training induce physiological hypertrophy by decreasing the expression of 
miRNA-208b (Soci et al. 2016). The downregulation of miRNA208b increased the expression 
of the target genes including SP3, Sox6 and PurB and modulating the ratio of α- and β-MHC. 
Soci et al. (2016) suggested that inhibition of miRNA-208 may increase the the expression of 
targeted proteins and thus stimulate the contractile and epigenetic interaction. The function of 
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miRNA-222 in the heart is believed to increase the α/β ratio of myosin heavy chain, as well as 
decrease the expression of mRNAs including nppa and nppb (Liu et al. 2015). In response to 
exercise, miRNA-222 is reported to be upregulated in mice and is necessary for the short-term 
growth of the heart and cardiomyocyte proliferation (Liu et al. 2015). This study however, did 
not observe any change in miRNA-222 expression following juvenile exercise at 9 weeks of 
age. This would suggest that miRNA-222 is not involved in regulating the sustained increases 
in cardiomyocyte number of heart mass following juvenile exercise. However, this study found 
a downregulation of miRNA-222 expression in the 24 weeks old hearts following adult 
exercise. One possible reason for the reduced expression of miRNA-222 in the adult heart 
comapred to the upregulation reported by (Liu et al. 2015) could be due to the study design. 
The increase in the miRNA-222 expression reported was in mice forced to swim-train in water 
tanks or allowed to run voluntarily (Liu et al. 2015; Taniike et al. 2008), whereas the present 
study used forced running on motorised treadmills. It is also possible there are species 
differences in the miRNA-222 responses to exercise between mice used by (Liu et al. 2015) 
and the rats used in the present study. Also, the hearts were excised 24 hours after the last 
swimming or voluntary running sesssion by (Liu et al. 2015), whereas the present study 
samples were collected 48 hours after the last bout of exercise. Perhaps, miRNA-222 does not 
play the same regulatory role in mice cardiac hypertrophy as it does in rats. Nevertheless, since 
there is no altered expression in juvenile rats at either age, the findings from the present study 
suggest that miRNA-222 is probably not involved in the sustained increase in heart mass and 
cardiomyocyte number following juvenile exercise. 
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CHAPTER 5 Conclusions and future direction 
Recently, Wadley et al. (2016) published the novel finding that  heart mass in adult rats aged 
24 weeks increased by approximately 10% when they were endurance trained in their juvenile 
life (at 5-9 weeks of age) despite them remaining sedentary thereafter. The findings were 
concluded to be physiological LV hypertrophy as there was no evidence of the development of 
hypertension in adult life. However, changes in heart structure and function were not examined 
in the study by Wadley et al. (2016) and these analyses are required in order to understand how 
the short-term endurance exercise in early life might exert sustained effects on the heart. 
Therefore, the overall aim of this thesis was to examine the impact of exercise performed in 
juvenile life on the adult heart structure, function, morphology, gene and miRNA expression. 
The main findings from the present study were that juvenile exercise led to increased heart 
mass in adulthood, with thicker LV walls, normal LV chamber size and normal cardiac 
function. Furthermore, the increase in heart mass in adulthood following juvenile exercise 
appears due to a sustained increase in the number of both mononucleated and binucleated 
cardiomyocytes and also to hypertrophy of binucleated cardiomyocytes. 
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5.1 Endurance exercise induced changes in heart structure and 
function 
Increased cardiac mass measured during adulthood was a result of a significant thickening of 
the interventricular septum and the LV posterior wall after endurance exercise training with 
juvenile exercise. Such adaptations are well documented in the rat and human heart following 
endurance exercise (Baggish et al. 2008; Bocalini et al. 2010; Pluim et al. 2000; Spence et al. 
2011; Waring et al. 2012). This increase in wall thickness was accompanied by a dilation of 
the LV in systole, which is not in agreement with previous findings (Baggish et al. 2008; 
Bocalini et al. 2010; Jin et al. 2000; Pluim et al. 2000; Waring et al. 2012; Weiner et al. 2012). 
Despite significant increases in LV mass and LV wall thickness, EF and FS were not 
significantly enhanced with exercise in the juvenile and adult exercise groups. EF was however, 
significantly lowered, albeit within the normal range in the adolescent exercise group compared 
to sedentary rats. Following juvenile, adolescent and adult exercise training, heart mass, LV 
posterior and relative wall thicknesses significantly increased which suggest concentric 
hypertrophy in all exercise trained groups by 24 weeks of age. This might be contrary to the 
concept of developing eccentric hypertrophy with endurance training. However, long-term 
endurance training in humans suggests that concentric cardiac hypertrophy occurs prior to 
eccentric hypertrophy (Arbab-Zadeh et al. 2014). Therefore, it is possible that a much longer 
training period, such as several weeks or a few months, is required to develop eccentric 
hypertrophy in the exercise rats of the present study. 
Juvenile exercise increased resting CO at 9 weeks of age which was sustained at 24 weeks of 
age with no changes in SV, EF, FAC and a small but significant reduction in FS with juvenile 
exercise that still remained within the normal healthy range. The adolescent exercise group had 
an increased CO, no changes in SV, FAC, FS and a significant increase in EF that still remained 
within the normal healthy range. The adult exercise group had no changes in SV, FAC, EF and 
in exception with an increased FS and decreased CO but again they were in the normal range. 
The present study approached 2D-Doppler echocardiography imaging to derive information 
about SV and CO. These parameters are relevant for systolic LV function and were calculated 
from the velocity time integral (VTI), which represents the total flow of blood across the 
specific site of the sample volume over time (Domanski et al. 1992) and the cross-section of 
the LV outflow tract measured from the parasternal long-axis view. However, to draw clear 
conclusions about the heart having improved or impaired function, it is important to apply 
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further measurements to investigate the systolic function in detail. For example, to assess the 
global systolic function and the regional differences of strain and the components of strain 
(longitudinal, circumferential and radial). For LV regional function, the E/A ratio (the ratio of 
the velocity of early (E) to late (A) ventricular filling) measured which is a marker of the LV 
function and is determined with Doppler echocardiography. Regional function is commonly 
assessed by dividing the LV into 17 segments (Thomas et al. 2006). The present study 
measured heart contractility only in the PSAX and PLAX views of the heart. There are 
however, methods which are reported to be more reliable to measure the myocardial 
contractility (Mor-Avi et al. 2011; Spence et al. 2013) by using information of filling velocities, 
the segmental and global longitudinal and global straining in another view of the heart such as 
apical four chamber view with the help of tissue Doppler imaging (Gottdiener et al. 1990) and 
speckle tracking echocardiography (STE) (Aaron et al. 2011). These methods allow the various 
components of contraction (radial, longitudinal and circumferential) to be studied, and provide 
detailed information on global and regional systolic function (Mor-Avi et al. 2011; Spence et 
al. 2013; Thomas et al. 2006; Woodiwiss et al. 1995). A group of rats should be also trained 
during the whole period from 5-9 weeks of age for a comprehensive and clear comparison of 
exercise induced changes with different life stages including juvenile and adolescence and 
adulthood. To have a clear idea of exercise induced changes at different time points, it would 
be worth assessing cardiac structure and functional changes using echocardiography for 
multiple times during the whole period of training and detraining. 
To further investigate the cardiovascular function in a future study, it would be worth 
measuring the VO2 max of rats in adult life. Although juvenile exercise did not lead to 
improvements in resting cardiac function, a more relevant functional measurement is VO2 max. 
This may help to understand heart function under exercise conditions and thus if juvenile 
exercise, in addition to sustained increased in heart mass and structure also leads to sustained 
improvements in heart function. VO2 max is one of the strongest predictors of all-cause 
mortality in humans (Lee et al. 2010; Rivera et al. 1999; Scribbans et al. 2016). Enhanced O2 
delivery and utilization during exercise improves mitochondrial respiration and subsequently 
the capacity for endurance exercise (Burton et al. 2004). Also VO2 max is one of the most 
important predictors of endurance exercise performance (Arbab-Zadeh et al. 2014; Bostrom et 
al. 2010; Fernandes et al. 2015b; Garland et al. 2011; Obert et al. 2003; Scribbans et al. 2016; 
Waring et al. 2015). The assessment of maximal O2 uptake was beyond the scope of this thesis 
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and not initially a priority however given the current findings and its importance as a predictor 
of health, future studies are now warranted to assess if juvenile exercise can lead to sustained 
improvements in maximal cardiac function in adulthood.  
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5.2 Endurance exercise-induced changes in cardiomyocyte 
The major finding of this study was that juvenile exercise significantly increased the number 
and proportion of mononucleated cardiomyocytes. The source of newly formed 
cardiomyocytes is a hot debate in the field with the observation of a very small number of new 
cycling cardiomyocytes as the product of already existed cardiomyocytes (Senyo et al. 2014). 
New cardiomyocytes are reported to predominantly originate from resident endogenous 
progenitor or cardiac stem cells (Ellison et al. 2011; Hsieh et al. 2007). Exercise training is a 
stimulus for hypertrophic growth for the newly formed BrdU-positive cardiomyocytes, which 
leads to improved maturation (Waring et al. 2012). This proliferation could be due to cardiac 
stem cells. It is believed that cardiac stem cells transiently reside within the adult heart (Leri et 
al. 2014; Nadal-Ginard et al. 2014) and stem cells comprise a small population of 
cardiomyocytes (Anversa et al. 2006; Bernal et al. 2013; Leri et al. 2014). The increase in 
mononucleated cardiomyocytes following juvenile exercise in the present study is likely due 
to increased cardiomyocyte proliferation but it is not clear as it was not directly measured. 
Given the increase in mononucleated cardiomyocytes following both juvenile and adolescent 
exercise, it is possible that this population of mononucleated cells are capable of proliferating 
postnatally (Thornburg et al. 2011; Zhang et al. 2010) as evidenced previously with exercise 
training (Bostrom et al. 2010; Ellison et al. 2012; Waring et al. 2012). In contrast, it is likely 
that upon reaching terminal differentiation, binucleated cardiomyocytes are incapable of 
further proliferation as this would compromise their contractile function. Alternatively, 
mononucleated cardiomyocytes may also be terminally differentiated but have remained 
mononucleated (Paradis et al. 2014; Thornburg et al. 2011). Thus in future studies, it would be 
worth assessing the ultrastructure of cardiomyocytes to measure the phenotype (and thus 
maturity) of the mononucleated cardiomyocytes. 3H-thymidine, Ki67 and BrdU incorporation 
by using confocal microscopic immunofluorescent image analysis BrdU may detect 
proliferation in the cardiomyocytes (Waring et al. 2015). It is possible, but unlikely that the 
increase in cardiomyocyte number in the juvenile group could also be due to reduced apoptosis 
compared to sedentary rats. Increases in cardiomyocyte number have been linked to apoptosis 
(Condorelli et al. 1999; Kwak 2013) so it would be important to investigate the cardiomyocytes 
for markers of apoptosis, necrosis or proliferation in the juvenile exercise group. DNA 
fragmentation assays may help to detect the presence of inter-nucleosomal laddering in the 
genomic DNA, which is the hallmark of apoptosis in cardiomyocytes. The extensive DNA 
fragmentation can be detected using techniques such as DNA ladder assay (agarose gel 
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electrophoresis), terminal deoxynucleotidyl transferase mediated dUTP-biotin nick end 
labeling (TUNEL assay) and comet assays (Chandna 2004; Otsuki 2000). Measurement of cell 
cycle activity could be also a future direction and this can be analysed by employing 
immunostaining against pH3-S10 or Aurora B in cardiac sections (Kajstura et al. 2010; 
Mollova et al. 2013). DNA fragmentation assay using agarose gel electrophoresis is the most 
frequent technique used for the detection of apoptosis and can easily discriminate between 
apoptotic and non-apoptotic (necrotic) modes of cell death, as in most cases the inter-
nucleosomal cleavage of genomic DNA yielding the characteristic DNA ladder is a molecular 
hallmark of apoptotic cells (Pandey et al. 1994; Suman et al. 2012). LSC (laser scanning 
cytometry) is a powerful tool to analyse heterogenous population and subpopulation of 
numerous cells (Henriksen et al. 2011). It has been previously used for quantifying the amount 
of DNA in cardiomyocyte nuclei could also be used (Mollova et al. 2013; Takeuchi 2014) and 
therefore could be effective if employed in future studies for the detection of cardiomyocyte 
nuclei and other newly formed cells. 
Indeed, in addition to changes to nuclearity it is possible that changes to ploidy (number of 
genome copies per nucleus) may also occur in the adult heart (Bensley et al. 2016), however 
as far as can be determined, there is no evidence in the literature that endurance exercise alters 
cardiomyocyte ploidy. The present study was intended to investigate the polidy levels however, 
due to time constraints the present study did not measure ploidy. Assessing cardiomyocyte 
ploidy will provide a greater insight to the changes that occur to the myocardium at the DNA 
level. It is known that increased ploidy levels occur within the human heart in adulthood (Leri 
et al. 2015; Steinhauser et al. 2011). It is proposed that polyploidisation in the contracting 
cardiomyocytes could be an adaptive response which helps to increase the DNA: protein ratio 
without compromising cell function during cellular division (Brodsky et al. 1994; Brodsky et 
al. 1985). Ploidy is also correlated with cardiomyocyte size and mass, and as such increases in 
ploidy are considered to a be a mode of cellular growth (Brodsky et al. 1994). Ploidy 
determination could also be performed by examine the isolated cardiomyocytes using LSC for 
observer-independent quantitative analyses of nuclear DNA content. 
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5.3 Endurance exercise induced changes in gene and miRNA 
expression 
This study investigated the expression of several genes and miRNA species known to be 
involved in the regulation of cardiac growth and metabolism in relation to the effects of juvenile 
exercise. However contrary to the third hypothesis, endurance training during juvenile 
development did not result in a sustained increase in the expression of selected mRNA and 
miRNA species in the heart involved with muscle growth and development. Only the miRNA-
1 and miRNA-133b were significantly up and down regulated respectively, in response to 
juvenile exercise training at 9 weeks of age. Given miRNA-1 and miRNA-133b are altered by 
juvenile exercise, it would be worth investigating them further to explore the direct 
involvement of these species. Perhaps, a rat miRNA-133b knock out model being or miRNA-
1 overexpression model addition to training in the juvenile and adult life could examine if 
manipulating miRNA-1 and miRNA-133b levels during exercise prevents the exercise induced 
changes in the adult heart.  
Several genes have been explored in relation with LVM in previous exercise studies and would 
be worth looking in the juvenile model of the present study. Genes including glycogen synthase 
kinase (GSK)-3beta, calcineurin-inhibitor (Cain), and endothelin (ET)-1, angiotensin-
correcting enzyme (ACE), interleukin-6 and vascular cell adhesion molecule (VCAM)-1 have 
been implicated in pathological and physiological cardiac hypertrophy by using microarray 
analysis at mRNA and protein/peptide levels using quantitative PCR, Western blot and EIA 
(enzyme immunoassay) analyses (Bruel et al. 2002; Catalucci et al. 2008; Iemitsu et al. 2005; 
Matkovich et al. 2009; Torella et al. 2004; Xin et al. 2011). In addition, pathways including 
Akt and IGF-1 have been linked with exercised induced hypertrophy (DeBosch et al. 2006; 
Kawaguchi et al. 2010; Li et al. 2015; McMullen et al. 2004a; McMullen et al. 2004b; Xin et 
al. 2011) and should be explored in future. Perhaps, a microarray would be a better approach 
to investigate the whole genome to generate data for the expressed genes and to investigate the 
molecular pathways that juvenile exercise might be regulating the increase in heart mass, wall 
thicknesses and novel changes in cardiomyocytes. For future analysis of miRNAs, the heat map 
profiling of miRNAs and their target gene expression can be employed by sequencing the small 
RNA to find the differentially expressed miRNAs and, then to select the miRNAs with a higher 
read count would be a more economical approach than focusing on individual miRNA species 
(Ramasamy et al. 2015). 
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5.4 Cardiac capillarisation 
The myocardium is highly vascularised as it is composed of a large number of capillaries. A 
high capillary density helps to meet the O2 requirements of cardiac muscle (Pelster et al. 2003; 
Smith et al. 1979). Exercise training increases the capillary density, dimensions and the 
capillary to myocardial fiber ratio (Medeiro et al. 2008; Pereira et al. 2013; Waring et al. 2015). 
Capillarisation along with cardiomyocyte number has recently been shown to be increased with 
endurance training and maintained with 4 weeks of detraining in adolescent rats (Waring et al. 
2015). The finding of Waring et al. (2015) suggests that endurance training in adolescent, and 
perhaps even juvenile life might therefore be a long term adaptation in the heart (Waring et al. 
2015). Therefore, immunohistochemical analysis of capillarisation is required in future studies 
to examine if juvenile exercise leads to long term increases in cardiac vascularisation. 
5.5 Investigation of endurance training in female rats  
The present study only examined male rats. However, it is well established that there are 
important differences between males and females in cardiac morphology, function, and disease 
progression, both in humans and animal models (Du et al. 2006; Leinwand 2003). In animal 
studies, heart weights were found similar in both male and females however, stroke volume 
and myocardial O2 consumption were significantly higher in male exercised rats compared to 
sedentary controls, whereas these variables were almost identical in sedentary and exercised 
female rats (Kemi et al. 2002). Both in humans and rats, females have been found to exhibit 
eccentric remodeling in response to endurance and resistance training much earlier in a training 
program compared to males (Du et al. 2006; La Gerche et al. 2012). Given the interpretation 
of results from the present study is limited to male rats only, future studies are now required in 
female rats so that the findings can be translated to the entire population. 
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SIGNIFICANCE OF THE STUDY TO HUMAN HEALTH 
Humans are not programmed to be physically inactive (Lees et al. 2004). Indeed, the “sedentary 
death syndrome” is a major risk factor for numerous worldwide diseases and millions of 
premature deaths each year (Leeson et al. 2001). It has been shown that long-lived species are 
more efficient in cellular homeostasis than short-lived species, suggesting that enhancement of 
the homeostatic maintenance may slow with aging (Lees et al. 2004). About two thirds of the 
major causes of death are lifestyle-related and the major “actual causes of death” are “physical 
inactivity” (Knight 2012; Mokdad et al. 2004). Physical inactivity is an important risk factor 
for the development of CVD, particularly CHD, heart failure and stroke. Heart disease is not a 
major cause of death among children and teenagers, but it is the largest cause of death among 
adults. The findings of the present study demonstrate that the physiological cardiac adaptation 
produced by four weeks of juvenile exercise training persist into adulthood, and may protect 
against cardiovascular disease in later life.  
Cardiovascular as well as ischemic heart diseases are linked to physical inactivity (Hamer et 
al. 2009; Talbot et al. ; Talbot et al. 2002). It has been recently reported in humans that aerobic 
fitness in adolescent life is associated with a lower risk of myocardial infarction (MI) in adult 
life (Högström et al. 2014). Given the novel findings of the juvenile exercise on the adult heart, 
it could be suggested that juvenile life exercise has more benefits to the heart in later life. The 
importance of the present study is to implement the cardiovascular physiological adaptations 
in children with endurance exercise training. Hence, it might be possible to increase 
cardiovascular fitness in children through endurance exercise training to potentially program 
their heart with an increased mass and structure into adulthood even if they stay sedentary in 
later years. Endurance exercise has benefits for heart health at any age however the significance 
of this project for human health is that should these findings translate into humans, it would 
mean that regular physical activity during childhood could result in improved adult heart 
health, even if people were sedentary during adulthood. Importantly, childhood represents a 
stage in life in which government intervention in physical activity levels is more feasible than 
during adulthood. For example, the amount and type of physical activity could be mandated by 
changes to the school curriculum. The outcomes from this thesis if translated into the 
community could mean that short-term, practical public health interventions in childhood could 
perhaps improve adult heart health and reduce the burden of disease on the health system. 
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APPENDICE-1 
 
 
Optimization for r18s 
 
 
 
Well Well Name Well Comment Assay Ct (dR) 
A1 r18s 1:10 SYBR 8.81 
A2 r18s 1:20 SYBR 10.4 
A3 r18s 1:40 SYBR 10.94 
A4 r18s 1:80 SYBR 12.45 
A5 r18s 1:160 SYBR 13.44 
A6 r18s NTC SYBR 33.54 
 
Well Comment: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 
1:20, 1:40, 1:80 and 1:160 in water. 
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Optimization for gata4 
 
 
 
Well Well Name Well Comment Assay Ct (dR) 
A1 gata4 1:10 SYBR 21.95 
A2 gata4 1:20 SYBR 23.69 
A3 gata4 1:40 SYBR 24.25 
A4 gata4 1:80 SYBR 25.28 
A5 gata4 1:160 SYBR 27.81 
A6 gata4 NTC SYBR No Ct 
 
NTC: Non Template Control 
Well Comment: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 
1:20, 1:40, 1:80 and 1:160 in water. 
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Optimization for foxo1 
 
 
 
Well Well Name Well Comment Assay Ct (dR) 
A1 foxo1 1:10 SYBR 23.24 
A2 foxo1 1:20 SYBR 24.27 
A3 foxo1 1:40 SYBR 25.18 
A4 foxo1 1:80 SYBR 26.31 
A5 foxo1 1:160 SYBR 27.91 
A6 foxo1 NTC SYBR No Ct 
 
NTC: Non Template Control 
Well Comment: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 
1:20, 1:40, 1:80 and 1:160 in water. 
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Optimization for myh6 
 
 
 
Well Well Name Well Comment Assay Ct (dR) 
A1 myh6 1:10 SYBR 15.24 
A2 myh6 1:20 SYBR 15.86 
A3 myh6 1:40 SYBR 17.26 
A4 myh6 1:80 SYBR 18.37 
A5 myh6 1:160 SYBR 19.72 
A6 myh6 NTC SYBR 34.47 
 
Well Comment: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 
1:20, 1:40, 1:80 and 1:160 in water. 
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Optimization for nkx2.5 
 
 
 
Well Well Name Well Comment Assay Ct (dR) 
A1 nkx 2.5 1:10 SYBR 21.72 
A2 nkx 2.5 1:20 SYBR 22.33 
A3 nkx 2.5 1:40 SYBR 23.38 
A4 nkx 2.5 1:80 SYBR 24.32 
A5 nkx 2.5 1:160 SYBR 25.68 
A6 nkx 2.5 NTC SYBR No Ct 
 
NTC: Non Template Control 
Well Comment: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 
1:20, 1:40, 1:80 and 1:160 in water. 
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Optimization for nppa 
 
 
 
Well Well Name Well Comment Assay Ct (dR) 
A1 nppa 1:10 SYBR 18.14 
A2 nppa 1:20 SYBR 18.76 
A3 nppa 1:40 SYBR 19.37 
A4 nppa 1:80 SYBR 20.96 
A5 nppa 1:160 SYBR 22.18 
A6 nppa NTC SYBR No Ct 
 
NTC: Non Template Control 
Well Comment: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 
1:20, 1:40, 1:80 and 1:160 in water. 
  
Page | 208  
 
 
Optimization for nppb 
 
 
 
Well Well Name Well Comment Assay Ct (dR) 
A1 nppb 1:10 SYBR 18.48 
A2 nppb 1:20 SYBR 18.74 
A3 nppb 1:40 SYBR 19.84 
A4 nppb 1:80 SYBR 20.74 
A5 nppb 1:160 SYBR 22.13 
A6 nppb NTC SYBR No Ct 
 
NTC: Non Template Control 
Well Comment: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 
1:20, 1:40, 1:80 and 1:160 in water. 
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Optimization for U6 
 
 
 
Well Well Name Assay Ct (dR) 
 
A1 U6 1:10 FAM 19.58 
 
A2 U6 1:20 FAM 20.89 
 
A3 U6 1:40 FAM 21.78 
 
A4 U6 1:80 FAM 22.66 
 
A5 U6 NTC FAM 33.45 
 
 
Well Name: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 1:20, 
1:40 and 1:80 in water. 
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Optimization for miRNA-1 
 
 
 
Well Well Name Assay Ct (dR) 
A1 miR1 1:10 FAM 19.73 
A2 miR1 1:20 FAM 20.27 
A3 miR1 1:40 FAM 21.37 
A4 miR1 1:80 FAM 22.5 
A5 miR1 NTC FAM 35.94 
 
NTC: Non Template Control 
Well Name: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 1:20, 
1:40 and 1:80 in water. 
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Optimization for miRNA-30e 
 
 
 
Well Well Name Assay Ct (dR) 
A1 miR30e 1:10 FAM 21.12 
A2 miR30e 1:20 FAM 22.44 
A3 miR30e 1:40 FAM 23.23 
A4 miR30e 1:80 FAM 24.44 
A5 miR30e NTC FAM No Ct 
 
NTC: Non Template Control 
Well Name: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 1:20, 
1:40 and 1:80 in water. 
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Optimization for miRNA-99b 
 
 
 
Well Well Name Assay Ct (dR) 
A1 miR99b 1:10 FAM 26.79 
A2 miR99b 12:0 FAM 27.96 
A3 miR99b 1:40 FAM 29.2 
A4 miR99b 1:80 FAM 30.24 
A5 miR99b NTC FAM No Ct 
 
NTC: Non Template Control 
Well Name: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 1:20, 
1:40 and 1:80 in water. 
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Optimization for miRNA-125b 
 
 
 
Well Well Name Assay Ct (dR) 
A1 miR125b 1:10 FAM 28.91 
A2 miR125b 1:20 FAM 29.88 
A3 miR125b 1:40 FAM 30.89 
A4 miR125b 1:80 FAM 31.81 
A5 miR125b NTC FAM No Ct 
 
NTC: Non Template Control 
Well Name: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 1:20, 
1:40 and 1:80 in water.  
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Optimization for miRNA-133b 
 
 
 
Well Well Name Assay Ct (dR) 
A1 miR133b 1:10 FAM 19.7 
A2 miR133b 1:20 FAM 20.74 
A3 miR133b 1:40 FAM 21.66 
A4 miR133b 1:80 FAM 22.59 
A5 miR133b 1: NTC FAM 38.2 
 
Well Name: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 1:20, 
1:40 and 1:80 in water. 
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Optimization for miRNA-204 
 
 
 
Well Well Name Assay Ct (dR) 
A1 miR204 1:10 FAM 30.42 
A2 miR204 1:20 FAM 31.25 
A3 miR204 1:40 FAM 32.06 
A4 miR204 1:80 FAM 33.76 
A5 miR204 NTC FAM No Ct 
 
NTC: Non Template Control 
Well Name: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 1:20, 
1:40 and 1:80 in water. 
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Optimization for miRNA-208b 
 
 
 
Well Well Name Assay Ct (dR) 
A1 miR208b 1:10 FAM 33.14 
A2 miR208b 1:20 FAM 34.44 
A3 miR208b 1:40 FAM 35.37 
A4 miR208b 1:80 FAM 36.95 
A5 miR208b NTC FAM No Ct 
 
NTC: Non Template Control 
Well Name: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 1:20, 
1:40 and 1:80 in water. 
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Optimization for miRNA-222 
 
 
 
Well Well Name Assay Ct (dR) 
A1 miR222 1:10 FAM 25.62 
A2 miR222 1:20 FAM 26.25 
A3 miR222 1:40 FAM 27.37 
A4 miR222 1:80 FAM 28.46 
A5 miR222 NTC FAM No Ct 
 
NTC: Non Template Control 
Well Name: PCR was performed on a serial dilution of a cDNA sample, diluted 1:10, 1:20, 
1:40 and 1:80 in water. 
